Category	Term	Count	%	PValue	Genes	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
GOTERM_BP_FAT	GO:0009605~response to external stimulus	42	28.965517241379313	1.3378514154545496E-8	33963_AT, 33684_AT, 35648_AT, 33284_AT, 34467_G_AT, 35367_AT, 1910_S_AT, 39469_S_AT, 37061_AT, 37711_AT, 32073_AT, 679_AT, 822_S_AT, 37983_AT, 39698_AT, 31506_S_AT, 39094_AT, 33979_AT, 1974_S_AT, 32439_AT, 38604_AT, 38236_AT, 37454_AT, 31793_AT, 35595_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 32250_AT, 1901_S_AT, 37172_AT, 36766_AT, 34623_AT, 34546_AT, 31512_AT, 37096_AT, 36703_AT, 34720_AT, 40317_AT, 1419_G_AT, 40790_AT, 1372_AT, 37105_AT, 36436_AT	133	2073	16650	2.536369868230634	4.2382235070470564E-5	4.2382235070470564E-5	2.4236504259089742E-5
GOTERM_CC_FAT	GO:0005615~extracellular space	35	24.137931034482758	3.2722709173079216E-8	33963_AT, 33530_AT, 33684_AT, 33284_AT, 31525_S_AT, 35915_AT, 35367_AT, 37061_AT, 679_AT, 35090_G_AT, 34012_AT, 35091_AT, 34618_AT, 31506_S_AT, 33979_AT, 38604_AT, 37454_AT, 31793_AT, 38691_S_AT, 1403_S_AT, 33516_AT, 32250_AT, 37905_R_AT, 34623_AT, 37172_AT, 1645_AT, 1786_AT, 34546_AT, 31512_AT, 37096_AT, 36703_AT, 1890_AT, 37898_R_AT, 31687_F_AT, 2090_I_AT, 1372_AT, 37105_AT, 36436_AT	126	1444	14527	2.794513696522007	9.914931899279722E-6	9.914931899279722E-6	4.379376248309086E-5
GOTERM_BP_FAT	GO:0044364~disruption of cells of other organism	7	4.827586206896552	1.1249480421271596E-7	33963_AT, 37096_AT, 679_AT, 31793_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 34623_AT, 34546_AT	133	30	16650	29.210526315789473	3.5632006283115025E-4	1.781759047421172E-4	2.037953132583148E-4
GOTERM_BP_FAT	GO:0031640~killing of cells of other organism	7	4.827586206896552	1.1249480421271596E-7	33963_AT, 37096_AT, 679_AT, 31793_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 34623_AT, 34546_AT	133	30	16650	29.210526315789473	3.5632006283115025E-4	1.781759047421172E-4	2.037953132583148E-4
GOTERM_BP_FAT	GO:0050832~defense response to fungus	7	4.827586206896552	5.830340515594731E-7	37096_AT, 679_AT, 38604_AT, 31793_AT, 33284_AT, 31506_S_AT, 37105_AT, 34623_AT, 34546_AT	133	39	16650	22.469635627530362	0.0018453476623351284	6.154946433777342E-4	0.0010562188139218165
GAD_DISEASE_CLASS	IMMUNE	50	34.48275862068966	1.668299115130059E-6	38646_S_AT, 35648_AT, 33284_AT, 37968_AT, 37711_AT, 1575_AT, 33979_AT, 1974_S_AT, 40350_AT, 37454_AT, 34636_AT, 32418_AT, 1403_S_AT, 32250_AT, 37905_R_AT, 36766_AT, 37172_AT, 1786_AT, 34546_AT, 34972_S_AT, 31512_AT, 919_AT, 40790_AT, 40294_AT, 1372_AT, 36436_AT, 966_AT, 33684_AT, 36317_AT, 31525_S_AT, 35367_AT, 35373_AT, 37061_AT, 1910_S_AT, 37983_AT, 35121_AT, 34618_AT, 37953_S_AT, 32439_AT, 38604_AT, 38691_S_AT, 38229_AT, 32084_AT, 967_G_AT, 1331_S_AT, 34623_AT, 36328_AT, 40317_AT, 1419_G_AT, 32279_AT, 37166_AT	115	2986	12971	1.8886688604793385	3.002895824222307E-5	3.002895824222307E-5	0.0012297352297241382
GOTERM_BP_FAT	GO:0009620~response to fungus	7	4.827586206896552	3.7463384397141595E-6	37096_AT, 679_AT, 38604_AT, 31793_AT, 33284_AT, 31506_S_AT, 37105_AT, 34623_AT, 34546_AT	133	53	16650	16.53426017874876	0.011798270488431517	0.0029627080946680318	0.00678664653221972
GAD_DISEASE_CLASS	UNKNOWN	32	22.06896551724138	1.5592428321044298E-5	35038_AT, 38646_S_AT, 31621_S_AT, 33284_AT, 31525_S_AT, 34467_G_AT, 1355_G_AT, 1910_S_AT, 37983_AT, 34249_AT, 1575_AT, 37953_S_AT, 33979_AT, 1974_S_AT, 38604_AT, 34636_AT, 38691_S_AT, 38229_AT, 32084_AT, 1403_S_AT, 32250_AT, 1901_S_AT, 37172_AT, 36766_AT, 1645_AT, 37096_AT, 36328_AT, 31687_F_AT, 37097_AT, 1419_G_AT, 32279_AT, 39187_AT	115	1613	12971	2.2376452195476966	2.806265149275511E-4	1.4032310275036153E-4	0.011492967746351557
GOTERM_BP_FAT	GO:0010941~regulation of cell death	29	20.0	1.6259862401049466E-5	33963_AT, 32717_AT, 33284_AT, 31525_S_AT, 35915_AT, 35367_AT, 1355_G_AT, 35373_AT, 38128_AT, 1910_S_AT, 37711_AT, 32073_AT, 822_S_AT, 33293_AT, 34618_AT, 41280_R_AT, 1974_S_AT, 38236_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 35069_AT, 1786_AT, 40271_AT, 38482_AT, 1890_AT, 31687_F_AT, 40317_AT, 1983_AT	133	1509	16650	2.405865558528528	0.05020742741346107	0.010249445323056161	0.029452256915474262
GAD_DISEASE	null	23	15.862068965517242	1.825962600184972E-5	35038_AT, 1974_S_AT, 38604_AT, 31621_S_AT, 38229_AT, 38691_S_AT, 33284_AT, 32084_AT, 1403_S_AT, 32250_AT, 34467_G_AT, 1331_S_AT, 1355_G_AT, 1901_S_AT, 1910_S_AT, 37061_AT, 37172_AT, 37983_AT, 1575_AT, 37097_AT, 1419_G_AT, 31687_F_AT, 39187_AT	115	936	12971	2.771581196581197	0.02971474903735405	0.02971474903735405	0.03068873943956607
GOTERM_BP_FAT	GO:0060548~negative regulation of cell death	21	14.482758620689657	2.587164780577567E-5	33963_AT, 1974_S_AT, 33284_AT, 1403_S_AT, 41489_AT, 35367_AT, 35069_AT, 1355_G_AT, 38128_AT, 35373_AT, 37711_AT, 1910_S_AT, 1786_AT, 32073_AT, 33293_AT, 40271_AT, 34618_AT, 38482_AT, 40317_AT, 41280_R_AT, 1983_AT	133	897	16650	2.9308220383735257	0.07869343814422558	0.013567526801491092	0.04685868343391464
GOTERM_BP_FAT	GO:0009617~response to bacterium	16	11.03448275862069	2.7147176376664416E-5	33963_AT, 32439_AT, 38604_AT, 31793_AT, 1403_S_AT, 33284_AT, 1331_S_AT, 37711_AT, 37061_AT, 34623_AT, 34546_AT, 31512_AT, 37096_AT, 679_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 33979_AT	133	544	16650	3.6819991154356475	0.08240890891178809	0.012211035923905489	0.049168381866981914
GOTERM_BP_FAT	GO:0035821~modification of morphology or physiology of other organism	8	5.517241379310345	3.0456043894852696E-5	33963_AT, 37096_AT, 679_AT, 31793_AT, 1403_S_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 34623_AT, 34546_AT	133	112	16650	8.941997851772287	0.09197758663294398	0.011988337392235593	0.05515976963781366
GOTERM_BP_FAT	GO:0001906~cell killing	8	5.517241379310345	3.0456043894852696E-5	33963_AT, 37096_AT, 679_AT, 31793_AT, 1419_G_AT, 37968_AT, 31506_S_AT, 37105_AT, 34623_AT, 34546_AT	133	112	16650	8.941997851772287	0.09197758663294398	0.011988337392235593	0.05515976963781366
GAD_DISEASE_CLASS	OTHER	31	21.379310344827587	3.391778733488214E-5	31621_S_AT, 33284_AT, 31525_S_AT, 1855_AT, 1910_S_AT, 37711_AT, 37983_AT, 34618_AT, 1575_AT, 1391_S_AT, 33922_AT, 1974_S_AT, 38604_AT, 33080_S_AT, 38236_AT, 34636_AT, 38691_S_AT, 38229_AT, 32084_AT, 1403_S_AT, 967_G_AT, 32250_AT, 36378_AT, 1901_S_AT, 36328_AT, 1890_AT, 37898_R_AT, 31687_F_AT, 1419_G_AT, 40790_AT, 34703_F_AT, 966_AT	115	1595	12971	2.1921820907727954	6.103441901698092E-4	2.0348946854509276E-4	0.024998882292415203
GOTERM_BP_FAT	GO:0048584~positive regulation of response to stimulus	34	23.448275862068964	3.748598093271572E-5	33963_AT, 33684_AT, 32717_AT, 35915_AT, 37968_AT, 35367_AT, 40186_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 37711_AT, 679_AT, 822_S_AT, 37983_AT, 34618_AT, 39698_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 38604_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 32250_AT, 1331_S_AT, 1901_S_AT, 37172_AT, 1645_AT, 31512_AT, 37096_AT, 40271_AT, 36703_AT, 1890_AT, 37105_AT	133	2030	16650	2.0967443238638466	0.11197715812197373	0.013108636131952789	0.06788779575548354
GAD_DISEASE_CLASS	NORMALVARIATION	16	11.03448275862069	4.551330568938801E-5	1974_S_AT, 38604_AT, 38229_AT, 1403_S_AT, 32084_AT, 33284_AT, 1331_S_AT, 36766_AT, 37983_AT, 36328_AT, 34618_AT, 1575_AT, 1419_G_AT, 31687_F_AT, 919_AT, 38201_AT	115	517	12971	3.490639979816668	8.189226457948617E-4	2.047935634654774E-4	0.03354404382300835
GOTERM_BP_FAT	GO:0042742~defense response to bacterium	11	7.586206896551724	5.1623465480996084E-5	33963_AT, 31512_AT, 37096_AT, 679_AT, 38604_AT, 31793_AT, 33284_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 34623_AT, 33979_AT, 34546_AT	133	266	16650	5.1769461247102715	0.15087371667425498	0.01622172343282391	0.09347972878605004
GOTERM_BP_FAT	GO:0040011~locomotion	28	19.310344827586206	5.719590226386068E-5	33963_AT, 33530_AT, 32717_AT, 35367_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 37711_AT, 35090_G_AT, 37983_AT, 35091_AT, 31506_S_AT, 38236_AT, 37454_AT, 31793_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 36766_AT, 1786_AT, 34972_S_AT, 37096_AT, 36479_AT, 40271_AT, 36703_AT, 38482_AT, 34720_AT, 919_AT, 1372_AT, 36436_AT	133	1530	16650	2.291021671826625	0.16573301372187887	0.016337954824651946	0.10356535427641367
GOTERM_BP_FAT	GO:0009607~response to biotic stimulus	20	13.793103448275861	5.8285032962302235E-5	33963_AT, 1974_S_AT, 32439_AT, 38604_AT, 35595_AT, 31793_AT, 1403_S_AT, 33284_AT, 1331_S_AT, 37968_AT, 37711_AT, 1910_S_AT, 37061_AT, 34623_AT, 34546_AT, 31512_AT, 37096_AT, 679_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 33979_AT	133	873	16650	2.867994729090768	0.16860674557644184	0.015269911455030427	0.10553647364771601
GAD_DISEASE	Body Weight	14	9.655172413793103	6.221429174141431E-5	38604_AT, 38229_AT, 34467_G_AT, 37968_AT, 35367_AT, 1355_G_AT, 35373_AT, 39469_S_AT, 40271_AT, 35090_G_AT, 35091_AT, 34720_AT, 1575_AT, 40317_AT, 32279_AT	115	410	12971	3.851410392364793	0.09767562605599167	0.050092439263689004	0.10452651025345538
GAD_DISEASE	several psychiatric disorders	12	8.275862068965518	6.351499418324819E-5	38604_AT, 35090_G_AT, 35648_AT, 38236_AT, 37983_AT, 36328_AT, 35091_AT, 1112_G_AT, 1575_AT, 1419_G_AT, 34467_G_AT, 32279_AT, 1355_G_AT	115	299	12971	4.526741311618438	0.09961254500017347	0.03437208575715611	0.10671072922530112
GOTERM_BP_FAT	GO:0042127~regulation of cell proliferation	28	19.310344827586206	7.302933643732888E-5	38646_S_AT, 34629_AT, 32717_AT, 35367_AT, 1355_G_AT, 1855_AT, 1910_S_AT, 37711_AT, 39469_S_AT, 37983_AT, 34618_AT, 39511_AT, 1974_S_AT, 33080_S_AT, 1403_S_AT, 1331_S_AT, 35069_AT, 1901_S_AT, 35439_AT, 1645_AT, 37172_AT, 37096_AT, 36479_AT, 38482_AT, 34720_AT, 1419_G_AT, 1983_AT, 39187_AT	133	1552	16650	2.25854584915898	0.2065505024072074	0.017639900159666322	0.13221724231267107
GOTERM_BP_FAT	GO:0043066~negative regulation of apoptotic process	19	13.10344827586207	8.084410334822562E-5	33963_AT, 1974_S_AT, 1403_S_AT, 33284_AT, 41489_AT, 35367_AT, 35069_AT, 1355_G_AT, 38128_AT, 35373_AT, 37711_AT, 1910_S_AT, 1786_AT, 33293_AT, 34618_AT, 38482_AT, 40317_AT, 41280_R_AT, 1983_AT	133	818	16650	2.9077890324834086	0.22595438469254914	0.01812827475888701	0.1463558372784557
GOTERM_BP_FAT	GO:0043069~negative regulation of programmed cell death	19	13.10344827586207	9.57681157778351E-5	33963_AT, 1974_S_AT, 1403_S_AT, 33284_AT, 41489_AT, 35367_AT, 35069_AT, 1355_G_AT, 38128_AT, 35373_AT, 37711_AT, 1910_S_AT, 1786_AT, 33293_AT, 34618_AT, 38482_AT, 40317_AT, 41280_R_AT, 1983_AT	133	829	16650	2.8692055833189727	0.2617021311009248	0.020023997270353533	0.17335133301872307
GAD_DISEASE_CLASS	HEMATOLOGICAL	29	20.0	1.0609334616509244E-4	32717_AT, 33284_AT, 31525_S_AT, 1910_S_AT, 37711_AT, 36713_AT, 33293_AT, 37983_AT, 1575_AT, 39511_AT, 33922_AT, 32680_AT, 38236_AT, 32418_AT, 38229_AT, 32084_AT, 33516_AT, 1403_S_AT, 37172_AT, 33371_S_AT, 37096_AT, 32413_AT, 31687_F_AT, 37097_AT, 1419_G_AT, 40317_AT, 39187_AT, 37166_AT, 34436_AT	115	1528	12971	2.140672661051673	0.0019079590679131897	3.8188337203970413E-4	0.07817742728402077
GOTERM_BP_FAT	GO:0008283~cell proliferation	31	21.379310344827587	1.0851611392755934E-4	38646_S_AT, 33684_AT, 34629_AT, 31621_S_AT, 32717_AT, 35367_AT, 1355_G_AT, 1855_AT, 1910_S_AT, 39469_S_AT, 37711_AT, 34618_AT, 1575_AT, 39511_AT, 1974_S_AT, 38604_AT, 33080_S_AT, 1403_S_AT, 35069_AT, 1901_S_AT, 35439_AT, 37172_AT, 1645_AT, 37096_AT, 36479_AT, 38482_AT, 38816_AT, 34720_AT, 38201_AT, 39187_AT, 1983_AT	133	1861	16650	2.085345012181178	0.2909276432872774	0.021258147828689955	0.19640525602893089
GOTERM_BP_FAT	GO:0019730~antimicrobial humoral response	6	4.137931034482759	1.1176195671366363E-4	33963_AT, 38604_AT, 31793_AT, 31506_S_AT, 34623_AT, 33979_AT, 34546_AT	133	60	16650	12.518796992481201	0.29818234939185695	0.02061292168804607	0.20227434747412953
GOTERM_BP_FAT	GO:0006952~defense response	27	18.620689655172416	1.3150909841106443E-4	33963_AT, 33284_AT, 37968_AT, 35367_AT, 37711_AT, 1910_S_AT, 679_AT, 37983_AT, 31506_S_AT, 39094_AT, 33979_AT, 38604_AT, 34636_AT, 35595_AT, 31793_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 32250_AT, 1331_S_AT, 34623_AT, 34546_AT, 31512_AT, 37096_AT, 36703_AT, 37898_R_AT, 1419_G_AT, 1372_AT, 37105_AT	133	1518	16650	2.22666349668638	0.34074720947721293	0.022881283812759667	0.23797385065079668
GOTERM_BP_FAT	GO:0006959~humoral immune response	10	6.896551724137931	1.6132704625912192E-4	33963_AT, 31512_AT, 38604_AT, 31793_AT, 32250_AT, 31506_S_AT, 37711_AT, 1910_S_AT, 34623_AT, 33979_AT, 34546_AT	133	248	16650	5.047902013097259	0.40017978649472097	0.026542714377776	0.2918568100289676
GAD_DISEASE	kidney failure, chronic	9	6.206896551724138	1.6511984419816269E-4	679_AT, 31621_S_AT, 37983_AT, 38229_AT, 1403_S_AT, 33284_AT, 1575_AT, 35373_AT, 37105_AT, 37172_AT	115	177	12971	5.73515106853353	0.23875536349416526	0.06592647790599426	0.27719307073993393
GAD_DISEASE	lung cancer 	15	10.344827586206897	1.6853500665909852E-4	1974_S_AT, 38229_AT, 34636_AT, 1403_S_AT, 33284_AT, 967_G_AT, 32250_AT, 1901_S_AT, 1910_S_AT, 37096_AT, 36328_AT, 1890_AT, 1575_AT, 1419_G_AT, 37898_R_AT, 966_AT	115	516	12971	3.2788169868554093	0.24303881027145136	0.05416643324980441	0.2829186009173701
GOTERM_CC_FAT	GO:0099503~secretory vesicle	14	9.655172413793103	1.9161119513333644E-4	33963_AT, 38236_AT, 35595_AT, 31793_AT, 38691_S_AT, 33284_AT, 34623_AT, 34546_AT, 679_AT, 37096_AT, 33685_AT, 606_AT, 37898_R_AT, 32279_AT, 31506_S_AT, 37105_AT	126	467	14527	3.4563407090173683	0.056410213175977386	0.02861450143415123	0.2561349249203815
GOTERM_BP_FAT	GO:0001934~positive regulation of protein phosphorylation	19	13.10344827586207	2.314993500276767E-4	33963_AT, 1974_S_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 1983_AT	133	890	16650	2.672552166934189	0.5197626622510256	0.03600940648326456	0.41855422315776325
GOTERM_BP_FAT	GO:0042981~regulation of apoptotic process	25	17.24137931034483	2.461511267285943E-4	33963_AT, 1974_S_AT, 38236_AT, 32717_AT, 33284_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 35915_AT, 35069_AT, 35367_AT, 1355_G_AT, 38128_AT, 35373_AT, 1910_S_AT, 37711_AT, 1786_AT, 33293_AT, 822_S_AT, 38482_AT, 34618_AT, 1890_AT, 40317_AT, 41280_R_AT, 1983_AT	133	1400	16650	2.235499462943072	0.5415494113038731	0.036457061202724406	0.44498907904623186
GOTERM_CC_FAT	GO:0030141~secretory granule	12	8.275862068965518	2.6389166990253377E-4	33963_AT, 38691_S_AT, 31793_AT, 35595_AT, 33284_AT, 34623_AT, 34546_AT, 679_AT, 37096_AT, 33685_AT, 606_AT, 37898_R_AT, 31506_S_AT, 37105_AT	126	358	14527	3.864591646714551	0.07685570872049374	0.026304425496969763	0.35259755912087076
GOTERM_BP_FAT	GO:0043067~regulation of programmed cell death	25	17.24137931034483	2.8239597511721035E-4	33963_AT, 1974_S_AT, 38236_AT, 32717_AT, 33284_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 35915_AT, 35069_AT, 35367_AT, 1355_G_AT, 38128_AT, 35373_AT, 1910_S_AT, 37711_AT, 1786_AT, 33293_AT, 822_S_AT, 38482_AT, 34618_AT, 1890_AT, 40317_AT, 41280_R_AT, 1983_AT	133	1413	16650	2.214932235046214	0.5912930130360502	0.03985480706643363	0.5103538485815573
GOTERM_BP_FAT	GO:0043207~response to external biotic stimulus	18	12.413793103448276	2.9806881480290686E-4	33963_AT, 32439_AT, 38604_AT, 35595_AT, 31793_AT, 1403_S_AT, 33284_AT, 1331_S_AT, 37711_AT, 1910_S_AT, 37061_AT, 34623_AT, 34546_AT, 31512_AT, 37096_AT, 679_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 33979_AT	133	829	16650	2.71819476314429	0.6110960044035012	0.04023024256872465	0.5386060385172087
GOTERM_BP_FAT	GO:0051707~response to other organism	18	12.413793103448276	2.9806881480290686E-4	33963_AT, 32439_AT, 38604_AT, 35595_AT, 31793_AT, 1403_S_AT, 33284_AT, 1331_S_AT, 37711_AT, 1910_S_AT, 37061_AT, 34623_AT, 34546_AT, 31512_AT, 37096_AT, 679_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 33979_AT	133	829	16650	2.71819476314429	0.6110960044035012	0.04023024256872465	0.5386060385172087
GOTERM_BP_FAT	GO:0042327~positive regulation of phosphorylation	19	13.10344827586207	4.038608839780007E-4	33963_AT, 1974_S_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 1983_AT	133	932	16650	2.552115266707541	0.7218764128952659	0.0519238039935338	0.7291108723795903
GOTERM_CC_FAT	GO:0044421~extracellular region part	52	35.86206896551724	4.0895402742556085E-4	38646_S_AT, 31621_S_AT, 33284_AT, 35915_AT, 39908_AT, 35090_G_AT, 35956_S_AT, 36234_AT, 1575_AT, 33979_AT, 37454_AT, 1403_S_AT, 33516_AT, 1112_G_AT, 32250_AT, 37905_R_AT, 37172_AT, 1645_AT, 36766_AT, 1786_AT, 34546_AT, 31512_AT, 37096_AT, 1890_AT, 37898_R_AT, 1372_AT, 37105_AT, 36436_AT, 33963_AT, 33530_AT, 33684_AT, 31525_S_AT, 35367_AT, 37061_AT, 679_AT, 34012_AT, 34618_AT, 35091_AT, 1391_S_AT, 31506_S_AT, 38604_AT, 32680_AT, 38691_S_AT, 31793_AT, 32084_AT, 35169_AT, 36378_AT, 34623_AT, 36703_AT, 36328_AT, 32413_AT, 31687_F_AT, 38508_S_AT, 2090_I_AT, 37166_AT	126	3878	14527	1.5459695310133679	0.1165657541363031	0.030509500422501667	0.5459315843431067
GOTERM_BP_FAT	GO:0042493~response to drug	12	8.275862068965518	4.3312540685712945E-4	1974_S_AT, 38236_AT, 32084_AT, 967_G_AT, 37172_AT, 1910_S_AT, 37711_AT, 1575_AT, 1419_G_AT, 919_AT, 32279_AT, 34436_AT, 966_AT	133	411	16650	3.6551232094835626	0.7465119328338687	0.053417871322453236	0.7817479934364546
GAD_DISEASE	Depression	8	5.517241379310345	4.464147713014251E-4	1974_S_AT, 38604_AT, 37983_AT, 40058_S_AT, 1575_AT, 40790_AT, 32279_AT, 1355_G_AT	115	156	12971	5.7841694537346715	0.5217596561969061	0.11568355439495426	0.7477502494042998
GOTERM_MF_FAT	GO:0005102~receptor binding	25	17.24137931034483	4.5607676127340605E-4	38646_S_AT, 33684_AT, 35915_AT, 37968_AT, 35373_AT, 1855_AT, 35090_G_AT, 37983_AT, 35091_AT, 34618_AT, 936_S_AT, 40350_AT, 1974_S_AT, 38604_AT, 37454_AT, 1403_S_AT, 35169_AT, 1901_S_AT, 1645_AT, 31512_AT, 36703_AT, 38816_AT, 1890_AT, 1419_G_AT, 919_AT, 2090_I_AT	124	1462	15478	2.1344490534398304	0.22966933038702053	0.22966933038702053	0.6671019743115014
GOTERM_BP_FAT	GO:0006955~immune response	26	17.93103448275862	4.571760353681422E-4	33963_AT, 33530_AT, 37968_AT, 35367_AT, 35373_AT, 1910_S_AT, 37711_AT, 37061_AT, 679_AT, 31506_S_AT, 33979_AT, 38604_AT, 34636_AT, 35595_AT, 31793_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 32250_AT, 1331_S_AT, 37905_R_AT, 34623_AT, 34546_AT, 31512_AT, 37096_AT, 36703_AT, 1419_G_AT, 37105_AT	133	1551	16650	2.0985733191780223	0.765116316854251	0.05419406998382026	0.8249873146155995
GOTERM_CC_FAT	GO:0005766~primary lysosome	4	2.7586206896551726	4.6177022018587395E-4	33963_AT, 31793_AT, 33284_AT, 31506_S_AT, 34546_AT	126	18	14527	25.620811287477952	0.1305971577922056	0.02760165474564369	0.6162369233436826
GOTERM_CC_FAT	GO:0042582~azurophil granule	4	2.7586206896551726	4.6177022018587395E-4	33963_AT, 31793_AT, 33284_AT, 31506_S_AT, 34546_AT	126	18	14527	25.620811287477952	0.1305971577922056	0.02760165474564369	0.6162369233436826
GAD_DISEASE_CLASS	RENAL	26	17.93103448275862	4.85127659560544E-4	31621_S_AT, 33284_AT, 34467_G_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 679_AT, 37983_AT, 40058_S_AT, 34618_AT, 1575_AT, 1974_S_AT, 40350_AT, 38604_AT, 38229_AT, 1403_S_AT, 32084_AT, 32250_AT, 1901_S_AT, 37172_AT, 1786_AT, 36328_AT, 1419_G_AT, 37097_AT, 1983_AT, 37105_AT, 34436_AT	115	1417	12971	2.0695652173913044	0.008696382495556043	0.0014546770463176317	0.3570466255366389
GAD_DISEASE	HIV	9	6.206896551724138	4.914337182904843E-4	33963_AT, 679_AT, 37454_AT, 38229_AT, 1403_S_AT, 1575_AT, 1419_G_AT, 35373_AT, 37105_AT, 34546_AT	115	208	12971	4.880392976588629	0.5560520942653152	0.10953088952171453	0.8228649354144024
GOTERM_BP_FAT	GO:0023056~positive regulation of signaling	26	17.93103448275862	5.126369223283085E-4	33684_AT, 32717_AT, 35915_AT, 1355_G_AT, 40186_AT, 35373_AT, 1910_S_AT, 37711_AT, 822_S_AT, 34618_AT, 41280_R_AT, 936_S_AT, 39094_AT, 1974_S_AT, 32680_AT, 38236_AT, 37454_AT, 34636_AT, 1403_S_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 37096_AT, 40271_AT, 36703_AT, 1890_AT	133	1563	16650	2.082461431890667	0.8029800294616634	0.05839067672296483	0.9246295823831296
GOTERM_BP_FAT	GO:0098542~defense response to other organism	13	8.96551724137931	5.657956241746412E-4	33963_AT, 38604_AT, 35595_AT, 31793_AT, 33284_AT, 34623_AT, 1910_S_AT, 34546_AT, 31512_AT, 679_AT, 37096_AT, 1419_G_AT, 31506_S_AT, 37105_AT, 33979_AT	133	494	16650	3.2944202611792637	0.833531271870037	0.06202675161018811	1.0200469092705
GOTERM_BP_FAT	GO:0010562~positive regulation of phosphorus metabolic process	20	13.793103448275861	6.086351859591335E-4	33963_AT, 1974_S_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 1419_G_AT, 1983_AT	133	1049	16650	2.3868059089573315	0.8546692760868684	0.06434493332850233	1.0968786896010219
GOTERM_BP_FAT	GO:0045937~positive regulation of phosphate metabolic process	20	13.793103448275861	6.086351859591335E-4	33963_AT, 1974_S_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 1419_G_AT, 1983_AT	133	1049	16650	2.3868059089573315	0.8546692760868684	0.06434493332850233	1.0968786896010219
GOTERM_BP_FAT	GO:0035556~intracellular signal transduction	37	25.517241379310345	6.319578197305103E-4	40959_AT, 33963_AT, 32148_AT, 36317_AT, 35915_AT, 40186_AT, 1355_G_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 35090_G_AT, 37983_AT, 34249_AT, 35091_AT, 606_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 33080_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 41489_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 1786_AT, 33371_S_AT, 37096_AT, 36703_AT, 1890_AT, 1419_G_AT, 919_AT	133	2657	16650	1.7433025544667087	0.8650262876337923	0.06457643485716458	1.1386836109130383
GOTERM_MF_FAT	GO:0019825~oxygen binding	5	3.4482758620689653	6.59375432190818E-4	38229_AT, 33516_AT, 1391_S_AT, 31687_F_AT, 31525_S_AT	124	50	15478	12.48225806451613	0.3142808571374748	0.17191839601249126	0.963127977310807
GAD_DISEASE_CLASS	REPRODUCTION	20	13.793103448275861	6.656357084808932E-4	1974_S_AT, 38604_AT, 31621_S_AT, 34636_AT, 38229_AT, 1403_S_AT, 33284_AT, 31525_S_AT, 32250_AT, 37968_AT, 35373_AT, 1910_S_AT, 34623_AT, 37172_AT, 1645_AT, 37983_AT, 36328_AT, 1575_AT, 1419_G_AT, 34436_AT	115	960	12971	2.3498188405797102	0.011913892963738792	0.0017107396084012905	0.48961626100723077
GAD_DISEASE	Lung Cancer	15	10.344827586206897	6.868780368216686E-4	1974_S_AT, 38229_AT, 34636_AT, 1403_S_AT, 33284_AT, 967_G_AT, 32250_AT, 1901_S_AT, 37096_AT, 36328_AT, 1890_AT, 1575_AT, 1419_G_AT, 37898_R_AT, 33922_AT, 966_AT	115	593	12971	2.85306840677469	0.6786140055626498	0.13228247596011233	1.14834679798268
GOTERM_MF_FAT	GO:0020037~heme binding	7	4.827586206896552	7.847865051456108E-4	38229_AT, 33516_AT, 33284_AT, 1391_S_AT, 31687_F_AT, 31525_S_AT, 1419_G_AT	124	137	15478	6.377796091358606	0.36178120633921973	0.13902634447240536	1.1453305771836675
GOTERM_BP_FAT	GO:0009967~positive regulation of signal transduction	24	16.551724137931036	8.069459378984962E-4	1974_S_AT, 33684_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 35915_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 822_S_AT, 40271_AT, 36703_AT, 34618_AT, 1890_AT, 41280_R_AT, 39094_AT	133	1428	16650	2.103999494534656	0.9224968522007396	0.07918668269631024	1.4518109409465851
GAD_DISEASE	normal variation	10	6.896551724137931	8.233387836021468E-4	1974_S_AT, 37983_AT, 36328_AT, 38229_AT, 1403_S_AT, 32084_AT, 1575_AT, 1419_G_AT, 38201_AT, 34467_G_AT	115	281	12971	4.013925421630821	0.7435229039479174	0.14031622164914948	1.375004887519371
GOTERM_BP_FAT	GO:1902531~regulation of intracellular signal transduction	27	18.620689655172416	8.658392821876848E-4	40959_AT, 1974_S_AT, 33080_S_AT, 32148_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 35915_AT, 1355_G_AT, 40186_AT, 1901_S_AT, 35373_AT, 1855_AT, 1910_S_AT, 1645_AT, 37711_AT, 37096_AT, 35090_G_AT, 36703_AT, 34249_AT, 35091_AT, 1890_AT, 919_AT, 41280_R_AT, 39094_AT	133	1714	16650	1.9720391995157087	0.9356981592925859	0.08218113203500022	1.5569849801439273
GOTERM_BP_FAT	GO:0044419~interspecies interaction between organisms	19	13.10344827586207	8.987837216693279E-4	33963_AT, 1974_S_AT, 35595_AT, 31793_AT, 1403_S_AT, 32084_AT, 33284_AT, 1112_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 32073_AT, 37096_AT, 679_AT, 40271_AT, 36234_AT, 32413_AT, 34606_S_AT, 31506_S_AT, 39094_AT, 37105_AT	133	998	16650	2.3833381047809903	0.9420762142863935	0.08270121913446893	1.6157721863484742
GOTERM_BP_FAT	GO:0044403~symbiosis, encompassing mutualism through parasitism	19	13.10344827586207	8.987837216693279E-4	33963_AT, 1974_S_AT, 35595_AT, 31793_AT, 1403_S_AT, 32084_AT, 33284_AT, 1112_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 32073_AT, 37096_AT, 679_AT, 40271_AT, 36234_AT, 32413_AT, 34606_S_AT, 31506_S_AT, 39094_AT, 37105_AT	133	998	16650	2.3833381047809903	0.9420762142863935	0.08270121913446893	1.6157721863484742
GOTERM_BP_FAT	GO:0070942~neutrophil mediated cytotoxicity	3	2.0689655172413794	9.163794343325708E-4	33963_AT, 37096_AT, 679_AT, 37105_AT	133	6	16650	62.59398496240601	0.9452195021576285	0.08187721800696468	1.6471569993674162
GOTERM_BP_FAT	GO:0070943~neutrophil mediated killing of symbiont cell	3	2.0689655172413794	9.163794343325708E-4	33963_AT, 37096_AT, 679_AT, 37105_AT	133	6	16650	62.59398496240601	0.9452195021576285	0.08187721800696468	1.6471569993674162
GOTERM_BP_FAT	GO:0019731~antibacterial humoral response	5	3.4482758620689653	9.413787072570089E-4	38604_AT, 31793_AT, 31506_S_AT, 34623_AT, 33979_AT, 34546_AT	133	55	16650	11.380724538619276	0.9493943656078876	0.08171580261512623	1.691730999068508
GOTERM_BP_FAT	GO:0051246~regulation of protein metabolic process	35	24.137931034482758	9.573286024722051E-4	33963_AT, 35648_AT, 32717_AT, 38103_AT, 35915_AT, 40186_AT, 1355_G_AT, 1910_S_AT, 37711_AT, 32073_AT, 679_AT, 822_S_AT, 37983_AT, 36234_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 32250_AT, 1331_S_AT, 1901_S_AT, 37172_AT, 1645_AT, 37096_AT, 36703_AT, 32413_AT, 1890_AT, 1419_G_AT, 919_AT, 1983_AT, 37105_AT, 37954_AT	133	2512	16650	1.7442591350988936	0.9518902125382762	0.08083099063555921	1.720159877206362
GOTERM_BP_FAT	GO:0043408~regulation of MAPK cascade	15	10.344827586206897	9.788037813236547E-4	32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 1645_AT, 37711_AT, 37096_AT, 36703_AT, 1890_AT, 41280_R_AT	133	678	16650	2.7696453523188502	0.9550573898106985	0.0804288040757356	1.7584246771593648
GOTERM_BP_FAT	GO:0000165~MAPK cascade	17	11.724137931034482	0.001013229167286649	32680_AT, 38236_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 1855_AT, 37711_AT, 1645_AT, 37096_AT, 35090_G_AT, 36703_AT, 35091_AT, 41280_R_AT	133	841	16650	2.530553494318436	0.9597053788227919	0.08104133802838831	1.8197349868880996
GOTERM_MF_FAT	GO:0001664~G-protein coupled receptor binding	9	6.206896551724138	0.0010320495792859518	38604_AT, 33684_AT, 36703_AT, 37983_AT, 37454_AT, 1403_S_AT, 919_AT, 2090_I_AT, 1645_AT	124	257	15478	4.371218777457011	0.4460258174623307	0.13727500369041556	1.5036503144106428
GAD_DISEASE	chronic obstructive pulmonary disease	12	8.275862068965518	0.0010328577781017639	1974_S_AT, 36328_AT, 34636_AT, 1403_S_AT, 33284_AT, 1575_AT, 1890_AT, 967_G_AT, 37898_R_AT, 1419_G_AT, 32250_AT, 1901_S_AT, 966_AT	115	414	12971	3.269313169502205	0.8186203316547382	0.15693926975070738	1.7220598493848605
GOTERM_MF_FAT	GO:0046906~tetrapyrrole binding	7	4.827586206896552	0.0010925961894901431	38229_AT, 33516_AT, 33284_AT, 1391_S_AT, 31687_F_AT, 31525_S_AT, 1419_G_AT	124	146	15478	5.984644277507733	0.4649027037543474	0.1175572257290145	1.5912064004728221
GOTERM_BP_FAT	GO:0010647~positive regulation of cell communication	25	17.24137931034483	0.001112673409056805	1974_S_AT, 33684_AT, 38236_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 35915_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 822_S_AT, 40271_AT, 36703_AT, 34618_AT, 1890_AT, 41280_R_AT, 39094_AT	133	1555	16650	2.012668326765467	0.9706044469974897	0.08646504392805643	1.9966384405139315
GAD_DISEASE	Gastritis|Helicobacter Infections|Stomach Neoplasms	3	2.0689655172413794	0.0011223822546471965	1974_S_AT, 1403_S_AT, 33284_AT	115	6	12971	56.39565217391304	0.8435809743292062	0.15520059784373408	1.8700009562123143
GOTERM_BP_FAT	GO:0043085~positive regulation of catalytic activity	25	17.24137931034483	0.0011528060441818974	40959_AT, 33963_AT, 35038_AT, 32148_AT, 32717_AT, 40186_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 35090_G_AT, 37983_AT, 35091_AT, 39511_AT, 33080_S_AT, 32680_AT, 38236_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 37096_AT, 33027_AT, 36703_AT, 1419_G_AT, 1983_AT	133	1559	16650	2.007504328492816	0.9741177077923089	0.08730626713063727	2.0679459013061674
GOTERM_BP_FAT	GO:0006468~protein phosphorylation	28	19.310344827586206	0.001233934333390218	33963_AT, 32717_AT, 35915_AT, 40186_AT, 1355_G_AT, 1855_AT, 35373_AT, 1910_S_AT, 37711_AT, 679_AT, 35090_G_AT, 35091_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 32680_AT, 38236_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 1786_AT, 37096_AT, 36703_AT, 1890_AT, 1983_AT, 37105_AT	133	1852	16650	1.8926906900079572	0.979989892194313	0.09099335243251983	2.2119445523859804
GOTERM_BP_FAT	GO:0023051~regulation of signaling	40	27.586206896551722	0.0012490695830058179	40959_AT, 33684_AT, 32148_AT, 32717_AT, 35915_AT, 35367_AT, 1355_G_AT, 40186_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 33293_AT, 35090_G_AT, 34249_AT, 35091_AT, 34618_AT, 37953_S_AT, 936_S_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 33080_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 41489_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 37096_AT, 40271_AT, 36703_AT, 1890_AT, 1419_G_AT, 919_AT, 39187_AT	133	3070	16650	1.6311136146555312	0.9809278441355587	0.08996700709014294	2.2387867113571547
GOTERM_BP_FAT	GO:0008219~cell death	29	20.0	0.0013238706269883545	33963_AT, 32717_AT, 33284_AT, 31525_S_AT, 35915_AT, 35367_AT, 1355_G_AT, 35373_AT, 38128_AT, 1910_S_AT, 37711_AT, 32073_AT, 822_S_AT, 33293_AT, 34618_AT, 41280_R_AT, 1974_S_AT, 38236_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 35069_AT, 1786_AT, 40271_AT, 38482_AT, 1890_AT, 31687_F_AT, 40317_AT, 1983_AT	133	1958	16650	1.854162986628983	0.9849563720623906	0.09298838039101376	2.371343158067407
GAD_DISEASE_CLASS	PSYCH	31	21.379310344827587	0.0014605630515741744	33684_AT, 34629_AT, 35648_AT, 33284_AT, 34467_G_AT, 1355_G_AT, 1910_S_AT, 33685_AT, 35090_G_AT, 37983_AT, 40058_S_AT, 40735_AT, 35091_AT, 1575_AT, 38945_AT, 1974_S_AT, 32439_AT, 38604_AT, 38236_AT, 32680_AT, 38229_AT, 1112_G_AT, 36328_AT, 37097_AT, 1419_G_AT, 40317_AT, 919_AT, 40790_AT, 32279_AT, 1983_AT, 39187_AT, 34436_AT	115	1974	12971	1.7712920135676842	0.02596627710463839	0.003283267356291142	1.071618534318286
GOTERM_BP_FAT	GO:0006935~chemotaxis	13	8.96551724137931	0.0014752588313788515	33963_AT, 31793_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 35367_AT, 1901_S_AT, 36766_AT, 37096_AT, 36703_AT, 37983_AT, 34720_AT, 31506_S_AT, 36436_AT	133	552	16650	2.9482674076495585	0.9906937659150085	0.10084249802009726	2.6391018102303265
GOTERM_BP_FAT	GO:0042330~taxis	13	8.96551724137931	0.0014979305859189537	33963_AT, 31793_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 35367_AT, 1901_S_AT, 36766_AT, 37096_AT, 36703_AT, 37983_AT, 34720_AT, 31506_S_AT, 36436_AT	133	553	16650	2.942936001849107	0.9913396645568293	0.10015555891036965	2.6791413090049954
GAD_DISEASE	Esophageal Cancer	5	3.4482758620689653	0.0015618387518215886	1974_S_AT, 38229_AT, 33284_AT, 1575_AT, 1910_S_AT	115	57	12971	9.89397406559878	0.9243905961141109	0.1936047062392856	2.5931795883373687
GOTERM_BP_FAT	GO:0023014~signal transduction by protein phosphorylation	17	11.724137931034482	0.0015651159197028	32680_AT, 38236_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 1855_AT, 37711_AT, 1645_AT, 37096_AT, 35090_G_AT, 36703_AT, 35091_AT, 41280_R_AT	133	877	16650	2.426676726022582	0.9930022837566295	0.10225865980719118	2.797702765176846
GOTERM_BP_FAT	GO:0043410~positive regulation of MAPK cascade	12	8.275862068965518	0.0016673619382911787	37096_AT, 36703_AT, 32680_AT, 37454_AT, 34636_AT, 1403_S_AT, 1331_S_AT, 1355_G_AT, 40186_AT, 1901_S_AT, 37711_AT, 1645_AT	133	485	16650	3.0974343074180295	0.9949411252075542	0.10638575411087081	2.9778737135165656
GOTERM_BP_FAT	GO:0031401~positive regulation of protein modification process	20	13.793103448275861	0.0016772504651273066	33963_AT, 1974_S_AT, 35648_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 1983_AT	133	1143	16650	2.190515659226807	0.9950974045102114	0.10487460933132786	2.9952818565940453
GOTERM_BP_FAT	GO:0051852~disruption by host of symbiont cells	3	2.0689655172413794	0.0016928600612253401	33963_AT, 37096_AT, 679_AT, 37105_AT	133	8	16650	46.94548872180451	0.9953343363412497	0.10375487860574117	3.0227555842919807
GOTERM_BP_FAT	GO:0051873~killing by host of symbiont cells	3	2.0689655172413794	0.0016928600612253401	33963_AT, 37096_AT, 679_AT, 37105_AT	133	8	16650	46.94548872180451	0.9953343363412497	0.10375487860574117	3.0227555842919807
GAD_DISEASE	prostate cancer	13	8.96551724137931	0.0017318650266691172	1974_S_AT, 38229_AT, 1403_S_AT, 33284_AT, 1901_S_AT, 35373_AT, 1910_S_AT, 37983_AT, 36328_AT, 40058_S_AT, 1890_AT, 1575_AT, 1419_G_AT	115	510	12971	2.8750724637681158	0.9429325488157733	0.1976985537453828	2.8716311025736907
GOTERM_BP_FAT	GO:0010646~regulation of cell communication	39	26.89655172413793	0.00176702562280316	40959_AT, 33684_AT, 32148_AT, 32717_AT, 35915_AT, 35367_AT, 1355_G_AT, 40186_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 33293_AT, 35090_G_AT, 34249_AT, 35091_AT, 34618_AT, 37953_S_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 33080_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 41489_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 37096_AT, 40271_AT, 36703_AT, 1890_AT, 1419_G_AT, 919_AT, 39187_AT	133	3020	16650	1.6166658367773739	0.996312803464932	0.10600739631473599	3.1531905422086837
GOTERM_BP_FAT	GO:0007267~cell-cell signaling	24	16.551724137931036	0.0018074457226567638	38604_AT, 33684_AT, 38236_AT, 32680_AT, 32717_AT, 37454_AT, 1403_S_AT, 41489_AT, 1112_G_AT, 34467_G_AT, 1355_G_AT, 1855_AT, 37711_AT, 1645_AT, 1786_AT, 34618_AT, 1890_AT, 37953_S_AT, 1419_G_AT, 40317_AT, 39511_AT, 2090_I_AT, 32279_AT, 1372_AT	133	1517	16650	1.9805611589950485	0.9967567163801863	0.10629171727522224	3.224207562415027
GAD_DISEASE	kidney transplant	4	2.7586206896551726	0.0018455071093237236	37983_AT, 38229_AT, 1403_S_AT, 1575_AT	115	28	12971	16.11304347826087	0.9527165283523302	0.19585126599584357	3.057324800967809
GOTERM_BP_FAT	GO:0009611~response to wounding	14	9.655172413793103	0.0019488437361556514	38236_AT, 34636_AT, 33516_AT, 1901_S_AT, 35373_AT, 37172_AT, 1910_S_AT, 1786_AT, 39698_AT, 37898_R_AT, 40317_AT, 31687_F_AT, 919_AT, 37954_AT	133	649	16650	2.7005109074689804	0.9979294909891115	0.11205493359211449	3.472253124615454
GOTERM_BP_FAT	GO:0008285~negative regulation of cell proliferation	14	9.655172413793103	0.00200213145602758	1974_S_AT, 33080_S_AT, 34629_AT, 32717_AT, 1901_S_AT, 35439_AT, 37172_AT, 1910_S_AT, 1645_AT, 37711_AT, 39469_S_AT, 36479_AT, 34720_AT, 34618_AT	133	651	16650	2.6922144069852045	0.9982516983580334	0.11289731508628176	3.56557645341109
GAD_DISEASE	Renal Insufficiency	3	2.0689655172413794	0.0020711306151642525	37983_AT, 38229_AT, 1575_AT	115	8	12971	42.29673913043478	0.9674525375175738	0.20414403504483336	3.425009552557867
GAD_DISEASE	Malaria	5	3.4482758620689653	0.002132780095553592	38229_AT, 1575_AT, 31687_F_AT, 1419_G_AT, 37968_AT	115	62	12971	9.096072931276296	0.9706104272810901	0.19783800967357346	3.525247530455744
GOTERM_BP_FAT	GO:0022008~neurogenesis	23	15.862068965517242	0.0022172683604171437	33963_AT, 38604_AT, 33684_AT, 33080_S_AT, 38236_AT, 32680_AT, 32148_AT, 32717_AT, 38103_AT, 1112_G_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 39469_S_AT, 32073_AT, 33293_AT, 40058_S_AT, 34720_AT, 606_AT, 39511_AT, 2090_I_AT, 39187_AT	133	1447	16650	1.9898571584455265	0.9991169291140428	0.12210138807807724	3.941481817992687
GOTERM_MF_FAT	GO:0005506~iron ion binding	7	4.827586206896552	0.002300727129862211	34636_AT, 38229_AT, 33516_AT, 1391_S_AT, 31687_F_AT, 31525_S_AT, 37166_AT	124	169	15478	5.170166062225616	0.7322046316615796	0.19715105028529867	3.323187786289983
GAD_DISEASE	Bladder Cancer	13	8.96551724137931	0.002347695158291587	1974_S_AT, 38229_AT, 34636_AT, 1403_S_AT, 33284_AT, 967_G_AT, 32250_AT, 1901_S_AT, 36328_AT, 1890_AT, 1575_AT, 1419_G_AT, 37898_R_AT, 966_AT	115	529	12971	2.771808991534478	0.979410049892248	0.2042012500724224	3.8739206075072308
GOTERM_BP_FAT	GO:0008217~regulation of blood pressure	7	4.827586206896552	0.002424250944956968	679_AT, 38604_AT, 37983_AT, 1391_S_AT, 40317_AT, 31687_F_AT, 1419_G_AT, 37105_AT	133	171	16650	5.124653739612189	0.9995423249953349	0.13047342826217678	4.301832232557201
GAD_DISEASE	atherosclerosis, coronary	7	4.827586206896552	0.002441804184063374	38604_AT, 37983_AT, 34636_AT, 1403_S_AT, 31687_F_AT, 1419_G_AT, 32250_AT	115	155	12971	5.093800841514726	0.9823812832922462	0.200986483238622	4.026227427425644
GOTERM_BP_FAT	GO:0051345~positive regulation of hydrolase activity	17	11.724137931034482	0.0024569382105007987	40959_AT, 35038_AT, 33080_S_AT, 32148_AT, 38236_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 1855_AT, 37711_AT, 822_S_AT, 35090_G_AT, 36703_AT, 33027_AT, 37983_AT, 35091_AT, 39511_AT	133	917	16650	2.320823869925632	0.9995874519316431	0.12991427062084515	4.358622864023398
GAD_DISEASE_CLASS	PHARMACOGENOMIC	38	26.20689655172414	0.0026568193801816036	35038_AT, 33684_AT, 35648_AT, 31621_S_AT, 33284_AT, 37968_AT, 35367_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 37061_AT, 37711_AT, 679_AT, 37983_AT, 1391_S_AT, 1575_AT, 1974_S_AT, 38604_AT, 34636_AT, 38229_AT, 1403_S_AT, 32084_AT, 1112_G_AT, 967_G_AT, 32250_AT, 1331_S_AT, 35169_AT, 1901_S_AT, 37172_AT, 36328_AT, 34720_AT, 1890_AT, 31687_F_AT, 1419_G_AT, 38201_AT, 40790_AT, 32279_AT, 40294_AT, 37105_AT, 966_AT	115	2717	12971	1.5775007601094557	0.04675792104413945	0.005306580071144262	1.9419063264001113
GOTERM_CC_FAT	GO:0005576~extracellular region	56	38.62068965517241	0.0027570018286667336	38646_S_AT, 31621_S_AT, 33284_AT, 35915_AT, 1855_AT, 39908_AT, 35090_G_AT, 35956_S_AT, 36234_AT, 1575_AT, 33979_AT, 40350_AT, 37454_AT, 1403_S_AT, 33516_AT, 1112_G_AT, 32250_AT, 37905_R_AT, 37172_AT, 1645_AT, 36766_AT, 1786_AT, 34546_AT, 31512_AT, 37096_AT, 1890_AT, 37898_R_AT, 34703_F_AT, 1372_AT, 37105_AT, 36436_AT, 33963_AT, 33530_AT, 33684_AT, 31525_S_AT, 35367_AT, 37061_AT, 679_AT, 34012_AT, 34618_AT, 35091_AT, 1391_S_AT, 31506_S_AT, 38604_AT, 32680_AT, 31793_AT, 38691_S_AT, 32084_AT, 1331_S_AT, 35169_AT, 36378_AT, 34623_AT, 36703_AT, 36328_AT, 32413_AT, 31687_F_AT, 38508_S_AT, 2090_I_AT, 37166_AT	126	4623	14527	1.3965919196289087	0.5667867749115293	0.13013814959658487	3.627445543097274
GAD_DISEASE	Coronary Disease|Coronary heart disease	5	3.4482758620689653	0.002990695001591377	1974_S_AT, 37983_AT, 31687_F_AT, 1419_G_AT, 32250_AT	115	68	12971	8.293478260869565	0.9929026291176687	0.22927425105115706	4.910044209234288
GOTERM_BP_FAT	GO:0042325~regulation of phosphorylation	22	15.172413793103448	0.003113741060320219	33963_AT, 1974_S_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 41280_R_AT, 1983_AT, 39094_AT	133	1393	16650	1.9771251531556815	0.9999487974447794	0.15913860362824905	5.493022190345598
GOTERM_BP_FAT	GO:0001932~regulation of protein phosphorylation	21	14.482758620689657	0.0031220486872289505	33963_AT, 1974_S_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 41280_R_AT, 1983_AT, 39094_AT	133	1300	16650	2.0222672064777325	0.9999501315489039	0.15700580477427695	5.5072889854100415
GAD_DISEASE	alcohol	5	3.4482758620689653	0.0031535189962880023	38604_AT, 1112_G_AT, 1419_G_AT, 32279_AT, 35373_AT	115	69	12971	8.173282923755513	0.9945810055117437	0.2296360781254171	5.170745476109595
GAD_DISEASE	HIV Infections	5	3.4482758620689653	0.0031535189962880023	38229_AT, 1403_S_AT, 1575_AT, 34623_AT, 34546_AT	115	69	12971	8.173282923755513	0.9945810055117437	0.2296360781254171	5.170745476109595
GOTERM_BP_FAT	GO:0048245~eosinophil chemotaxis	3	2.0689655172413794	0.0032738185412513887	37454_AT, 1403_S_AT, 35367_AT	133	11	16650	34.14217361585782	0.9999692146434465	0.16144557037704832	5.767567444543542
GOTERM_BP_FAT	GO:0043087~regulation of GTPase activity	14	9.655172413793103	0.0033485597282487058	40959_AT, 33080_S_AT, 32148_AT, 38236_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1355_G_AT, 1901_S_AT, 1855_AT, 35090_G_AT, 36703_AT, 33027_AT, 35091_AT, 39511_AT	133	691	16650	2.536369868230634	0.999975724382986	0.16230452157261144	5.895496146534818
GAD_DISEASE_CLASS	METABOLIC	62	42.758620689655174	0.0034248383493566377	31621_S_AT, 35648_AT, 33284_AT, 37968_AT, 35915_AT, 1355_G_AT, 1855_AT, 39469_S_AT, 37711_AT, 33293_AT, 35090_G_AT, 40058_S_AT, 1575_AT, 33922_AT, 1974_S_AT, 40350_AT, 38236_AT, 32418_AT, 34636_AT, 1403_S_AT, 1112_G_AT, 32250_AT, 1901_S_AT, 37172_AT, 1645_AT, 40271_AT, 34720_AT, 37097_AT, 38201_AT, 919_AT, 1983_AT, 1372_AT, 37105_AT, 36436_AT, 34436_AT, 32148_AT, 36317_AT, 31525_S_AT, 34467_G_AT, 35367_AT, 40186_AT, 35373_AT, 1910_S_AT, 679_AT, 822_S_AT, 37983_AT, 35121_AT, 34618_AT, 35091_AT, 1391_S_AT, 38945_AT, 38604_AT, 33080_S_AT, 32680_AT, 38229_AT, 32084_AT, 35439_AT, 36703_AT, 36328_AT, 1419_G_AT, 40317_AT, 31687_F_AT, 32279_AT, 39187_AT	115	5263	12971	1.328721426860197	0.059884837194054685	0.0061562618458581575	2.4971524753976015
GAD_DISEASE	aging	4	2.7586206896551726	0.0035262332642584894	37983_AT, 36328_AT, 38229_AT, 1575_AT	115	35	12971	12.890434782608695	0.9970784246666898	0.24261779063615085	5.764978585459146
GOTERM_BP_FAT	GO:0006928~movement of cell or subcellular component	26	17.93103448275862	0.003561291837165254	33963_AT, 35038_AT, 33530_AT, 32717_AT, 35367_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 37711_AT, 35090_G_AT, 37983_AT, 35091_AT, 38604_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 1786_AT, 34972_S_AT, 37096_AT, 36479_AT, 40271_AT, 36703_AT, 38482_AT, 34720_AT, 919_AT, 1372_AT	133	1795	16650	1.8133076423649652	0.9999876556232059	0.16913152445509294	6.258715659111502
GAD_DISEASE	Schizophrenia	16	11.03448275862069	0.003587088049321005	1974_S_AT, 38604_AT, 35090_G_AT, 38236_AT, 32680_AT, 40058_S_AT, 40735_AT, 38229_AT, 35091_AT, 1575_AT, 1112_G_AT, 37097_AT, 34467_G_AT, 32279_AT, 39187_AT, 1355_G_AT, 34436_AT	115	785	12971	2.2989310440321242	0.9973588035144215	0.23649985615465274	5.861668552826904
GOTERM_BP_FAT	GO:0030182~neuron differentiation	20	13.793103448275861	0.0036758212334434904	38604_AT, 33080_S_AT, 33684_AT, 32680_AT, 32148_AT, 32717_AT, 38103_AT, 1112_G_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 39469_S_AT, 32073_AT, 33293_AT, 40058_S_AT, 34720_AT, 606_AT, 2090_I_AT, 39187_AT	133	1226	16650	2.042218106440653	0.999991423260536	0.17152503263407326	6.453714616276152
GOTERM_BP_FAT	GO:0019220~regulation of phosphate metabolic process	24	16.551724137931036	0.003846628605933035	33963_AT, 1974_S_AT, 32680_AT, 32148_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 35915_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 1419_G_AT, 41280_R_AT, 1983_AT, 39094_AT	133	1610	16650	1.8661560734133469	0.999995017692593	0.1761801910298647	6.743821192771615
GAD_DISEASE	epithelial ovarian cancer 	7	4.827586206896552	0.0038572776553742346	1974_S_AT, 36328_AT, 38229_AT, 1419_G_AT, 33922_AT, 35915_AT, 1901_S_AT	115	170	12971	4.644347826086957	0.9983125623730563	0.2423917699217093	6.289837340697602
GOTERM_BP_FAT	GO:0051174~regulation of phosphorus metabolic process	24	16.551724137931036	0.0038762593766348322	33963_AT, 1974_S_AT, 32680_AT, 32148_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 35915_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 36703_AT, 1890_AT, 1419_G_AT, 41280_R_AT, 1983_AT, 39094_AT	133	1611	16650	1.864997689755114	0.9999954657533217	0.17489751924579033	6.7940607670539555
GOTERM_BP_FAT	GO:0009966~regulation of signal transduction	35	24.137931034482758	0.0038910285023590046	40959_AT, 33684_AT, 32148_AT, 32717_AT, 35915_AT, 35367_AT, 40186_AT, 1355_G_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 33293_AT, 35090_G_AT, 34249_AT, 35091_AT, 34618_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 33080_S_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 37096_AT, 40271_AT, 36703_AT, 1890_AT, 919_AT, 39187_AT	133	2728	16650	1.606150640530946	0.9999956738069676	0.1730513316034532	6.819092569629714
GOTERM_BP_FAT	GO:0032270~positive regulation of cellular protein metabolic process	22	15.172413793103448	0.0038984032492642333	33963_AT, 1974_S_AT, 35648_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 35915_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 822_S_AT, 36703_AT, 37983_AT, 1890_AT, 1983_AT	133	1420	16650	1.9395319284125807	0.9999957740951609	0.1709618021046252	6.83158945636444
GOTERM_BP_FAT	GO:0042060~wound healing	12	8.275862068965518	0.003918862530958544	34636_AT, 33516_AT, 39698_AT, 40317_AT, 31687_F_AT, 37898_R_AT, 919_AT, 35373_AT, 1901_S_AT, 37172_AT, 37954_AT, 1786_AT	133	542	16650	2.7716893710290487	0.9999960403166323	0.16944563205820673	6.8662504685841785
GAD_DISEASE	Type 2 Diabetes| edema | rosiglitazone	32	22.06896551724138	0.003929556423866353	35038_AT, 33684_AT, 35648_AT, 31621_S_AT, 33284_AT, 37968_AT, 35367_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 37061_AT, 37711_AT, 679_AT, 37983_AT, 1575_AT, 1974_S_AT, 38604_AT, 34636_AT, 38229_AT, 32084_AT, 1403_S_AT, 1112_G_AT, 32250_AT, 35169_AT, 37172_AT, 34720_AT, 1890_AT, 31687_F_AT, 1419_G_AT, 38201_AT, 40790_AT, 32279_AT, 37105_AT	115	2198	12971	1.6420936028800885	0.998503184356884	0.23739670094113763	6.4040664137152365
GOTERM_BP_FAT	GO:0001909~leukocyte mediated cytotoxicity	5	3.4482758620689653	0.004096520373671	33963_AT, 37096_AT, 679_AT, 1419_G_AT, 37968_AT, 37105_AT	133	82	16650	7.633412800293416	0.9999977496644645	0.1740670108395329	7.166717021196389
GAD_DISEASE	Gout	4	2.7586206896551726	0.004133308962297301	40317_AT, 37097_AT, 35439_AT, 34436_AT	115	37	12971	12.193654524089308	0.9989324372115639	0.23943604882273506	6.725371588700324
GAD_DISEASE	autism	10	6.896551724137931	0.004202189065599948	38604_AT, 38236_AT, 36328_AT, 1575_AT, 40317_AT, 1419_G_AT, 32279_AT, 1355_G_AT, 1910_S_AT, 38945_AT	115	357	12971	3.1594202898550723	0.9990477121065233	0.23475803301381382	6.833756428174964
GAD_DISEASE	Colorectal Cancer	11	7.586206896551724	0.004272510839544813	1974_S_AT, 33684_AT, 38229_AT, 33284_AT, 32084_AT, 41489_AT, 1575_AT, 1890_AT, 1419_G_AT, 33922_AT, 1901_S_AT	115	426	12971	2.912451520718514	0.9991525757343198	0.230469284673246	6.944287575491814
GOTERM_BP_FAT	GO:2000106~regulation of leukocyte apoptotic process	5	3.4482758620689653	0.004277925156509448	1974_S_AT, 1403_S_AT, 35367_AT, 37711_AT, 1786_AT	133	83	16650	7.5414439713742185	0.9999987363902532	0.17867294314931603	7.472575465135456
GAD_DISEASE_CLASS	CANCER	42	28.965517241379313	0.004457942691369131	33684_AT, 38674_AT, 33284_AT, 37408_AT, 35915_AT, 35367_AT, 35373_AT, 1910_S_AT, 37061_AT, 37711_AT, 37983_AT, 40058_S_AT, 40735_AT, 1575_AT, 33922_AT, 38945_AT, 33979_AT, 1974_S_AT, 38604_AT, 33080_S_AT, 34636_AT, 37454_AT, 38229_AT, 1403_S_AT, 32084_AT, 41489_AT, 967_G_AT, 1331_S_AT, 32250_AT, 1901_S_AT, 34623_AT, 37172_AT, 1645_AT, 34546_AT, 37096_AT, 36328_AT, 38816_AT, 1890_AT, 37898_R_AT, 1419_G_AT, 1372_AT, 1983_AT, 966_AT	115	3197	12971	1.481775033659273	0.07727345969457677	0.007284462482517462	3.239756876087274
GOTERM_BP_FAT	GO:0043547~positive regulation of GTPase activity	13	8.96551724137931	0.004565479994767871	40959_AT, 33080_S_AT, 38236_AT, 32148_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 1855_AT, 35090_G_AT, 33027_AT, 36703_AT, 35091_AT, 39511_AT	133	634	16650	2.566945755556082	0.9999994939132467	0.1870565116736853	7.95545873454696
GOTERM_CC_FAT	GO:0005833~hemoglobin complex	3	2.0689655172413794	0.004581837430780546	33516_AT, 31687_F_AT, 31525_S_AT	126	12	14527	28.823412698412696	0.7512947863961965	0.1802729435639786	5.9610377832577495
GOTERM_BP_FAT	GO:0051883~killing of cells in other organism involved in symbiotic interaction	3	2.0689655172413794	0.004594935664855659	33963_AT, 37096_AT, 679_AT, 37105_AT	133	13	16650	28.889531521110467	0.999999539200433	0.1857576423858991	8.004788200879098
GOTERM_BP_FAT	GO:0001878~response to yeast	3	2.0689655172413794	0.004594935664855659	37096_AT, 38604_AT, 33284_AT	133	13	16650	28.889531521110467	0.999999539200433	0.1857576423858991	8.004788200879098
GOTERM_BP_FAT	GO:0051818~disruption of cells of other organism involved in symbiotic interaction	3	2.0689655172413794	0.004594935664855659	33963_AT, 37096_AT, 679_AT, 37105_AT	133	13	16650	28.889531521110467	0.999999539200433	0.1857576423858991	8.004788200879098
GOTERM_BP_FAT	GO:0008340~determination of adult lifespan	3	2.0689655172413794	0.004594935664855659	1974_S_AT, 967_G_AT, 33922_AT, 966_AT	133	13	16650	28.889531521110467	0.999999539200433	0.1857576423858991	8.004788200879098
GOTERM_BP_FAT	GO:0032268~regulation of cellular protein metabolic process	31	21.379310344827587	0.0048431215347358655	33963_AT, 35648_AT, 32717_AT, 38103_AT, 35915_AT, 40186_AT, 1355_G_AT, 1910_S_AT, 37711_AT, 32073_AT, 822_S_AT, 37983_AT, 36234_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 1901_S_AT, 37172_AT, 1645_AT, 37096_AT, 36703_AT, 32413_AT, 1890_AT, 919_AT, 1983_AT, 37954_AT	133	2346	16650	1.6542314866450012	0.9999997908644958	0.19234076469774908	8.419434830781213
GOTERM_BP_FAT	GO:0048699~generation of neurons	21	14.482758620689657	0.005052520697032354	38604_AT, 33684_AT, 33080_S_AT, 32680_AT, 32148_AT, 32717_AT, 38103_AT, 1112_G_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 39469_S_AT, 32073_AT, 33293_AT, 40058_S_AT, 34720_AT, 606_AT, 39511_AT, 2090_I_AT, 39187_AT	133	1357	16650	1.9373230423147034	0.9999998926271615	0.19733781965481123	8.767906099446654
GOTERM_BP_FAT	GO:0050830~defense response to Gram-positive bacterium	5	3.4482758620689653	0.005266602814770335	679_AT, 38604_AT, 31793_AT, 31506_S_AT, 37105_AT, 33979_AT, 34546_AT	133	88	16650	7.112952836637047	0.9999999456970978	0.2023324350271396	9.122875155174137
GAD_DISEASE	ovarian cancer	10	6.896551724137931	0.0052954744828316155	1974_S_AT, 36328_AT, 37454_AT, 38229_AT, 33284_AT, 1575_AT, 1983_AT, 1372_AT, 1901_S_AT, 1910_S_AT	115	370	12971	3.048413631022327	0.999844888861726	0.2689425029794701	8.538291242817364
GOTERM_MF_FAT	GO:0005344~oxygen transporter activity	3	2.0689655172413794	0.005355015531610302	33516_AT, 31687_F_AT, 31525_S_AT	124	14	15478	26.747695852534562	0.953639138226488	0.35516260580544656	7.57597909315767
GOTERM_BP_FAT	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	6	4.137931034482759	0.005474595423101002	35090_G_AT, 1403_S_AT, 35091_AT, 1355_G_AT, 35373_AT, 1855_AT, 1901_S_AT	133	142	16650	5.289632532034311	0.9999999720029491	0.20696047965417852	9.466497159751198
GAD_DISEASE	Chronic renal failure|Kidney Failure, Chronic	17	11.724137931034482	0.005591089959807153	1974_S_AT, 40350_AT, 38604_AT, 38229_AT, 1403_S_AT, 32084_AT, 33284_AT, 1901_S_AT, 1910_S_AT, 1786_AT, 37983_AT, 36328_AT, 40058_S_AT, 34618_AT, 1575_AT, 1419_G_AT, 1983_AT	115	905	12971	2.118731683881816	0.9999050726087311	0.27341008825402	8.994120612017076
GAD_DISEASE	beta-thalassemia	3	2.0689655172413794	0.005606262876165601	31687_F_AT, 31525_S_AT, 1419_G_AT	115	13	12971	26.028762541806017	0.9999074355170614	0.26624994639398103	9.017459006835127
GOTERM_BP_FAT	GO:1901700~response to oxygen-containing compound	22	15.172413793103448	0.005616224186409212	32439_AT, 38236_AT, 32717_AT, 33284_AT, 1403_S_AT, 31525_S_AT, 1331_S_AT, 35169_AT, 1355_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 37172_AT, 33371_S_AT, 37096_AT, 679_AT, 40271_AT, 37983_AT, 34618_AT, 1419_G_AT, 31687_F_AT, 2090_I_AT, 37105_AT	133	1466	16650	1.878673491368257	0.9999999821693788	0.20924551447398965	9.699777342030714
GOTERM_BP_FAT	GO:0072677~eosinophil migration	3	2.0689655172413794	0.00612170871539835	37454_AT, 1403_S_AT, 35367_AT	133	15	16650	25.037593984962403	0.9999999964388329	0.2232515053473787	10.52775099079646
GOTERM_BP_FAT	GO:0015671~oxygen transport	3	2.0689655172413794	0.00612170871539835	33516_AT, 31687_F_AT, 31525_S_AT	133	15	16650	25.037593984962403	0.9999999964388329	0.2232515053473787	10.52775099079646
GOTERM_BP_FAT	GO:0002062~chondrocyte differentiation	5	3.4482758620689653	0.006159717098494566	33684_AT, 34618_AT, 34720_AT, 39187_AT, 37711_AT	133	92	16650	6.803694017652827	0.9999999968451725	0.2219410408212723	10.589717147451083
GAD_DISEASE	Breast Cancer	13	8.96551724137931	0.006253937525277974	1974_S_AT, 37983_AT, 36328_AT, 38229_AT, 38816_AT, 33284_AT, 1575_AT, 967_G_AT, 1419_G_AT, 33922_AT, 1983_AT, 1901_S_AT, 966_AT, 1910_S_AT	115	598	12971	2.4519848771266544	0.9999684502979836	0.284175928249611	10.008455004822181
GOTERM_CC_FAT	GO:0098590~plasma membrane region	17	11.724137931034482	0.006475220187533578	32680_AT, 38236_AT, 32717_AT, 32084_AT, 36378_AT, 1355_G_AT, 1901_S_AT, 1645_AT, 33293_AT, 40058_S_AT, 38482_AT, 1575_AT, 1391_S_AT, 936_S_AT, 919_AT, 32279_AT, 34436_AT	126	936	14527	2.094008614841948	0.8603158443307671	0.21811407848759679	8.326934885695692
GAD_DISEASE	HIV infection	3	2.0689655172413794	0.006503261529491782	38229_AT, 1403_S_AT, 1575_AT	115	14	12971	24.169565217391302	0.9999791566118471	0.2859678612981428	10.387228119564895
GOTERM_BP_FAT	GO:0045087~innate immune response	15	10.344827586206897	0.006535801291618778	38604_AT, 31793_AT, 37454_AT, 35595_AT, 1403_S_AT, 1112_G_AT, 32250_AT, 37968_AT, 35367_AT, 34623_AT, 34546_AT, 31512_AT, 36703_AT, 1419_G_AT, 31506_S_AT, 33979_AT	133	836	16650	2.2461956326222254	0.9999999990488773	0.23122285669437437	11.200676376081176
GAD_DISEASE	diabetes, type 1	7	4.827586206896552	0.0065937172017079505	38646_S_AT, 32084_AT, 1419_G_AT, 32250_AT, 1331_S_AT, 32279_AT, 1910_S_AT	115	190	12971	4.155469107551488	0.9999820674229953	0.2819230420936485	10.524277346958444
GOTERM_BP_FAT	GO:0044130~negative regulation of growth of symbiont in host	3	2.0689655172413794	0.0069601080514301115	37096_AT, 679_AT, 33284_AT, 37105_AT	133	16	16650	23.472744360902254	0.9999999997542519	0.24163003072047373	11.885238526016273
GOTERM_BP_FAT	GO:0044146~negative regulation of growth of symbiont involved in interaction with host	3	2.0689655172413794	0.0069601080514301115	37096_AT, 679_AT, 33284_AT, 37105_AT	133	16	16650	23.472744360902254	0.9999999997542519	0.24163003072047373	11.885238526016273
GOTERM_BP_FAT	GO:0008015~blood circulation	11	7.586206896551724	0.007048950229224704	35038_AT, 33963_AT, 679_AT, 38604_AT, 31621_S_AT, 37983_AT, 39698_AT, 1391_S_AT, 40317_AT, 31687_F_AT, 1419_G_AT, 37105_AT	133	506	16650	2.721477607061131	0.999999999814905	0.24169419395525304	12.027940781021707
GAD_DISEASE	Hypercholesterolemia|LDLC levels	7	4.827586206896552	0.007101428037401071	38604_AT, 37983_AT, 38229_AT, 1575_AT, 32279_AT, 1372_AT, 35373_AT	115	193	12971	4.090876323496283	0.999992293240786	0.29268335841227777	11.28985803401833
GAD_DISEASE	endometrial cancer	4	2.7586206896551726	0.007174728522173319	1974_S_AT, 36328_AT, 1575_AT, 1901_S_AT	115	45	12971	10.025893719806763	0.9999931781221292	0.2881356314493294	11.399878041988899
GOTERM_BP_FAT	GO:0007155~cell adhesion	24	16.551724137931036	0.00735635882194231	33963_AT, 35038_AT, 32439_AT, 40350_AT, 38103_AT, 34636_AT, 1403_S_AT, 1112_G_AT, 37968_AT, 35367_AT, 35169_AT, 1901_S_AT, 35373_AT, 1910_S_AT, 1786_AT, 37096_AT, 36703_AT, 40058_S_AT, 34618_AT, 38482_AT, 31687_F_AT, 39511_AT, 1372_AT, 39187_AT	133	1699	16650	1.7683998105918122	0.9999999999305967	0.2481791098958792	12.520031079805992
GAD_DISEASE_CLASS	VISION	14	9.655172413793103	0.00738883163769488	1974_S_AT, 38604_AT, 31621_S_AT, 1403_S_AT, 33284_AT, 37968_AT, 35915_AT, 32250_AT, 1786_AT, 35090_G_AT, 37983_AT, 34720_AT, 35091_AT, 1575_AT, 1419_G_AT	115	689	12971	2.291840726951474	0.12496619301785306	0.011062749112059733	5.319961512709659
GOTERM_BP_FAT	GO:0003013~circulatory system process	11	7.586206896551724	0.007432446563358478	35038_AT, 33963_AT, 679_AT, 38604_AT, 31621_S_AT, 37983_AT, 39698_AT, 1391_S_AT, 40317_AT, 31687_F_AT, 1419_G_AT, 37105_AT	133	510	16650	2.700132684652808	0.9999999999455603	0.2477948083383913	12.641427876578382
GAD_DISEASE	cerebral infarct, atherothrombotic	3	2.0689655172413794	0.007460910010617084	1974_S_AT, 1403_S_AT, 37172_AT	115	15	12971	22.558260869565217	0.9999957629054069	0.2908274886294038	11.82819337793396
GOTERM_BP_FAT	GO:0009416~response to light stimulus	8	5.517241379310345	0.007532195907311077	1974_S_AT, 37096_AT, 38236_AT, 40317_AT, 40790_AT, 35373_AT, 39469_S_AT, 1910_S_AT	133	284	16650	3.526421688022874	0.999999999960405	0.24809600685875488	12.800335295681665
GOTERM_BP_FAT	GO:0022610~biological adhesion	24	16.551724137931036	0.007666446562811082	33963_AT, 35038_AT, 32439_AT, 40350_AT, 38103_AT, 34636_AT, 1403_S_AT, 1112_G_AT, 37968_AT, 35367_AT, 35169_AT, 1901_S_AT, 35373_AT, 1910_S_AT, 1786_AT, 37096_AT, 36703_AT, 40058_S_AT, 34618_AT, 38482_AT, 31687_F_AT, 39511_AT, 1372_AT, 39187_AT	133	1705	16650	1.762176702753952	0.999999999974206	0.2493635870514157	13.013774536825062
GOTERM_BP_FAT	GO:0051247~positive regulation of protein metabolic process	22	15.172413793103448	0.007693949909336432	33963_AT, 1974_S_AT, 35648_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 35915_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 37096_AT, 822_S_AT, 36703_AT, 37983_AT, 1890_AT, 1983_AT	133	1508	16650	1.8263496938633055	0.9999999999763742	0.24762438514636143	13.057439941417105
GOTERM_BP_FAT	GO:0044144~modulation of growth of symbiont involved in interaction with host	3	2.0689655172413794	0.007847411494836358	37096_AT, 679_AT, 33284_AT, 37105_AT	133	17	16650	22.091994692613884	0.9999999999855259	0.2493990553476405	13.30070174204735
GOTERM_BP_FAT	GO:2000811~negative regulation of anoikis	3	2.0689655172413794	0.007847411494836358	41489_AT, 1355_G_AT, 1910_S_AT	133	17	16650	22.091994692613884	0.9999999999855259	0.2493990553476405	13.30070174204735
GOTERM_BP_FAT	GO:0044126~regulation of growth of symbiont in host	3	2.0689655172413794	0.007847411494836358	37096_AT, 679_AT, 33284_AT, 37105_AT	133	17	16650	22.091994692613884	0.9999999999855259	0.2493990553476405	13.30070174204735
GOTERM_BP_FAT	GO:0065009~regulation of molecular function	35	24.137931034482758	0.008300800916512044	40959_AT, 35038_AT, 33963_AT, 32148_AT, 32717_AT, 1355_G_AT, 40186_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 39908_AT, 822_S_AT, 35090_G_AT, 37983_AT, 35091_AT, 39698_AT, 39511_AT, 41280_R_AT, 1974_S_AT, 33080_S_AT, 38236_AT, 32680_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 37096_AT, 36479_AT, 33027_AT, 36703_AT, 34720_AT, 1419_G_AT, 40790_AT, 1983_AT, 37954_AT	133	2863	16650	1.5304152802544257	0.999999999996598	0.25923807844880953	14.015647434386402
GOTERM_BP_FAT	GO:0072593~reactive oxygen species metabolic process	7	4.827586206896552	0.008556787759096188	1974_S_AT, 37983_AT, 33284_AT, 31687_F_AT, 31525_S_AT, 1419_G_AT, 1910_S_AT	133	222	16650	3.947368421052631	0.9999999999984985	0.2635351687061752	14.41684670595299
GOTERM_BP_FAT	GO:0048870~cell motility	20	13.793103448275861	0.008674001660839228	33963_AT, 33530_AT, 32717_AT, 37454_AT, 1403_S_AT, 35367_AT, 1355_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 1786_AT, 34972_S_AT, 37096_AT, 36479_AT, 40271_AT, 36703_AT, 37983_AT, 38482_AT, 919_AT, 1372_AT	133	1330	16650	1.8825258635310078	0.9999999999989676	0.26409685116166703	14.599961046750598
GOTERM_BP_FAT	GO:0051674~localization of cell	20	13.793103448275861	0.008674001660839228	33963_AT, 33530_AT, 32717_AT, 37454_AT, 1403_S_AT, 35367_AT, 1355_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 1786_AT, 34972_S_AT, 37096_AT, 36479_AT, 40271_AT, 36703_AT, 37983_AT, 38482_AT, 919_AT, 1372_AT	133	1330	16650	1.8825258635310078	0.9999999999989676	0.26409685116166703	14.599961046750598
GOTERM_MF_FAT	GO:0015238~drug transmembrane transporter activity	3	2.0689655172413794	0.008818758582826412	32084_AT, 1575_AT, 34436_AT	124	18	15478	20.803763440860216	0.9936968382787364	0.46918302068141726	12.18767125382081
GOTERM_BP_FAT	GO:0071887~leukocyte apoptotic process	5	3.4482758620689653	0.00881904088143607	1974_S_AT, 1403_S_AT, 35367_AT, 37711_AT, 1786_AT	133	102	16650	6.136665192392746	0.9999999999993505	0.26536443777822605	14.826032372049402
GAD_DISEASE	hypertension	14	9.655172413793103	0.008877431275105301	38604_AT, 31621_S_AT, 38229_AT, 31525_S_AT, 32250_AT, 37061_AT, 1645_AT, 36713_AT, 32073_AT, 37983_AT, 1391_S_AT, 1575_AT, 1419_G_AT, 31687_F_AT	115	705	12971	2.2398273203823624	0.9999995996795015	0.32842873795757765	13.919716009088578
GOTERM_BP_FAT	GO:0000082~G1/S transition of mitotic cell cycle	7	4.827586206896552	0.008921223157698993	1974_S_AT, 822_S_AT, 38103_AT, 38201_AT, 1983_AT, 39094_AT, 1910_S_AT	133	224	16650	3.9121240601503753	0.9999999999995315	0.2655099913422686	14.98496334091769
GOTERM_BP_FAT	GO:0051240~positive regulation of multicellular organismal process	21	14.482758620689657	0.00894733426544566	33963_AT, 33684_AT, 32717_AT, 35595_AT, 32084_AT, 35367_AT, 1355_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 1645_AT, 39469_S_AT, 37172_AT, 32073_AT, 37096_AT, 34618_AT, 606_AT, 1419_G_AT, 40317_AT, 2090_I_AT, 39187_AT	133	1431	16650	1.837140019860973	0.999999999999569	0.26372995194297444	15.025530733552639
GOTERM_MF_FAT	GO:0017111~nucleoside-triphosphatase activity	14	9.655172413793103	0.008986507558516026	37814_G_AT, 32439_AT, 33080_S_AT, 967_G_AT, 37905_R_AT, 39469_S_AT, 34972_S_AT, 33371_S_AT, 33685_AT, 36234_AT, 1575_AT, 606_AT, 919_AT, 40294_AT, 966_AT	124	779	15478	2.2432812952917307	0.9942784654272211	0.43657680094886075	12.40547620907424
GAD_DISEASE_CLASS	CARDIOVASCULAR	51	35.172413793103445	0.009102930997535952	31621_S_AT, 35648_AT, 33284_AT, 37968_AT, 1355_G_AT, 37711_AT, 36713_AT, 32073_AT, 1575_AT, 33922_AT, 1974_S_AT, 38236_AT, 32418_AT, 34636_AT, 35595_AT, 33516_AT, 1403_S_AT, 1112_G_AT, 32250_AT, 37172_AT, 1645_AT, 1786_AT, 37096_AT, 1890_AT, 37097_AT, 919_AT, 37105_AT, 33963_AT, 35038_AT, 31525_S_AT, 34467_G_AT, 35373_AT, 37061_AT, 1910_S_AT, 679_AT, 822_S_AT, 37983_AT, 1391_S_AT, 32439_AT, 38604_AT, 32680_AT, 38691_S_AT, 38229_AT, 32084_AT, 33371_S_AT, 36479_AT, 36328_AT, 40317_AT, 31687_F_AT, 1419_G_AT, 32279_AT, 37166_AT	115	4266	12971	1.3484192502904664	0.15176968742847752	0.012581952745960745	6.518541389015676
GOTERM_BP_FAT	GO:0051336~regulation of hydrolase activity	20	13.793103448275861	0.009148947999269762	40959_AT, 35038_AT, 1974_S_AT, 33080_S_AT, 32148_AT, 38236_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1355_G_AT, 1855_AT, 1901_S_AT, 37711_AT, 822_S_AT, 35090_G_AT, 36703_AT, 33027_AT, 37983_AT, 35091_AT, 39511_AT, 37954_AT	133	1337	16650	1.8726697071774423	0.9999999999997737	0.2663756489479673	15.338151664890132
GAD_DISEASE	Myocardial Infarction|Stroke	3	2.0689655172413794	0.009553706219692842	37983_AT, 38229_AT, 1575_AT	115	17	12971	19.904347826086955	0.9999998703721352	0.3411975278410315	14.901709572576339
GOTERM_BP_FAT	GO:0050790~regulation of catalytic activity	30	20.689655172413794	0.009616764099672855	40959_AT, 33963_AT, 35038_AT, 32148_AT, 32717_AT, 40186_AT, 1355_G_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 35090_G_AT, 37983_AT, 35091_AT, 41280_R_AT, 39511_AT, 1974_S_AT, 33080_S_AT, 38236_AT, 32680_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 37096_AT, 33027_AT, 36703_AT, 1419_G_AT, 1983_AT, 37954_AT	133	2357	16650	1.593398004982758	0.9999999999999494	0.2754798835651445	16.05936343414799
GOTERM_BP_FAT	GO:0044093~positive regulation of molecular function	25	17.24137931034483	0.009628411904704592	40959_AT, 33963_AT, 35038_AT, 32148_AT, 32717_AT, 40186_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 35090_G_AT, 37983_AT, 35091_AT, 39511_AT, 33080_S_AT, 32680_AT, 38236_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1901_S_AT, 37096_AT, 33027_AT, 36703_AT, 1419_G_AT, 1983_AT	133	1840	16650	1.7009235044132067	0.9999999999999512	0.27332586709608475	16.07724606885895
GAD_DISEASE	Bipolar Disorder	10	6.896551724137931	0.009638056444590443	32439_AT, 33685_AT, 33684_AT, 35648_AT, 38236_AT, 40058_S_AT, 1112_G_AT, 34467_G_AT, 40790_AT, 1355_G_AT	115	407	12971	2.771285119111206	0.9999998873854319	0.3365078967504125	15.023449675800315
GOTERM_MF_FAT	GO:0005088~Ras guanyl-nucleotide exchange factor activity	7	4.827586206896552	0.009748079070687882	40959_AT, 35090_G_AT, 32148_AT, 38236_AT, 35091_AT, 1112_G_AT, 1855_AT, 1901_S_AT	124	228	15478	3.8322722127900395	0.9963141580887646	0.4289769092277812	13.38798346883545
GOTERM_BP_FAT	GO:0006855~drug transmembrane transport	3	2.0689655172413794	0.009765476183340099	32084_AT, 1575_AT, 34436_AT	133	19	16650	19.766521567075582	0.9999999999999685	0.2742182613473828	16.287407822875345
GOTERM_BP_FAT	GO:0015669~gas transport	3	2.0689655172413794	0.009765476183340099	33516_AT, 31687_F_AT, 31525_S_AT	133	19	16650	19.766521567075582	0.9999999999999685	0.2742182613473828	16.287407822875345
GOTERM_MF_FAT	GO:0004012~phospholipid-translocating ATPase activity	3	2.0689655172413794	0.009805388821542508	33685_AT, 1575_AT, 39469_S_AT	124	19	15478	19.708828522920204	0.9964341796674836	0.40094176646027224	13.461502034006134
GAD_DISEASE	Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma	7	4.827586206896552	0.009851423718492422	37454_AT, 34636_AT, 1403_S_AT, 33284_AT, 1419_G_AT, 34623_AT, 34546_AT	115	207	12971	3.814198697752573	0.9999999211127439	0.3356068116023675	15.330665347769356
GOTERM_BP_FAT	GO:0051851~modification by host of symbiont morphology or physiology	4	2.7586206896551726	0.00994221387192037	33963_AT, 37096_AT, 679_AT, 1403_S_AT, 37105_AT	133	56	16650	8.941997851772287	0.9999999999999821	0.27603023659416703	16.557667227377358
GAD_DISEASE	stomach cancer	5	3.4482758620689653	0.010117643492146463	1974_S_AT, 33284_AT, 1575_AT, 1419_G_AT, 1901_S_AT	115	96	12971	5.874547101449275	0.999999949408216	0.33617939075980907	15.712515684031858
GOTERM_BP_FAT	GO:0044764~multi-organism cellular process	16	11.03448275862069	0.010202836502157402	33963_AT, 1974_S_AT, 35595_AT, 31793_AT, 1403_S_AT, 32084_AT, 1112_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 32073_AT, 40271_AT, 36234_AT, 34606_S_AT, 32413_AT, 31506_S_AT, 39094_AT	133	973	16650	2.058589433501534	0.9999999999999922	0.27975781136945843	16.95469607525689
GAD_DISEASE	Bone Mineral Density	10	6.896551724137931	0.010233688828312864	38604_AT, 36328_AT, 34636_AT, 34618_AT, 33922_AT, 39187_AT, 1355_G_AT, 1855_AT, 37711_AT, 1910_S_AT	115	411	12971	2.7443139743996614	0.9999999583162446	0.3327556196706144	15.878457046448325
GOTERM_BP_FAT	GO:0050900~leukocyte migration	9	6.206896551724138	0.010236284522196987	33963_AT, 37096_AT, 33530_AT, 36703_AT, 37454_AT, 1403_S_AT, 35367_AT, 35373_AT, 1786_AT	133	376	16650	2.996520556710926	0.999999999999993	0.27816351947106044	17.005520894398906
GOTERM_BP_FAT	GO:0050808~synapse organization	7	4.827586206896552	0.010284550795878249	32148_AT, 40058_S_AT, 32717_AT, 40317_AT, 1355_G_AT, 1901_S_AT, 37711_AT	133	231	16650	3.793574846206425	0.999999999999994	0.2769370438299491	17.078810495099773
GOTERM_BP_FAT	GO:0032496~response to lipopolysaccharide	8	5.517241379310345	0.010357395732928928	32439_AT, 37096_AT, 679_AT, 1403_S_AT, 33284_AT, 1419_G_AT, 1331_S_AT, 37105_AT, 37711_AT	133	302	16650	3.316237613902305	0.9999999999999952	0.2762911057349422	17.189305630570484
GOTERM_BP_FAT	GO:0012501~programmed cell death	25	17.24137931034483	0.01039205521464425	33963_AT, 1974_S_AT, 38236_AT, 32717_AT, 33284_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 35915_AT, 35069_AT, 35367_AT, 1355_G_AT, 38128_AT, 35373_AT, 1910_S_AT, 37711_AT, 1786_AT, 33293_AT, 822_S_AT, 38482_AT, 34618_AT, 1890_AT, 40317_AT, 41280_R_AT, 1983_AT	133	1852	16650	1.689902401792819	0.9999999999999958	0.2747970832941876	17.241830150430403
GAD_DISEASE_CLASS	INFECTION	30	20.689655172413794	0.010403831045060121	33963_AT, 31621_S_AT, 33284_AT, 31525_S_AT, 37968_AT, 35373_AT, 1910_S_AT, 37061_AT, 36713_AT, 679_AT, 37983_AT, 1575_AT, 31506_S_AT, 33979_AT, 1974_S_AT, 38236_AT, 38691_S_AT, 38229_AT, 31793_AT, 37454_AT, 32084_AT, 1403_S_AT, 32250_AT, 34623_AT, 34546_AT, 31512_AT, 36703_AT, 32413_AT, 31687_F_AT, 1419_G_AT, 38201_AT, 37105_AT	115	2154	12971	1.57090953130677	0.17159235918697946	0.01335642397197645	7.4194173930426155
GOTERM_BP_FAT	GO:0051155~positive regulation of striated muscle cell differentiation	4	2.7586206896551726	0.01043472120258194	39698_AT, 1890_AT, 37711_AT, 1910_S_AT	133	57	16650	8.785120696478037	0.9999999999999963	0.2735078976186265	17.30644486391627
GAD_DISEASE	Meningeal Neoplasms|meningioma	7	4.827586206896552	0.010527420368249647	37454_AT, 34636_AT, 1403_S_AT, 33284_AT, 1419_G_AT, 34623_AT, 34546_AT	115	210	12971	3.7597101449275367	0.9999999744719705	0.33408467928250185	16.297112262232616
GOTERM_BP_FAT	GO:0044116~growth of symbiont involved in interaction with host	3	2.0689655172413794	0.010794634302385529	37096_AT, 679_AT, 33284_AT, 37105_AT	133	20	16650	18.778195488721803	0.9999999999999988	0.27924798089696934	17.84961484618005
GOTERM_BP_FAT	GO:0044117~growth of symbiont in host	3	2.0689655172413794	0.010794634302385529	37096_AT, 679_AT, 33284_AT, 37105_AT	133	20	16650	18.778195488721803	0.9999999999999988	0.27924798089696934	17.84961484618005
GOTERM_BP_FAT	GO:0044110~growth involved in symbiotic interaction	3	2.0689655172413794	0.010794634302385529	37096_AT, 679_AT, 33284_AT, 37105_AT	133	20	16650	18.778195488721803	0.9999999999999988	0.27924798089696934	17.84961484618005
GOTERM_BP_FAT	GO:0051702~interaction with symbiont	4	2.7586206896551726	0.010941169726767156	33963_AT, 37096_AT, 679_AT, 1403_S_AT, 37105_AT	133	58	16650	8.633653098262897	0.9999999999999992	0.28021195116438247	18.06979462544861
GOTERM_BP_FAT	GO:0050829~defense response to Gram-negative bacterium	4	2.7586206896551726	0.010941169726767156	33963_AT, 38604_AT, 1419_G_AT, 34546_AT	133	58	16650	8.633653098262897	0.9999999999999992	0.28021195116438247	18.06979462544861
KEGG_PATHWAY	hsa05200:Pathways in cancer	10	6.896551724137931	0.010989489973054923	1974_S_AT, 33684_AT, 37983_AT, 1419_G_AT, 919_AT, 2090_I_AT, 35373_AT, 1855_AT, 1901_S_AT, 1910_S_AT	66	393	6879	2.652093453620171	0.8554031980800829	0.8554031980800829	12.669603397084462
GOTERM_BP_FAT	GO:0031399~regulation of protein modification process	23	15.862068965517242	0.011401789577838212	33963_AT, 1974_S_AT, 35648_AT, 32680_AT, 32717_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 35915_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT, 32073_AT, 37096_AT, 36703_AT, 1890_AT, 41280_R_AT, 1983_AT, 39094_AT	133	1664	16650	1.7303625650665124	0.9999999999999998	0.28788614465438245	18.75828310424921
GOTERM_BP_FAT	GO:0050803~regulation of synapse structure or activity	7	4.827586206896552	0.011566048342954773	38236_AT, 40058_S_AT, 32717_AT, 1112_G_AT, 40317_AT, 1355_G_AT, 37711_AT	133	237	16650	3.6975349766822116	0.9999999999999999	0.28911742909008387	19.00247572982925
GOTERM_BP_FAT	GO:0045785~positive regulation of cell adhesion	9	6.206896551724138	0.01168513956533148	33963_AT, 37096_AT, 36703_AT, 34636_AT, 1403_S_AT, 34618_AT, 35169_AT, 35373_AT, 1901_S_AT	133	385	16650	2.9264720242163853	0.9999999999999999	0.2893813241181211	19.17908693067174
GOTERM_BP_FAT	GO:0072009~nephron epithelium development	5	3.4482758620689653	0.011772717648438413	33684_AT, 40271_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	111	16650	5.639097744360901	1.0	0.2889879255218015	19.308732204982714
GOTERM_MF_FAT	GO:0090484~drug transporter activity	3	2.0689655172413794	0.011917841615670012	32084_AT, 1575_AT, 34436_AT	124	21	15478	17.831797235023043	0.9989489368078636	0.4353200048739738	16.131191012128575
GOTERM_BP_FAT	GO:0032101~regulation of response to external stimulus	13	8.96551724137931	0.01211004035738102	33963_AT, 37096_AT, 38604_AT, 37983_AT, 37454_AT, 1403_S_AT, 39698_AT, 40317_AT, 1419_G_AT, 32250_AT, 1372_AT, 39094_AT, 37172_AT	133	721	16650	2.2572033412240726	1.0	0.2937153441787258	19.806250709841102
GOTERM_BP_FAT	GO:0051130~positive regulation of cellular component organization	18	12.413793103448276	0.012257052725299665	33963_AT, 1974_S_AT, 35648_AT, 32717_AT, 34636_AT, 35169_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 1910_S_AT, 36766_AT, 39469_S_AT, 37172_AT, 1786_AT, 606_AT, 1890_AT, 40317_AT, 39198_S_AT	133	1183	16650	1.9048042761171735	1.0	0.2944952477475987	20.02217174725195
GOTERM_BP_FAT	GO:0018193~peptidyl-amino acid modification	18	12.413793103448276	0.012448054216724687	34233_I_AT, 33963_AT, 1974_S_AT, 35648_AT, 32717_AT, 1403_S_AT, 1355_G_AT, 1855_AT, 38128_AT, 1901_S_AT, 1910_S_AT, 1786_AT, 32073_AT, 39908_AT, 35090_G_AT, 40271_AT, 35091_AT, 1419_G_AT, 33922_AT	133	1185	16650	1.9015894165794234	1.0	0.29614045455938176	20.301880478473233
GOTERM_BP_FAT	GO:0007417~central nervous system development	15	10.344827586206897	0.012488145981313231	40350_AT, 38604_AT, 33684_AT, 32717_AT, 38103_AT, 1355_G_AT, 1901_S_AT, 1910_S_AT, 37711_AT, 32073_AT, 33293_AT, 38816_AT, 34720_AT, 40317_AT, 39511_AT	133	904	16650	2.0772340142391372	1.0	0.29476496753405	20.36047466950248
GOTERM_BP_FAT	GO:0006954~inflammatory response	12	8.275862068965518	0.012505377488930654	33963_AT, 37096_AT, 36703_AT, 37983_AT, 37454_AT, 34636_AT, 1403_S_AT, 1419_G_AT, 37968_AT, 32250_AT, 1331_S_AT, 1372_AT	133	637	16650	2.35832910376412	1.0	0.29296005707585826	20.385646043054063
GOTERM_BP_FAT	GO:0002548~monocyte chemotaxis	4	2.7586206896551726	0.01254482143165419	36703_AT, 37454_AT, 1403_S_AT, 35367_AT	133	61	16650	8.209047208184394	1.0	0.2916170851183083	20.443236516717256
GOTERM_BP_FAT	GO:0050727~regulation of inflammatory response	8	5.517241379310345	0.012627311399242487	37096_AT, 37983_AT, 37454_AT, 1403_S_AT, 1419_G_AT, 32250_AT, 1372_AT, 39094_AT	133	314	16650	3.1895024184665486	1.0	0.2911318810387009	20.563549511654777
GOTERM_CC_FAT	GO:0045177~apical part of cell	9	6.206896551724138	0.012787237105558123	32680_AT, 32084_AT, 1575_AT, 1391_S_AT, 39511_AT, 36378_AT, 1901_S_AT, 34436_AT, 1645_AT	126	361	14527	2.874356944994064	0.9797483367638343	0.3516209611073967	15.82220153001358
GOTERM_BP_FAT	GO:0045332~phospholipid translocation	3	2.0689655172413794	0.012989265632605117	33685_AT, 1575_AT, 39469_S_AT	133	22	16650	17.07108680792891	1.0	0.296025700311936	21.089436706569455
GOTERM_BP_FAT	GO:0002237~response to molecule of bacterial origin	8	5.517241379310345	0.013037932042139457	32439_AT, 37096_AT, 679_AT, 1403_S_AT, 33284_AT, 1419_G_AT, 1331_S_AT, 37105_AT, 37711_AT	133	316	16650	3.169315694299039	1.0	0.29487233630978715	21.159893272465712
GAD_DISEASE	overall effect	3	2.0689655172413794	0.013120340942744424	36328_AT, 33922_AT, 1901_S_AT	115	20	12971	16.918695652173913	0.999999999665455	0.3909587698364312	19.90873975890144
GOTERM_MF_FAT	GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity	4	2.7586206896551726	0.013175770826360473	35090_G_AT, 35091_AT, 35373_AT, 1855_AT, 1901_S_AT	124	62	15478	8.053069719042664	0.9994928132368334	0.442106402052062	17.684277222137336
GOTERM_BP_FAT	GO:0044843~cell cycle G1/S phase transition	7	4.827586206896552	0.013199308092087846	1974_S_AT, 822_S_AT, 38103_AT, 38201_AT, 1983_AT, 39094_AT, 1910_S_AT	133	244	16650	3.591458153580673	1.0	0.29586269021020695	21.39309962112691
GOTERM_BP_FAT	GO:0007610~behavior	11	7.586206896551724	0.013253949571854039	1974_S_AT, 38604_AT, 35648_AT, 38236_AT, 38103_AT, 34249_AT, 37953_S_AT, 1355_G_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	557	16650	2.4722938405259103	1.0	0.29484149007974014	21.471914830725847
GOTERM_BP_FAT	GO:0050807~regulation of synapse organization	5	3.4482758620689653	0.013266587698195092	40058_S_AT, 32717_AT, 40317_AT, 1355_G_AT, 37711_AT	133	115	16650	5.442955214122262	1.0	0.2930546180286683	21.490133508188023
GOTERM_BP_FAT	GO:0030155~regulation of cell adhesion	12	8.275862068965518	0.013333649525226714	33963_AT, 37096_AT, 36703_AT, 34636_AT, 1403_S_AT, 34618_AT, 38482_AT, 35367_AT, 35169_AT, 35373_AT, 1901_S_AT, 1910_S_AT	133	643	16650	2.336322922391515	1.0	0.29229849348912784	21.586740676205572
GOTERM_CC_FAT	GO:0016324~apical plasma membrane	8	5.517241379310345	0.01337660145638528	32680_AT, 32084_AT, 1575_AT, 1391_S_AT, 36378_AT, 1901_S_AT, 34436_AT, 1645_AT	126	293	14527	3.1479495097242536	0.9831003583040314	0.33505189959121684	16.492285302855347
GOTERM_BP_FAT	GO:0044708~single-organism behavior	9	6.206896551724138	0.013467013927715843	38604_AT, 35648_AT, 38236_AT, 38103_AT, 34249_AT, 37953_S_AT, 1355_G_AT, 37711_AT, 1910_S_AT	133	395	16650	2.8523841248691344	1.0	0.2927692098943525	21.778527585310346
GAD_DISEASE_CLASS	NEUROLOGICAL	37	25.517241379310345	0.013475031781931376	32148_AT, 31621_S_AT, 32717_AT, 38103_AT, 33284_AT, 34467_G_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 679_AT, 822_S_AT, 35090_G_AT, 37983_AT, 35121_AT, 35091_AT, 1575_AT, 33922_AT, 41280_R_AT, 38945_AT, 1974_S_AT, 38604_AT, 38236_AT, 34636_AT, 38229_AT, 1403_S_AT, 1112_G_AT, 32250_AT, 38816_AT, 34720_AT, 1890_AT, 37097_AT, 1419_G_AT, 40317_AT, 38201_AT, 32279_AT, 39187_AT, 1983_AT, 37105_AT, 37166_AT	115	2890	12971	1.4440409207161125	0.21666872712220164	0.016148170186189414	9.516517185894646
GAD_DISEASE	Tuberculosis, Pulmonary	4	2.7586206896551726	0.013713607387804208	37983_AT, 1403_S_AT, 1575_AT, 1419_G_AT	115	57	12971	7.9151792524790245	0.9999999998761134	0.39765544908808836	20.714225881461157
GOTERM_BP_FAT	GO:1902533~positive regulation of intracellular signal transduction	15	10.344827586206897	0.013758712048801422	1974_S_AT, 32680_AT, 37454_AT, 34636_AT, 1403_S_AT, 1331_S_AT, 40186_AT, 1355_G_AT, 1901_S_AT, 1645_AT, 1910_S_AT, 37711_AT, 37096_AT, 36703_AT, 39094_AT	133	915	16650	2.0522618020460985	1.0	0.2961020339760192	22.196465293928124
GOTERM_MF_FAT	GO:0016462~pyrophosphatase activity	14	9.655172413793103	0.013890726776818893	37814_G_AT, 32439_AT, 33080_S_AT, 967_G_AT, 37905_R_AT, 39469_S_AT, 34972_S_AT, 33371_S_AT, 33685_AT, 36234_AT, 1575_AT, 606_AT, 919_AT, 40294_AT, 966_AT	124	824	15478	2.1207720012527402	0.9996649385094448	0.4353301387206784	18.555000933702004
GOTERM_MF_FAT	GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	14	9.655172413793103	0.014148890784184982	37814_G_AT, 32439_AT, 33080_S_AT, 967_G_AT, 37905_R_AT, 39469_S_AT, 34972_S_AT, 33371_S_AT, 33685_AT, 36234_AT, 1575_AT, 606_AT, 919_AT, 40294_AT, 966_AT	124	826	15478	2.1156369600874796	0.9997115434363566	0.41922841245039955	18.867296502707443
GOTERM_BP_FAT	GO:0042744~hydrogen peroxide catabolic process	3	2.0689655172413794	0.0141531923897573	33284_AT, 31687_F_AT, 31525_S_AT	133	23	16650	16.328865642366786	1.0	0.3012022557625992	22.7583118121247
GOTERM_BP_FAT	GO:0034204~lipid translocation	3	2.0689655172413794	0.0141531923897573	33685_AT, 1575_AT, 39469_S_AT	133	23	16650	16.328865642366786	1.0	0.3012022557625992	22.7583118121247
GAD_DISEASE	Coronary Artery Disease	11	7.586206896551724	0.01427269788450619	37983_AT, 36328_AT, 34636_AT, 38229_AT, 1403_S_AT, 33284_AT, 40317_AT, 1419_G_AT, 32250_AT, 32279_AT, 37061_AT	115	510	12971	2.4327536231884057	0.9999999999514477	0.403257226442313	21.466332249438192
GOTERM_BP_FAT	GO:0051128~regulation of cellular component organization	29	20.0	0.014311247114491304	33963_AT, 35648_AT, 31621_S_AT, 32717_AT, 35367_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 39469_S_AT, 37711_AT, 32073_AT, 37983_AT, 40058_S_AT, 606_AT, 1974_S_AT, 33080_S_AT, 32680_AT, 34636_AT, 37454_AT, 35169_AT, 1901_S_AT, 37172_AT, 36766_AT, 1786_AT, 38482_AT, 1890_AT, 40317_AT, 39198_S_AT, 919_AT	133	2323	16650	1.562828724846986	1.0	0.3020246616223976	22.98234697216589
GOTERM_MF_FAT	GO:0016817~hydrolase activity, acting on acid anhydrides	14	9.655172413793103	0.014410746115321388	37814_G_AT, 32439_AT, 33080_S_AT, 967_G_AT, 37905_R_AT, 39469_S_AT, 34972_S_AT, 33371_S_AT, 33685_AT, 36234_AT, 1575_AT, 606_AT, 919_AT, 40294_AT, 966_AT	124	828	15478	2.1105267258843696	0.9997522070716311	0.40484435560561594	19.182917197643945
GAD_DISEASE	pharmacogenetic studies	5	3.4482758620689653	0.014609402688388177	1974_S_AT, 37983_AT, 1575_AT, 1901_S_AT, 1910_S_AT	115	107	12971	5.270621698496545	0.9999999999723879	0.403867845794626	21.916035504113772
GOTERM_BP_FAT	GO:0002252~immune effector process	13	8.96551724137931	0.014899491823103815	33963_AT, 31793_AT, 35595_AT, 33284_AT, 37968_AT, 32250_AT, 35367_AT, 37905_R_AT, 35373_AT, 1910_S_AT, 679_AT, 37096_AT, 31512_AT, 31506_S_AT, 37105_AT	133	742	16650	2.1933202277932025	1.0	0.3103266542002948	23.810773572097656
GOTERM_MF_FAT	GO:0052813~phosphatidylinositol bisphosphate kinase activity	4	2.7586206896551726	0.014958931504205748	35090_G_AT, 35091_AT, 35373_AT, 1855_AT, 1901_S_AT	124	65	15478	7.681389578163771	0.9998197475899365	0.3977764833237345	19.83995737312193
GAD_DISEASE	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	4	2.7586206896551726	0.015045478922539516	1974_S_AT, 38229_AT, 1575_AT, 1910_S_AT	115	59	12971	7.646868091378041	0.99999999998671	0.4065190364056612	22.494860337234314
GAD_DISEASE	cardiovascular disease	4	2.7586206896551726	0.015045478922539516	1974_S_AT, 37983_AT, 33284_AT, 1575_AT	115	59	12971	7.646868091378041	0.99999999998671	0.4065190364056612	22.494860337234314
GOTERM_BP_FAT	GO:0016310~phosphorylation	28	19.310344827586206	0.015266575043366825	33963_AT, 32717_AT, 35915_AT, 40186_AT, 1355_G_AT, 1855_AT, 35373_AT, 1910_S_AT, 37711_AT, 679_AT, 35090_G_AT, 35091_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 32680_AT, 38236_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 1786_AT, 37096_AT, 36703_AT, 1890_AT, 1983_AT, 37105_AT	133	2229	16650	1.57257207622016	1.0	0.31463929801487434	24.32346410029619
GOTERM_BP_FAT	GO:0033032~regulation of myeloid cell apoptotic process	3	2.0689655172413794	0.015360510971176279	1403_S_AT, 37711_AT, 1910_S_AT	133	24	16650	15.648496240601503	1.0	0.31424065555674474	24.454135918262708
GOTERM_BP_FAT	GO:0048015~phosphatidylinositol-mediated signaling	6	4.137931034482759	0.01565351716652723	35090_G_AT, 1403_S_AT, 35091_AT, 1355_G_AT, 35373_AT, 1855_AT, 1901_S_AT	133	184	16650	4.0822164105916965	1.0	0.31719526655341934	24.860361014880862
GOTERM_CC_FAT	GO:0098794~postsynapse	9	6.206896551724138	0.015984484885373247	33293_AT, 32148_AT, 38236_AT, 40058_S_AT, 32717_AT, 40317_AT, 936_S_AT, 1355_G_AT, 37711_AT	126	376	14527	2.759688449848024	0.9924213882486883	0.35844274054737324	19.39852849349495
GOTERM_CC_FAT	GO:0031012~extracellular matrix	11	7.586206896551724	0.016124628906021378	33684_AT, 31621_S_AT, 31793_AT, 35367_AT, 35169_AT, 679_AT, 36234_AT, 32413_AT, 37898_R_AT, 38508_S_AT, 31506_S_AT, 2090_I_AT, 37105_AT	126	530	14527	2.3928870919436953	0.9927414975035413	0.33665837162850853	19.552024033364056
GOTERM_BP_FAT	GO:2000026~regulation of multicellular organismal development	23	15.862068965517242	0.016371544910960927	33684_AT, 33080_S_AT, 32680_AT, 32717_AT, 35367_AT, 1355_G_AT, 1855_AT, 1901_S_AT, 35373_AT, 37711_AT, 1910_S_AT, 39469_S_AT, 37172_AT, 32073_AT, 40058_S_AT, 34618_AT, 34720_AT, 606_AT, 39698_AT, 40317_AT, 39511_AT, 2090_I_AT, 39187_AT	133	1721	16650	1.6730524743002186	1.0	0.32710699799984255	25.84713006519579
GOTERM_BP_FAT	GO:2000209~regulation of anoikis	3	2.0689655172413794	0.016610471107132062	41489_AT, 1355_G_AT, 1910_S_AT	133	25	16650	15.022556390977442	1.0	0.32899371458479276	26.1727569392503
GOTERM_BP_FAT	GO:0002227~innate immune response in mucosa	3	2.0689655172413794	0.016610471107132062	31793_AT, 1419_G_AT, 31506_S_AT, 33979_AT	133	25	16650	15.022556390977442	1.0	0.32899371458479276	26.1727569392503
GOTERM_BP_FAT	GO:0015893~drug transport	3	2.0689655172413794	0.016610471107132062	32084_AT, 1575_AT, 34436_AT	133	25	16650	15.022556390977442	1.0	0.32899371458479276	26.1727569392503
GOTERM_BP_FAT	GO:0048017~inositol lipid-mediated signaling	6	4.137931034482759	0.016674109672540578	35090_G_AT, 1403_S_AT, 35091_AT, 1355_G_AT, 35373_AT, 1855_AT, 1901_S_AT	133	187	16650	4.016726307747979	1.0	0.32802176571607267	26.25926032279171
GOTERM_BP_FAT	GO:0051249~regulation of lymphocyte activation	9	6.206896551724138	0.016721374870929426	31512_AT, 1403_S_AT, 34618_AT, 35367_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	411	16650	2.741342407112672	1.0	0.3267998934004941	26.323445538804613
GAD_DISEASE	neutropenia	3	2.0689655172413794	0.017174577152033826	37096_AT, 38229_AT, 1575_AT	115	23	12971	14.711909262759923	0.9999999999996276	0.44236941039643385	25.26342692420479
GAD_DISEASE	inflammatory bowel disease 	4	2.7586206896551726	0.01717592350229348	1974_S_AT, 32084_AT, 1575_AT, 34623_AT	115	62	12971	7.276858345021038	0.9999999999996285	0.4358429739103372	25.265147841538717
GOTERM_BP_FAT	GO:0048667~cell morphogenesis involved in neuron differentiation	10	6.896551724137931	0.01731631807530102	32148_AT, 40058_S_AT, 34720_AT, 1112_G_AT, 606_AT, 1355_G_AT, 1901_S_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	496	16650	2.5239510065486295	1.0	0.334290324449969	27.12686625964863
GAD_DISEASE	ABT-773 plasma levels	2	1.3793103448275863	0.017501101294335294	38229_AT, 1575_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	tacrolimus pharmacokinetics; sirolimus pharmacokinetics	2	1.3793103448275863	0.017501101294335294	38229_AT, 1575_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	breast cancer survival	2	1.3793103448275863	0.017501101294335294	1974_S_AT, 33284_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	hemoglobin disorders	2	1.3793103448275863	0.017501101294335294	31687_F_AT, 31525_S_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	tacrolimus phamacokinetics	2	1.3793103448275863	0.017501101294335294	38229_AT, 1575_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	tacrolimus and cyclosporine	2	1.3793103448275863	0.017501101294335294	38229_AT, 1575_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	Albuminuria|Alpha Thalassemia|alpha-Thalassemia|Anemia, Sickle Cell|Sickle cell anemia	2	1.3793103448275863	0.017501101294335294	31687_F_AT, 31525_S_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	Dyslipidemias|Thalassemia	2	1.3793103448275863	0.017501101294335294	31687_F_AT, 31525_S_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	alpha-Thalassemia|Anemia, Hypochromic	2	1.3793103448275863	0.017501101294335294	31687_F_AT, 31525_S_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	tropical pulmonary eosinophilia	2	1.3793103448275863	0.017501101294335294	36766_AT, 33979_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	blood tacrolimus concentrations 	2	1.3793103448275863	0.017501101294335294	38229_AT, 1575_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	cyclosporine A	2	1.3793103448275863	0.017501101294335294	38229_AT, 1575_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	alpha-Thalassemia|Anemia, Sickle Cell|Glucosephosphate Dehydrogenase Deficiency|Hemolysis|Stroke	2	1.3793103448275863	0.017501101294335294	31687_F_AT, 31525_S_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	cyclosporine pharmacokinetics	2	1.3793103448275863	0.017501101294335294	38229_AT, 1575_AT	115	2	12971	112.79130434782608	0.999999999999785	0.43555805300779515	25.679703329189174
GAD_DISEASE	Stomach Neoplasms	5	3.4482758620689653	0.017516753696356867	1974_S_AT, 36328_AT, 1403_S_AT, 1575_AT, 1419_G_AT	115	113	12971	4.990765679107349	0.9999999999997905	0.42960458537795565	25.69960325792907
GOTERM_BP_FAT	GO:0048246~macrophage chemotaxis	3	2.0689655172413794	0.017902331534692124	33963_AT, 1403_S_AT, 35367_AT	133	26	16650	14.444765760555233	1.0	0.3414570065528363	27.910130813098288
GOTERM_MF_FAT	GO:0001106~RNA polymerase II transcription corepressor activity	3	2.0689655172413794	0.017974650887417384	37096_AT, 34720_AT, 41489_AT	124	26	15478	14.402605459057073	0.9999687979237449	0.4380769323819965	23.36638801204789
GOTERM_MF_FAT	GO:0035004~phosphatidylinositol 3-kinase activity	4	2.7586206896551726	0.01821996588154008	35090_G_AT, 35091_AT, 35373_AT, 1855_AT, 1901_S_AT	124	70	15478	7.1327188940092165	0.9999729529419221	0.4251093240929994	23.646793842365334
GOTERM_BP_FAT	GO:0009314~response to radiation	9	6.206896551724138	0.01831079633973006	1974_S_AT, 37096_AT, 38236_AT, 40317_AT, 967_G_AT, 40790_AT, 35373_AT, 39469_S_AT, 966_AT, 1910_S_AT	133	418	16650	2.6954347591466705	1.0	0.3457386044614653	28.451372498119188
GOTERM_BP_FAT	GO:0050878~regulation of body fluid levels	10	6.896551724137931	0.0187832095558468	32717_AT, 33516_AT, 1391_S_AT, 40317_AT, 31687_F_AT, 919_AT, 35373_AT, 37172_AT, 37954_AT, 1786_AT	133	503	16650	2.488826439857098	1.0	0.3508987629969248	29.072561638350003
GAD_DISEASE	Alzheimer's disease   	16	11.03448275862069	0.01906649330362569	1974_S_AT, 31621_S_AT, 32717_AT, 34636_AT, 33284_AT, 32250_AT, 1355_G_AT, 37983_AT, 38816_AT, 1890_AT, 1575_AT, 37097_AT, 1419_G_AT, 33922_AT, 32279_AT, 39187_AT	115	950	12971	1.8996430205949657	0.9999999999999846	0.4512090311804784	27.645267778201877
GOTERM_BP_FAT	GO:0006915~apoptotic process	23	15.862068965517242	0.019148886733029478	33963_AT, 1974_S_AT, 38236_AT, 32717_AT, 33284_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 35367_AT, 35069_AT, 1355_G_AT, 38128_AT, 35373_AT, 37711_AT, 1910_S_AT, 1786_AT, 33293_AT, 822_S_AT, 34618_AT, 38482_AT, 40317_AT, 41280_R_AT, 1983_AT	133	1747	16650	1.6481530098859052	1.0	0.35436077515418307	29.549898247806127
GOTERM_BP_FAT	GO:0002446~neutrophil mediated immunity	3	2.0689655172413794	0.019235359912209062	33963_AT, 37096_AT, 679_AT, 37105_AT	133	27	16650	13.909774436090226	1.0	0.3536359390738659	29.66233142165481
GOTERM_BP_FAT	GO:0033028~myeloid cell apoptotic process	3	2.0689655172413794	0.019235359912209062	1403_S_AT, 37711_AT, 1910_S_AT	133	27	16650	13.909774436090226	1.0	0.3536359390738659	29.66233142165481
GOTERM_MF_FAT	GO:0043492~ATPase activity, coupled to movement of substances	5	3.4482758620689653	0.019538797561205298	32439_AT, 33685_AT, 1575_AT, 40294_AT, 39469_S_AT	124	129	15478	4.838084521130283	0.9999874629247171	0.4312651884549621	25.137961242983575
GOTERM_BP_FAT	GO:0007399~nervous system development	27	18.620689655172416	0.01965615234976198	33963_AT, 33684_AT, 32148_AT, 32717_AT, 38103_AT, 1355_G_AT, 1910_S_AT, 39469_S_AT, 37711_AT, 32073_AT, 33293_AT, 40058_S_AT, 34249_AT, 606_AT, 39511_AT, 40350_AT, 38604_AT, 33080_S_AT, 32680_AT, 38236_AT, 1112_G_AT, 1901_S_AT, 38816_AT, 34720_AT, 40317_AT, 2090_I_AT, 39187_AT	133	2170	16650	1.5576383354700112	1.0	0.35782419943554	30.20703391224433
GAD_DISEASE	leukemia	5	3.4482758620689653	0.020197097590916535	1974_S_AT, 38229_AT, 33284_AT, 1575_AT, 1910_S_AT	115	118	12971	4.779292557111275	0.9999999999999977	0.46431372385950387	29.034374463846024
KEGG_PATHWAY	hsa05202:Transcriptional misregulation in cancer	6	4.137931034482759	0.02033295003749909	1974_S_AT, 37096_AT, 33284_AT, 1983_AT, 39187_AT, 37711_AT	66	167	6879	3.744692433315188	0.9725376484413094	0.8342823136816998	22.263187375750427
GOTERM_BP_FAT	GO:0043276~anoikis	3	2.0689655172413794	0.02060883271684525	41489_AT, 1355_G_AT, 1910_S_AT	133	28	16650	13.41299677765843	1.0	0.36955868082447396	31.425559398523472
GOTERM_BP_FAT	GO:0050670~regulation of lymphocyte proliferation	6	4.137931034482759	0.020792672222422887	1403_S_AT, 34618_AT, 35367_AT, 1901_S_AT, 37711_AT, 1910_S_AT	133	198	16650	3.793574846206425	1.0	0.37014235410128615	31.658373654808656
GOTERM_BP_FAT	GO:0009893~positive regulation of metabolic process	35	24.137931034482758	0.020946006410808	33963_AT, 35648_AT, 32717_AT, 35915_AT, 40186_AT, 1355_G_AT, 35373_AT, 38128_AT, 1910_S_AT, 37711_AT, 32073_AT, 822_S_AT, 37983_AT, 34618_AT, 936_S_AT, 39094_AT, 38945_AT, 1974_S_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 37096_AT, 36703_AT, 34720_AT, 1890_AT, 31687_F_AT, 1419_G_AT, 2090_I_AT, 39187_AT, 1983_AT	133	3052	16650	1.4356418569359177	1.0	0.37028939733930066	31.85198459866325
GOTERM_BP_FAT	GO:0016032~viral process	15	10.344827586206897	0.0210107450080073	33963_AT, 1974_S_AT, 35595_AT, 31793_AT, 1403_S_AT, 1112_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 32073_AT, 40271_AT, 36234_AT, 34606_S_AT, 32413_AT, 31506_S_AT, 39094_AT	133	966	16650	1.9439125764722365	1.0	0.36919720435794023	31.933572592962854
GAD_DISEASE	Cardiovascular Diseases|	4	2.7586206896551726	0.021082861163009517	38604_AT, 37983_AT, 33284_AT, 37172_AT	115	67	12971	6.7338092147955875	0.9999999999999994	0.472719811475539	30.105095381692614
GOTERM_BP_FAT	GO:0032944~regulation of mononuclear cell proliferation	6	4.137931034482759	0.021197149589941747	1403_S_AT, 34618_AT, 35367_AT, 1901_S_AT, 37711_AT, 1910_S_AT	133	199	16650	3.774511656024483	1.0	0.36980839590729475	32.167977247373905
GOTERM_BP_FAT	GO:0006814~sodium ion transport	6	4.137931034482759	0.021197149589941747	32439_AT, 32084_AT, 37953_S_AT, 40317_AT, 37097_AT, 34436_AT	133	199	16650	3.774511656024483	1.0	0.36980839590729475	32.167977247373905
GOTERM_BP_FAT	GO:0018108~peptidyl-tyrosine phosphorylation	8	5.517241379310345	0.02127542681804105	1974_S_AT, 35090_G_AT, 32717_AT, 1403_S_AT, 35091_AT, 1355_G_AT, 1855_AT, 1901_S_AT, 1786_AT	133	349	16650	2.8696382790787855	1.0	0.3689205267104949	32.26618367651448
GOTERM_MF_FAT	GO:0042802~identical protein binding	19	13.10344827586207	0.021366262887467395	35038_AT, 1974_S_AT, 33080_S_AT, 38691_S_AT, 1403_S_AT, 41489_AT, 37968_AT, 36378_AT, 1355_G_AT, 35439_AT, 1901_S_AT, 1910_S_AT, 38482_AT, 1419_G_AT, 41280_R_AT, 38201_AT, 40790_AT, 40294_AT, 36436_AT	124	1358	15478	1.7464131312651434	0.9999956873430592	0.44472047165022643	27.159410106129332
GAD_DISEASE	Carcinoma, Renal Cell|Kidney Neoplasms|Renal Cell Carcinoma	3	2.0689655172413794	0.02168894561052177	1974_S_AT, 38229_AT, 1575_AT	115	26	12971	13.014381270903009	0.9999999999999998	0.4763147461722306	30.82896176487935
GAD_DISEASE	malaria, plasmodium falciparum	3	2.0689655172413794	0.02168894561052177	31525_S_AT, 1419_G_AT, 37968_AT	115	26	12971	13.014381270903009	0.9999999999999998	0.4763147461722306	30.82896176487935
GOTERM_BP_FAT	GO:0018212~peptidyl-tyrosine modification	8	5.517241379310345	0.0218691798543459	1974_S_AT, 35090_G_AT, 32717_AT, 1403_S_AT, 35091_AT, 1355_G_AT, 1855_AT, 1901_S_AT, 1786_AT	133	351	16650	2.8532870638133794	1.0	0.37508311428902597	33.00674285915856
GOTERM_BP_FAT	GO:0099536~synaptic signaling	11	7.586206896551724	0.0219964689052101	38604_AT, 38236_AT, 32717_AT, 1112_G_AT, 37953_S_AT, 40317_AT, 34467_G_AT, 32279_AT, 1355_G_AT, 37711_AT, 1645_AT	133	604	16650	2.2799133595578347	1.0	0.37484209101915045	33.164505345173225
GOTERM_BP_FAT	GO:0007268~chemical synaptic transmission	11	7.586206896551724	0.0219964689052101	38604_AT, 38236_AT, 32717_AT, 1112_G_AT, 37953_S_AT, 40317_AT, 34467_G_AT, 32279_AT, 1355_G_AT, 37711_AT, 1645_AT	133	604	16650	2.2799133595578347	1.0	0.37484209101915045	33.164505345173225
GOTERM_BP_FAT	GO:0098916~anterograde trans-synaptic signaling	11	7.586206896551724	0.0219964689052101	38604_AT, 38236_AT, 32717_AT, 1112_G_AT, 37953_S_AT, 40317_AT, 34467_G_AT, 32279_AT, 1355_G_AT, 37711_AT, 1645_AT	133	604	16650	2.2799133595578347	1.0	0.37484209101915045	33.164505345173225
GOTERM_BP_FAT	GO:0099537~trans-synaptic signaling	11	7.586206896551724	0.0219964689052101	38604_AT, 38236_AT, 32717_AT, 1112_G_AT, 37953_S_AT, 40317_AT, 34467_G_AT, 32279_AT, 1355_G_AT, 37711_AT, 1645_AT	133	604	16650	2.2799133595578347	1.0	0.37484209101915045	33.164505345173225
GOTERM_BP_FAT	GO:0071346~cellular response to interferon-gamma	5	3.4482758620689653	0.022487740798971076	36703_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1419_G_AT	133	135	16650	4.636591478696741	1.0	0.37947009828879597	33.77010394350562
GAD_DISEASE	Lymphoma, Non-Hodgkin	7	4.827586206896552	0.022534179139484724	38604_AT, 36328_AT, 1403_S_AT, 33284_AT, 1419_G_AT, 32250_AT, 1910_S_AT	115	249	12971	3.1708398812641874	1.0	0.48344153162980663	31.826685854117244
GOTERM_BP_FAT	GO:0061333~renal tubule morphogenesis	4	2.7586206896551726	0.023278504409416836	33684_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	77	16650	6.5032711649253	1.0	0.38793040544268254	34.73401443452461
GAD_DISEASE	allergic rhinitis	3	2.0689655172413794	0.023291395375747363	33684_AT, 1403_S_AT, 33979_AT	115	27	12971	12.532367149758453	1.0	0.488931212252254	32.709004012567775
GOTERM_BP_FAT	GO:2000108~positive regulation of leukocyte apoptotic process	3	2.0689655172413794	0.02347426109936089	1974_S_AT, 1403_S_AT, 37711_AT	133	30	16650	12.518796992481201	1.0	0.3885065673994297	34.970579259531895
GOTERM_BP_FAT	GO:0010259~multicellular organism aging	3	2.0689655172413794	0.02347426109936089	1974_S_AT, 967_G_AT, 33922_AT, 966_AT	133	30	16650	12.518796992481201	1.0	0.3885065673994297	34.970579259531895
GOTERM_BP_FAT	GO:0010604~positive regulation of macromolecule metabolic process	33	22.758620689655174	0.02348485904075648	33963_AT, 35648_AT, 32717_AT, 35915_AT, 40186_AT, 1355_G_AT, 35373_AT, 38128_AT, 1910_S_AT, 37711_AT, 32073_AT, 822_S_AT, 37983_AT, 34618_AT, 936_S_AT, 39094_AT, 38945_AT, 1974_S_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 41489_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 37096_AT, 36703_AT, 34720_AT, 1890_AT, 2090_I_AT, 1983_AT, 39187_AT	133	2856	16650	1.446499652492576	1.0	0.3866873757460707	34.98336334056146
GOTERM_MF_FAT	GO:0031720~haptoglobin binding	2	1.3793103448275863	0.02365285420510504	31687_F_AT, 31525_S_AT	124	3	15478	83.21505376344086	0.9999988685449778	0.46332571530751365	29.617092391675335
GOTERM_MF_FAT	GO:0015081~sodium ion transmembrane transporter activity	5	3.4482758620689653	0.023758547309964833	35121_AT, 37953_S_AT, 40317_AT, 37097_AT, 34436_AT	124	137	15478	4.555568636684719	0.9999989364844076	0.4500879815707308	29.728803430056196
GOTERM_BP_FAT	GO:0050817~coagulation	8	5.517241379310345	0.024038053277300787	33516_AT, 40317_AT, 31687_F_AT, 919_AT, 35373_AT, 37172_AT, 37954_AT, 1786_AT	133	358	16650	2.797496534632671	1.0	0.39183447643818736	35.64738327292205
GOTERM_BP_FAT	GO:0007599~hemostasis	8	5.517241379310345	0.024038053277300787	33516_AT, 40317_AT, 31687_F_AT, 919_AT, 35373_AT, 37172_AT, 37954_AT, 1786_AT	133	358	16650	2.797496534632671	1.0	0.39183447643818736	35.64738327292205
GOTERM_BP_FAT	GO:0072006~nephron development	5	3.4482758620689653	0.024179709003402584	33684_AT, 40271_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	138	16650	4.535796011768551	1.0	0.3916884354925696	35.81638464652769
GOTERM_BP_FAT	GO:0050804~modulation of synaptic transmission	7	4.827586206896552	0.024198011635913192	38236_AT, 32717_AT, 1112_G_AT, 37953_S_AT, 1355_G_AT, 37711_AT, 1645_AT	133	280	16650	3.1296992481203003	1.0	0.38999036050434877	35.83818985928019
GAD_DISEASE	Hepatitis B, Chronic	4	2.7586206896551726	0.024530367810493378	1974_S_AT, 38229_AT, 1403_S_AT, 1575_AT	115	71	12971	6.354439681567667	1.0	0.5011326237036073	34.129546181007456
GOTERM_CC_FAT	GO:0016023~cytoplasmic, membrane-bounded vesicle	18	12.413793103448276	0.024909330895485818	33963_AT, 38236_AT, 35595_AT, 31793_AT, 38691_S_AT, 33284_AT, 31525_S_AT, 34623_AT, 34546_AT, 33371_S_AT, 33685_AT, 37096_AT, 679_AT, 606_AT, 37898_R_AT, 31687_F_AT, 2090_I_AT, 32279_AT, 31506_S_AT, 37105_AT	126	1183	14527	1.7542567322787104	0.9995206693763763	0.4445253495664637	28.651311151084656
GOTERM_BP_FAT	GO:0070663~regulation of leukocyte proliferation	6	4.137931034482759	0.025069958571010895	1403_S_AT, 34618_AT, 35367_AT, 1901_S_AT, 37711_AT, 1910_S_AT	133	208	16650	3.6111914401388083	1.0	0.39894979146055576	36.86893011050187
GOTERM_MF_FAT	GO:0005539~glycosaminoglycan binding	6	4.137931034482759	0.025230007684386366	33963_AT, 37096_AT, 679_AT, 33284_AT, 32250_AT, 1372_AT, 37105_AT	124	208	15478	3.600651364764268	0.9999995512230877	0.45612227646456616	31.266982646406493
GOTERM_BP_FAT	GO:0048167~regulation of synaptic plasticity	5	3.4482758620689653	0.025324991221950637	38236_AT, 32717_AT, 1112_G_AT, 1355_G_AT, 37711_AT	133	140	16650	4.470998925886144	1.0	0.4001572964463729	37.16743789004888
GOTERM_BP_FAT	GO:0051963~regulation of synapse assembly	4	2.7586206896551726	0.025704832420203962	40058_S_AT, 40317_AT, 1355_G_AT, 37711_AT	133	80	16650	6.2593984962406015	1.0	0.40286454239114655	37.60955908511977
GOTERM_BP_FAT	GO:2000045~regulation of G1/S transition of mitotic cell cycle	5	3.4482758620689653	0.025908222265428226	1974_S_AT, 822_S_AT, 38103_AT, 1983_AT, 1910_S_AT	133	141	16650	4.439289713645817	1.0	0.4034050441073286	37.84508744842252
GAD_DISEASE	alpha-Thalassemia|Anemia|Glucosephosphate Dehydrogenase Deficiency|Malaria, Falciparum|Sickle Cell Trait	2	1.3793103448275863	0.026137455250019672	31687_F_AT, 31525_S_AT	115	3	12971	75.19420289855073	1.0	0.5177165928508816	35.93015621290291
GAD_DISEASE	Delayed Graft Function|Diabetes mellitus	2	1.3793103448275863	0.026137455250019672	38229_AT, 1575_AT	115	3	12971	75.19420289855073	1.0	0.5177165928508816	35.93015621290291
GAD_DISEASE	liver transplant; prostate cancer; premature ovarian failure; lupus nephritis	2	1.3793103448275863	0.026137455250019672	38229_AT, 1575_AT	115	3	12971	75.19420289855073	1.0	0.5177165928508816	35.93015621290291
GAD_DISEASE	kidney transplant; cyclospoine pharmacokinetics; heart transplant	2	1.3793103448275863	0.026137455250019672	38229_AT, 1575_AT	115	3	12971	75.19420289855073	1.0	0.5177165928508816	35.93015621290291
GAD_DISEASE	cholesterol, HDL; cholesterol, LDL; leukemia; 9-hydroxyrisperidone; risperidone	2	1.3793103448275863	0.026137455250019672	38229_AT, 1575_AT	115	3	12971	75.19420289855073	1.0	0.5177165928508816	35.93015621290291
GAD_DISEASE	hypercholesterolemia; drug hypersensitivity	2	1.3793103448275863	0.026137455250019672	38229_AT, 1575_AT	115	3	12971	75.19420289855073	1.0	0.5177165928508816	35.93015621290291
KEGG_PATHWAY	hsa04020:Calcium signaling pathway	6	4.137931034482759	0.026509255795519854	38236_AT, 37983_AT, 32418_AT, 1419_G_AT, 34467_G_AT, 1901_S_AT	66	179	6879	3.4936515997968516	0.9909203382934434	0.7913797046527863	28.062751244723316
GOTERM_BP_FAT	GO:0044087~regulation of cellular component biogenesis	13	8.96551724137931	0.02668358938019412	1974_S_AT, 33080_S_AT, 31621_S_AT, 40058_S_AT, 32717_AT, 34636_AT, 38482_AT, 40317_AT, 39198_S_AT, 35169_AT, 1355_G_AT, 35373_AT, 37711_AT	133	807	16650	2.016658747239847	1.0	0.41074762531095055	38.735290818750535
GOTERM_BP_FAT	GO:0072073~kidney epithelium development	5	3.4482758620689653	0.027101131938735448	33684_AT, 40271_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	143	16650	4.377201745622798	1.0	0.41374203218387384	39.20966992334869
GOTERM_BP_FAT	GO:0007166~cell surface receptor signaling pathway	31	21.379310344827587	0.027324124700596718	33684_AT, 32717_AT, 38103_AT, 35915_AT, 35367_AT, 1355_G_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 822_S_AT, 35090_G_AT, 35091_AT, 34618_AT, 40350_AT, 38236_AT, 32680_AT, 37454_AT, 1403_S_AT, 41489_AT, 1112_G_AT, 1331_S_AT, 36378_AT, 35169_AT, 1901_S_AT, 1786_AT, 31512_AT, 40271_AT, 36703_AT, 1890_AT, 2090_I_AT, 39187_AT	133	2669	16650	1.454037867242103	1.0	0.41442872259911123	39.46159305550011
GAD_DISEASE	Alzheimer's Disease	8	5.517241379310345	0.02748614040248607	1974_S_AT, 679_AT, 33284_AT, 1575_AT, 41280_R_AT, 32250_AT, 1355_G_AT, 35373_AT, 37105_AT	115	333	12971	2.709701005353179	1.0	0.5298954726302147	37.40541664513837
GOTERM_CC_FAT	GO:0031988~membrane-bounded vesicle	42	28.965517241379313	0.0275201465006028	33963_AT, 38646_S_AT, 33530_AT, 33284_AT, 31525_S_AT, 35915_AT, 35367_AT, 39908_AT, 679_AT, 33685_AT, 35956_S_AT, 34012_AT, 36234_AT, 1391_S_AT, 1575_AT, 606_AT, 31506_S_AT, 33979_AT, 38236_AT, 32680_AT, 31793_AT, 38691_S_AT, 35595_AT, 32084_AT, 1112_G_AT, 32250_AT, 36378_AT, 34623_AT, 36766_AT, 37172_AT, 34546_AT, 33371_S_AT, 31512_AT, 37096_AT, 36328_AT, 32413_AT, 1890_AT, 37898_R_AT, 31687_F_AT, 38508_S_AT, 32279_AT, 2090_I_AT, 37105_AT, 37166_AT	126	3611	14527	1.3409951075417703	0.9997872714737359	0.45335945845907133	31.166056301275514
GOTERM_BP_FAT	GO:0002931~response to ischemia	3	2.0689655172413794	0.028058146087036755	33293_AT, 37711_AT, 1910_S_AT	133	33	16650	11.380724538619274	1.0	0.42098014484935486	40.28389487415641
GOTERM_MF_FAT	GO:0097367~carbohydrate derivative binding	27	18.620689655172416	0.028246074746063103	33963_AT, 37814_G_AT, 33284_AT, 1355_G_AT, 37061_AT, 39469_S_AT, 33685_AT, 679_AT, 36234_AT, 1575_AT, 606_AT, 1974_S_AT, 32680_AT, 32084_AT, 967_G_AT, 32250_AT, 37905_R_AT, 1901_S_AT, 1786_AT, 34972_S_AT, 33371_S_AT, 37096_AT, 1419_G_AT, 919_AT, 40294_AT, 1372_AT, 39187_AT, 37105_AT, 966_AT	124	2241	15478	1.503886513797124	0.999999923756005	0.48085553768890643	34.32224646652605
GOTERM_BP_FAT	GO:0015748~organophosphate ester transport	4	2.7586206896551726	0.02826197530482096	33685_AT, 1575_AT, 39469_S_AT, 34436_AT	133	83	16650	6.033155177099375	1.0	0.4213916717923918	40.51035957212863
GOTERM_BP_FAT	GO:0031175~neuron projection development	13	8.96551724137931	0.028975404851704023	38604_AT, 32148_AT, 32680_AT, 40058_S_AT, 32717_AT, 34720_AT, 1112_G_AT, 606_AT, 1355_G_AT, 1901_S_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	817	16650	1.9919750416432758	1.0	0.42752476434156916	41.29664252525526
GOTERM_BP_FAT	GO:0030593~neutrophil chemotaxis	4	2.7586206896551726	0.029143356667653688	36703_AT, 37454_AT, 1403_S_AT, 35367_AT	133	84	16650	5.961331901181525	1.0	0.4274914029581024	41.48031193497652
GOTERM_BP_FAT	GO:0002385~mucosal immune response	3	2.0689655172413794	0.029659574167181593	31793_AT, 1419_G_AT, 31506_S_AT, 33979_AT	133	34	16650	11.045997346306942	1.0	0.43129718895154023	42.04144608405922
GOTERM_BP_FAT	GO:0036211~protein modification process	41	28.27586206896552	0.030273761345821187	34233_I_AT, 33963_AT, 38674_AT, 35648_AT, 32717_AT, 35915_AT, 1355_G_AT, 40186_AT, 35373_AT, 38128_AT, 1855_AT, 1910_S_AT, 37711_AT, 36713_AT, 39908_AT, 32073_AT, 679_AT, 35090_G_AT, 34249_AT, 35091_AT, 38948_AT, 39698_AT, 33922_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 1786_AT, 37096_AT, 40271_AT, 36703_AT, 1890_AT, 1419_G_AT, 1983_AT, 37105_AT	133	3818	16650	1.3443443601145346	1.0	0.4360989227092128	42.702452109631885
GOTERM_BP_FAT	GO:0006464~cellular protein modification process	41	28.27586206896552	0.030273761345821187	34233_I_AT, 33963_AT, 38674_AT, 35648_AT, 32717_AT, 35915_AT, 1355_G_AT, 40186_AT, 35373_AT, 38128_AT, 1855_AT, 1910_S_AT, 37711_AT, 36713_AT, 39908_AT, 32073_AT, 679_AT, 35090_G_AT, 34249_AT, 35091_AT, 38948_AT, 39698_AT, 33922_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 1786_AT, 37096_AT, 40271_AT, 36703_AT, 1890_AT, 1419_G_AT, 1983_AT, 37105_AT	133	3818	16650	1.3443443601145346	1.0	0.4360989227092128	42.702452109631885
GOTERM_BP_FAT	GO:0007162~negative regulation of cell adhesion	6	4.137931034482759	0.030386751453317117	36703_AT, 34618_AT, 38482_AT, 35367_AT, 35373_AT, 1901_S_AT	133	219	16650	3.4298073952003296	1.0	0.43542669722760496	42.82327701196984
GOTERM_CC_FAT	GO:0005773~vacuole	18	12.413793103448276	0.030535510320647136	33963_AT, 33080_S_AT, 32680_AT, 31793_AT, 38691_S_AT, 33284_AT, 34467_G_AT, 1355_G_AT, 1901_S_AT, 37061_AT, 36766_AT, 39469_S_AT, 34546_AT, 33371_S_AT, 606_AT, 936_S_AT, 31506_S_AT, 40294_AT, 37954_AT	126	1212	14527	1.7122819424799622	0.9999169829065168	0.4655039480887371	33.96829558511529
GOTERM_BP_FAT	GO:0051050~positive regulation of transport	14	9.655172413793103	0.030816743544838477	33963_AT, 1974_S_AT, 40271_AT, 1403_S_AT, 1391_S_AT, 35367_AT, 35373_AT, 1901_S_AT, 1910_S_AT, 1645_AT, 37172_AT, 39469_S_AT, 36766_AT, 1786_AT	133	920	16650	1.9050343249427917	1.0	0.4381560663935993	43.28088742783985
GOTERM_BP_FAT	GO:0043648~dicarboxylic acid metabolic process	4	2.7586206896551726	0.030949494285509766	40735_AT, 38201_AT, 32279_AT, 37166_AT	133	86	16650	5.822696275572652	1.0	0.4376928417821724	43.421464216463846
GOTERM_MF_FAT	GO:0043125~ErbB-3 class receptor binding	2	1.3793103448275863	0.0314131578520353	35373_AT, 1901_S_AT	124	4	15478	62.41129032258065	0.9999999882169098	0.5044945553932279	37.39394454874303
GOTERM_MF_FAT	GO:0044736~acid-sensing ion channel activity	2	1.3793103448275863	0.0314131578520353	37953_S_AT, 40317_AT	124	4	15478	62.41129032258065	0.9999999882169098	0.5044945553932279	37.39394454874303
KEGG_PATHWAY	hsa04010:MAPK signaling pathway	7	4.827586206896552	0.03151996668894942	1974_S_AT, 41280_R_AT, 919_AT, 1355_G_AT, 40186_AT, 1855_AT, 37711_AT	66	253	6879	2.883758533956162	0.9963198331112486	0.7536986011476656	32.47286205719404
GAD_DISEASE	Multiple Sclerosis	11	7.586206896551724	0.031753787913939714	1974_S_AT, 37454_AT, 1403_S_AT, 33284_AT, 37953_S_AT, 40317_AT, 967_G_AT, 1419_G_AT, 37166_AT, 966_AT, 1910_S_AT, 1786_AT	115	581	12971	2.1354635935044524	1.0	0.5767572207021011	41.86588083756768
GOTERM_BP_FAT	GO:0016054~organic acid catabolic process	6	4.137931034482759	0.03195093267029194	40735_AT, 1391_S_AT, 1419_G_AT, 38201_AT, 32279_AT, 37166_AT	133	222	16650	3.383458646616541	1.0	0.4463505276189008	44.4713815453154
GOTERM_MF_FAT	GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding	4	2.7586206896551726	0.032035647499946286	37096_AT, 34720_AT, 41489_AT, 40790_AT	124	87	15478	5.738969225064887	0.9999999918425195	0.49831859772915577	37.981718950947084
GOTERM_CC_FAT	GO:0097060~synaptic membrane	7	4.827586206896552	0.03206613689177937	33293_AT, 38236_AT, 40058_S_AT, 32717_AT, 936_S_AT, 32279_AT, 1355_G_AT	126	276	14527	2.924114331723027	0.9999485669571132	0.46054820978401756	35.349990452309164
GOTERM_MF_FAT	GO:0046982~protein heterodimerization activity	9	6.206896551724138	0.03211791887044105	39908_AT, 1974_S_AT, 37983_AT, 40790_AT, 32279_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT	124	465	15478	2.4159209157127997	0.9999999922296392	0.48669806721796893	38.05901630507377
GOTERM_BP_FAT	GO:0050678~regulation of epithelial cell proliferation	7	4.827586206896552	0.03239215377013789	33080_S_AT, 1403_S_AT, 34618_AT, 34720_AT, 1901_S_AT, 37172_AT, 37711_AT	133	300	16650	2.9210526315789473	1.0	0.4490426976289428	44.92809599613834
GOTERM_BP_FAT	GO:0003073~regulation of systemic arterial blood pressure	4	2.7586206896551726	0.03281329129417311	679_AT, 37983_AT, 1391_S_AT, 40317_AT, 37105_AT	133	88	16650	5.690362269309637	1.0	0.4514884776996615	45.360709357905726
GOTERM_BP_FAT	GO:0002694~regulation of leukocyte activation	9	6.206896551724138	0.03294352834895707	31512_AT, 1403_S_AT, 34618_AT, 35367_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	468	16650	2.4074609600925387	1.0	0.4509492165556005	45.49384399100408
GOTERM_BP_FAT	GO:0002251~organ or tissue specific immune response	3	2.0689655172413794	0.03296863182145674	31793_AT, 1419_G_AT, 31506_S_AT, 33979_AT	133	36	16650	10.432330827067668	1.0	0.4493511740704691	45.51947072070981
GOTERM_BP_FAT	GO:0048872~homeostasis of number of cells	6	4.137931034482759	0.0330212956656253	38103_AT, 32084_AT, 32413_AT, 39511_AT, 37711_AT, 1910_S_AT	133	224	16650	3.3532491944146074	1.0	0.44804490849964873	45.57319530491504
GOTERM_BP_FAT	GO:0010035~response to inorganic substance	9	6.206896551724138	0.033299391346432124	40271_AT, 34636_AT, 33284_AT, 31687_F_AT, 31525_S_AT, 37166_AT, 37711_AT, 1910_S_AT, 38945_AT	133	469	16650	2.402327781073152	1.0	0.4490159083897879	45.856063267657674
GOTERM_BP_FAT	GO:1902806~regulation of cell cycle G1/S phase transition	5	3.4482758620689653	0.03355354545373125	1974_S_AT, 822_S_AT, 38103_AT, 1983_AT, 1910_S_AT	133	153	16650	4.091110128261831	1.0	0.4497367546068197	46.11336354019103
GOTERM_BP_FAT	GO:0045860~positive regulation of protein kinase activity	9	6.206896551724138	0.033657877802016456	33963_AT, 37096_AT, 32680_AT, 32717_AT, 1403_S_AT, 1983_AT, 40186_AT, 1901_S_AT, 37711_AT	133	470	16650	2.397216445368741	1.0	0.44896421213804316	46.21865259355309
GAD_DISEASE	nephropathy, diabetic	3	2.0689655172413794	0.03386559655499077	37983_AT, 1403_S_AT, 1419_G_AT	115	33	12971	10.253754940711461	1.0	0.5948169759926856	43.960853377348656
GOTERM_CC_FAT	GO:0031838~haptoglobin-hemoglobin complex	2	1.3793103448275863	0.033980433322274545	31687_F_AT, 31525_S_AT	126	4	14527	57.64682539682539	0.9999717684511915	0.45999701674832405	37.040371005875805
GOTERM_BP_FAT	GO:0022407~regulation of cell-cell adhesion	8	5.517241379310345	0.03419395343732426	37096_AT, 36703_AT, 34636_AT, 1403_S_AT, 34618_AT, 35367_AT, 35373_AT, 1901_S_AT	133	386	16650	2.5945693248665704	1.0	0.4524519681701513	46.756585869365885
GOTERM_BP_FAT	GO:1901991~negative regulation of mitotic cell cycle phase transition	5	3.4482758620689653	0.03424394629916931	1974_S_AT, 822_S_AT, 38103_AT, 39198_S_AT, 1910_S_AT	133	154	16650	4.064544478078313	1.0	0.45114607010217866	46.80649198229894
GOTERM_BP_FAT	GO:0045664~regulation of neuron differentiation	10	6.896551724137931	0.034264626025136	32073_AT, 33080_S_AT, 32680_AT, 40058_S_AT, 32717_AT, 606_AT, 1355_G_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	560	16650	2.235499462943072	1.0	0.44956521720382026	46.82712289944519
GOTERM_BP_FAT	GO:0040008~regulation of growth	11	7.586206896551724	0.03465976644509256	1974_S_AT, 37096_AT, 679_AT, 37983_AT, 33284_AT, 39698_AT, 606_AT, 37105_AT, 1901_S_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	652	16650	2.1120669772590985	1.0	0.45163119524303774	47.21988138995097
GOTERM_BP_FAT	GO:0070232~regulation of T cell apoptotic process	3	2.0689655172413794	0.03467495707309654	1974_S_AT, 1403_S_AT, 35367_AT	133	37	16650	10.150375939849624	1.0	0.45001316271281444	47.234925598471754
GAD_DISEASE	Efavirenz 	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	efavirenz pharmacokinetics	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	Diabetes Mellitus|Postoperative Complications	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	voriconazole	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	dose of nevirapine or efavirenz	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	Lymphoma, T-Cell, Cutaneous|Lymphoma, T-Cell, Peripheral|Skin Neoplasms	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	pharmacogenetic diversity 	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	repaglinide pharmacokinetics	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	cyclosporine	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	Genitourinary Neoplasms|Urogenital Neoplasms	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GAD_DISEASE	9-Hydroxyrisperidone and Risperidone	2	1.3793103448275863	0.03469855411633719	38229_AT, 1575_AT	115	4	12971	56.39565217391304	1.0	0.5981050307967672	44.7674742884998
GOTERM_BP_FAT	GO:0045597~positive regulation of cell differentiation	13	8.96551724137931	0.03505671429329398	32073_AT, 37983_AT, 32717_AT, 34618_AT, 606_AT, 1890_AT, 39698_AT, 35367_AT, 39187_AT, 1355_G_AT, 37711_AT, 1910_S_AT, 39469_S_AT	133	841	16650	1.935129142714098	1.0	0.451926694804466	47.6116755307619
GAD_DISEASE	esophageal adenocarcinoma	8	5.517241379310345	0.035114556912489936	1974_S_AT, 38604_AT, 38229_AT, 1403_S_AT, 1575_AT, 1419_G_AT, 1901_S_AT, 1910_S_AT	115	351	12971	2.5707419794376314	1.0	0.5968698064883192	45.16622294117316
GOTERM_BP_FAT	GO:0031325~positive regulation of cellular metabolic process	32	22.06896551724138	0.03549097948907015	33963_AT, 35648_AT, 32717_AT, 35915_AT, 40186_AT, 1355_G_AT, 35373_AT, 1910_S_AT, 37711_AT, 822_S_AT, 37983_AT, 34618_AT, 936_S_AT, 39094_AT, 38945_AT, 1974_S_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 37096_AT, 36703_AT, 34720_AT, 1890_AT, 31687_F_AT, 1419_G_AT, 2090_I_AT, 1983_AT, 39187_AT	133	2839	16650	1.4110655292687513	1.0	0.4543130223721158	48.03715444846334
GOTERM_BP_FAT	GO:0045595~regulation of cell differentiation	20	13.793103448275861	0.035590749900481555	33080_S_AT, 32680_AT, 32717_AT, 35367_AT, 35069_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 37711_AT, 1910_S_AT, 39469_S_AT, 32073_AT, 37983_AT, 40058_S_AT, 34618_AT, 606_AT, 1890_AT, 39698_AT, 39511_AT, 39187_AT	133	1544	16650	1.6216058280416066	1.0	0.4535140415390647	48.13444398258107
GOTERM_BP_FAT	GO:0051149~positive regulation of muscle cell differentiation	4	2.7586206896551726	0.035716556686147184	39698_AT, 1890_AT, 37711_AT, 1910_S_AT	133	91	16650	5.502767908782946	1.0	0.4529674099109622	48.25687715745121
GOTERM_CC_FAT	GO:0045211~postsynaptic membrane	6	4.137931034482759	0.036304226565693216	33293_AT, 38236_AT, 40058_S_AT, 32717_AT, 936_S_AT, 1355_G_AT	126	212	14527	3.263027852650494	0.9999863916289582	0.46339353986254894	39.037376407368576
GOTERM_MF_FAT	GO:0005085~guanyl-nucleotide exchange factor activity	7	4.827586206896552	0.036363836714868425	40959_AT, 35090_G_AT, 32148_AT, 38236_AT, 35091_AT, 1112_G_AT, 1855_AT, 1901_S_AT	124	308	15478	2.8368768328445744	0.999999999371526	0.5183854880441088	41.92853602847653
GOTERM_BP_FAT	GO:0021543~pallium development	5	3.4482758620689653	0.036364696838381866	38604_AT, 38816_AT, 39511_AT, 1355_G_AT, 37711_AT	133	157	16650	3.9868780230831855	1.0	0.45730029465989985	48.88332176231359
GOTERM_BP_FAT	GO:0097035~regulation of membrane lipid distribution	3	2.0689655172413794	0.036414957020808776	33685_AT, 1575_AT, 39469_S_AT	133	38	16650	9.883260783537791	1.0	0.4560448374427276	48.93159898618033
GOTERM_BP_FAT	GO:0072080~nephron tubule development	4	2.7586206896551726	0.03671285465058359	33684_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	92	16650	5.442955214122262	1.0	0.4570831574339467	49.21686022018896
GOTERM_BP_FAT	GO:0021537~telencephalon development	6	4.137931034482759	0.03694289693885523	38604_AT, 38816_AT, 34720_AT, 39511_AT, 1355_G_AT, 37711_AT	133	231	16650	3.25163558246265	1.0	0.4574890525223817	49.43611358077814
GAD_DISEASE	atherosclerosis	8	5.517241379310345	0.03698347620002779	1974_S_AT, 38604_AT, 31621_S_AT, 37983_AT, 34636_AT, 33284_AT, 32250_AT, 1786_AT	115	355	12971	2.541775872627067	1.0	0.610643412305822	46.92445469540366
GOTERM_BP_FAT	GO:0000904~cell morphogenesis involved in differentiation	12	8.275862068965518	0.037046558949047244	32148_AT, 32680_AT, 40058_S_AT, 34720_AT, 1112_G_AT, 606_AT, 1355_G_AT, 1901_S_AT, 39469_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	753	16650	1.9950274091603508	1.0	0.4567397322019169	49.5346212784373
GOTERM_BP_FAT	GO:0045666~positive regulation of neuron differentiation	7	4.827586206896552	0.03709467102843893	32073_AT, 32717_AT, 606_AT, 1355_G_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	310	16650	2.826825127334465	1.0	0.4554921679244567	49.580279483440236
GOTERM_BP_FAT	GO:0008284~positive regulation of cell proliferation	13	8.96551724137931	0.037273475921779785	38646_S_AT, 1403_S_AT, 35069_AT, 1355_G_AT, 1901_S_AT, 1855_AT, 1910_S_AT, 37711_AT, 37096_AT, 34618_AT, 38482_AT, 1983_AT, 39187_AT	133	849	16650	1.916894710273918	1.0	0.45543842254925937	49.74962291885029
GAD_DISEASE	Neoplasms	5	3.4482758620689653	0.03727970007690215	1974_S_AT, 38229_AT, 33284_AT, 1575_AT, 35373_AT	115	143	12971	3.943751900273639	1.0	0.6081071221285672	47.1982178442911
GOTERM_BP_FAT	GO:0001952~regulation of cell-matrix adhesion	4	2.7586206896551726	0.037723358126605856	36703_AT, 35169_AT, 35373_AT, 1910_S_AT	133	93	16650	5.384428813970409	1.0	0.4578220875443023	50.17332580894129
GOTERM_BP_FAT	GO:0051153~regulation of striated muscle cell differentiation	4	2.7586206896551726	0.037723358126605856	39698_AT, 1890_AT, 37711_AT, 1910_S_AT	133	93	16650	5.384428813970409	1.0	0.4578220875443023	50.17332580894129
GOTERM_BP_FAT	GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction	4	2.7586206896551726	0.037723358126605856	33963_AT, 37096_AT, 679_AT, 1403_S_AT, 37105_AT	133	93	16650	5.384428813970409	1.0	0.4578220875443023	50.17332580894129
GOTERM_BP_FAT	GO:0097529~myeloid leukocyte migration	5	3.4482758620689653	0.037819886919306406	33963_AT, 36703_AT, 37454_AT, 1403_S_AT, 35367_AT	133	159	16650	3.9367286139877997	1.0	0.4570235394968848	50.26379655782254
GOTERM_BP_FAT	GO:1901990~regulation of mitotic cell cycle phase transition	7	4.827586206896552	0.03808505307481459	1974_S_AT, 822_S_AT, 38103_AT, 39198_S_AT, 1983_AT, 39094_AT, 1910_S_AT	133	312	16650	2.8087044534412953	1.0	0.45773217864036353	50.511523089557684
GAD_DISEASE_CLASS	AGING	15	10.344827586206897	0.03814083896766968	1974_S_AT, 38229_AT, 33284_AT, 35367_AT, 35373_AT, 37061_AT, 679_AT, 822_S_AT, 37983_AT, 36328_AT, 40058_S_AT, 1575_AT, 1890_AT, 1419_G_AT, 39187_AT, 37105_AT	115	948	12971	1.7846725371491468	0.5033999688474833	0.042804999921725595	24.922316371118068
GOTERM_BP_FAT	GO:0038128~ERBB2 signaling pathway	3	2.0689655172413794	0.03818799931114449	35090_G_AT, 35091_AT, 35373_AT, 1901_S_AT	133	39	16650	9.629843840370157	1.0	0.45699900216922373	50.607384168437704
GAD_DISEASE	Bronchiolitis, Viral|Respiratory Syncytial Virus Infections	6	4.137931034482759	0.03840078495334985	36703_AT, 38691_S_AT, 37454_AT, 1403_S_AT, 32084_AT, 1419_G_AT	115	211	12971	3.207335668658562	1.0	0.6137605160066757	48.22232106228343
GOTERM_BP_FAT	GO:0003018~vascular process in circulatory system	5	3.4482758620689653	0.038559904323256254	33963_AT, 37983_AT, 40317_AT, 31687_F_AT, 1419_G_AT	133	160	16650	3.9121240601503757	1.0	0.4586404108121256	50.95223357511649
GOTERM_BP_FAT	GO:1903037~regulation of leukocyte cell-cell adhesion	7	4.827586206896552	0.03858654186593535	37096_AT, 36703_AT, 1403_S_AT, 34618_AT, 35367_AT, 35373_AT, 1901_S_AT	133	313	16650	2.7997309567849333	1.0	0.45724302224904767	50.97684576961772
GAD_DISEASE	breast cancer   	10	6.896551724137931	0.038689192017689764	1974_S_AT, 36328_AT, 38229_AT, 33284_AT, 1575_AT, 1983_AT, 1901_S_AT, 37711_AT, 1645_AT, 1910_S_AT	115	518	12971	2.1774383078730906	1.0	0.6112009422389038	48.48274140513762
GOTERM_BP_FAT	GO:1990266~neutrophil migration	4	2.7586206896551726	0.038748024333767984	36703_AT, 37454_AT, 1403_S_AT, 35367_AT	133	94	16650	5.327147656374979	1.0	0.4570339802462655	51.12580054244744
GOTERM_BP_FAT	GO:0046854~phosphatidylinositol phosphorylation	4	2.7586206896551726	0.038748024333767984	35090_G_AT, 35091_AT, 35373_AT, 1855_AT, 1901_S_AT	133	94	16650	5.327147656374979	1.0	0.4570339802462655	51.12580054244744
GOTERM_MF_FAT	GO:0008201~heparin binding	5	3.4482758620689653	0.03878310369800164	33963_AT, 37096_AT, 679_AT, 33284_AT, 32250_AT, 37105_AT	124	160	15478	3.9007056451612905	0.999999999850776	0.5296065255560527	44.03135888673839
GOTERM_BP_FAT	GO:0006897~endocytosis	11	7.586206896551724	0.03882550208650391	33371_S_AT, 33963_AT, 31512_AT, 37096_AT, 34636_AT, 37408_AT, 31687_F_AT, 31525_S_AT, 35367_AT, 35373_AT, 1786_AT	133	665	16650	2.070778449884109	1.0	0.4560965432387801	51.19711573032475
GAD_DISEASE	ovarian cancer  	5	3.4482758620689653	0.03891830311506075	1974_S_AT, 1575_AT, 1983_AT, 1901_S_AT, 37172_AT	115	145	12971	3.8893553223388304	1.0	0.6081289023079361	48.688741258365575
GOTERM_BP_FAT	GO:0033088~negative regulation of immature T cell proliferation in thymus	2	1.3793103448275863	0.03902069550355399	34618_AT, 1901_S_AT	133	5	16650	50.07518796992481	1.0	0.45618701023053243	51.376347896015375
GOTERM_BP_FAT	GO:0050915~sensory perception of sour taste	2	1.3793103448275863	0.03902069550355399	37953_S_AT, 40317_AT	133	5	16650	50.07518796992481	1.0	0.45618701023053243	51.376347896015375
GOTERM_BP_FAT	GO:0070944~neutrophil mediated killing of bacterium	2	1.3793103448275863	0.03902069550355399	33963_AT, 679_AT, 37105_AT	133	5	16650	50.07518796992481	1.0	0.45618701023053243	51.376347896015375
GOTERM_BP_FAT	GO:0022603~regulation of anatomical structure morphogenesis	15	10.344827586206897	0.03907400602230639	33684_AT, 32680_AT, 37454_AT, 1355_G_AT, 1901_S_AT, 37711_AT, 37172_AT, 1910_S_AT, 40058_S_AT, 34720_AT, 606_AT, 1890_AT, 919_AT, 2090_I_AT, 39187_AT	133	1051	16650	1.7866979532561182	1.0	0.4550527120415242	51.425190906408815
GOTERM_BP_FAT	GO:0048639~positive regulation of developmental growth	5	3.4482758620689653	0.03930820820128436	39698_AT, 606_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	161	16650	3.887825152944473	1.0	0.4554831554377745	51.63921793751454
GOTERM_BP_FAT	GO:0034341~response to interferon-gamma	5	3.4482758620689653	0.03930820820128436	36703_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1419_G_AT	133	161	16650	3.887825152944473	1.0	0.4554831554377745	51.63921793751454
GOTERM_BP_FAT	GO:0061326~renal tubule development	4	2.7586206896551726	0.03978680839955999	33684_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	95	16650	5.271072417886822	1.0	0.45799451849799344	52.073821890966045
GOTERM_BP_FAT	GO:0042743~hydrogen peroxide metabolic process	3	2.0689655172413794	0.039993459374255844	33284_AT, 31687_F_AT, 31525_S_AT	133	40	16650	9.389097744360901	1.0	0.4581727371189398	52.2603331436416
GOTERM_MF_FAT	GO:0048020~CCR chemokine receptor binding	3	2.0689655172413794	0.04015117823542637	36703_AT, 37454_AT, 1403_S_AT	124	40	15478	9.361693548387096	0.9999999999339273	0.5305237561060675	45.188856715914184
GOTERM_MF_FAT	GO:0008083~growth factor activity	5	3.4482758620689653	0.04029639967233654	38646_S_AT, 35090_G_AT, 35091_AT, 1890_AT, 35915_AT, 1855_AT	124	162	15478	3.852548785344484	0.9999999999394052	0.5205966189579061	45.31040686017025
GOTERM_BP_FAT	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	4	2.7586206896551726	0.04083966341342309	1974_S_AT, 822_S_AT, 38103_AT, 1910_S_AT	133	96	16650	5.216165413533834	1.0	0.46371802877547763	53.01693863716936
GOTERM_BP_FAT	GO:1903038~negative regulation of leukocyte cell-cell adhesion	4	2.7586206896551726	0.04083966341342309	36703_AT, 34618_AT, 35367_AT, 1901_S_AT	133	96	16650	5.216165413533834	1.0	0.46371802877547763	53.01693863716936
GAD_DISEASE	cervical cancer	4	2.7586206896551726	0.04116512166173395	1974_S_AT, 33284_AT, 1419_G_AT, 1901_S_AT	115	87	12971	5.185807096451774	1.0	0.6239700098341581	50.66827623649408
GOTERM_MF_FAT	GO:0046983~protein dimerization activity	16	11.03448275862069	0.04169555586634216	1974_S_AT, 33080_S_AT, 1403_S_AT, 37968_AT, 36378_AT, 1355_G_AT, 1901_S_AT, 35373_AT, 37711_AT, 1910_S_AT, 39908_AT, 37983_AT, 1419_G_AT, 40790_AT, 32279_AT, 40294_AT	124	1160	15478	1.7216907675194661	0.9999999999736972	0.5220372645472229	46.46869936923559
GOTERM_BP_FAT	GO:0040012~regulation of locomotion	12	8.275862068965518	0.04174803577779122	33963_AT, 37096_AT, 35090_G_AT, 36703_AT, 1403_S_AT, 35091_AT, 38482_AT, 919_AT, 35367_AT, 1372_AT, 35373_AT, 1901_S_AT, 1910_S_AT	133	768	16650	1.9560620300751879	1.0	0.4696733968274306	53.816514943742575
GOTERM_BP_FAT	GO:0007159~leukocyte cell-cell adhesion	9	6.206896551724138	0.04180482977691476	37096_AT, 36703_AT, 1403_S_AT, 34618_AT, 35367_AT, 39187_AT, 35373_AT, 1901_S_AT, 1910_S_AT	133	491	16650	2.2946878397623385	1.0	0.46856575596460626	53.86607722781596
GOTERM_BP_FAT	GO:0031667~response to nutrient levels	8	5.517241379310345	0.04204702936794721	32073_AT, 1974_S_AT, 38604_AT, 33684_AT, 33284_AT, 34467_G_AT, 37711_AT, 1910_S_AT	133	404	16650	2.478969701481426	1.0	0.46898255703823977	54.07687342079899
GOTERM_BP_FAT	GO:0051960~regulation of nervous system development	12	8.275862068965518	0.04207558014892254	32073_AT, 33080_S_AT, 32680_AT, 40058_S_AT, 32717_AT, 606_AT, 40317_AT, 39511_AT, 1355_G_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	769	16650	1.9535183863429704	1.0	0.467656950644763	54.101662285085276
GAD_DISEASE	Fibrinogen	5	3.4482758620689653	0.04231789311960448	32084_AT, 33922_AT, 39511_AT, 39187_AT, 37711_AT	115	149	12971	3.7849430989203383	1.0	0.6292041699648696	51.65581265939896
GOTERM_BP_FAT	GO:0010948~negative regulation of cell cycle process	6	4.137931034482759	0.04239035382962586	1974_S_AT, 822_S_AT, 38103_AT, 39198_S_AT, 39094_AT, 1910_S_AT	133	240	16650	3.1296992481203003	1.0	0.46866354351489126	54.37412395004119
GOTERM_BP_FAT	GO:0042063~gliogenesis	6	4.137931034482759	0.04239035382962586	32073_AT, 33963_AT, 34720_AT, 39511_AT, 1355_G_AT, 1901_S_AT	133	240	16650	3.1296992481203003	1.0	0.46866354351489126	54.37412395004119
GOTERM_BP_FAT	GO:0098609~cell-cell adhesion	16	11.03448275862069	0.042482347717006014	38103_AT, 34636_AT, 1403_S_AT, 37968_AT, 35367_AT, 1901_S_AT, 35373_AT, 1910_S_AT, 37096_AT, 36703_AT, 40058_S_AT, 34618_AT, 38482_AT, 31687_F_AT, 39511_AT, 39187_AT	133	1164	16650	1.7207968374544609	1.0	0.4678634812464566	54.45346296618041
KEGG_PATHWAY	hsa04550:Signaling pathways regulating pluripotency of stem cells	5	3.4482758620689653	0.04283040924686144	33684_AT, 35915_AT, 2090_I_AT, 40186_AT, 35373_AT	66	140	6879	3.722402597402598	0.9995289617098876	0.7839216562212621	41.53001324764388
GOTERM_BP_FAT	GO:0071229~cellular response to acid chemical	5	3.4482758620689653	0.043174088140942854	32717_AT, 2090_I_AT, 35169_AT, 1355_G_AT, 37711_AT	133	166	16650	3.7707219856871093	1.0	0.47187848315794934	55.04588464772835
GOTERM_BP_FAT	GO:1901988~negative regulation of cell cycle phase transition	5	3.4482758620689653	0.043174088140942854	1974_S_AT, 822_S_AT, 38103_AT, 39198_S_AT, 1910_S_AT	133	166	16650	3.7707219856871093	1.0	0.47187848315794934	55.04588464772835
GAD_DISEASE	docetaxel elimination	2	1.3793103448275863	0.04318504789615776	38229_AT, 1575_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	Hypertension|Hypertrophy, Left Ventricular|Ventricular Remodeling	2	1.3793103448275863	0.04318504789615776	37983_AT, 1890_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	paclitaxel pharmacokinetics	2	1.3793103448275863	0.04318504789615776	38229_AT, 1575_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	Body Weight|Gastrointestinal Stromal Tumors	2	1.3793103448275863	0.04318504789615776	38229_AT, 1575_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	Urologic Neoplasms	2	1.3793103448275863	0.04318504789615776	38229_AT, 1575_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	Coronary Disease|Inflammation	2	1.3793103448275863	0.04318504789615776	1403_S_AT, 33284_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	Atherosclerosis|Carotid Artery Diseases	2	1.3793103448275863	0.04318504789615776	34636_AT, 32250_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	Carcinoma, Papillary|DNA Damage|Neoplasms, Radiation-Induced|thyroid neoplasm|Thyroid Neoplasms	2	1.3793103448275863	0.04318504789615776	1974_S_AT, 38945_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	renal transplant	2	1.3793103448275863	0.04318504789615776	38229_AT, 1575_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GAD_DISEASE	Carcinoma, Squamous Cell|Mouth Neoplasms|Neoplasm Metastasis|Squamous cell carcinoma	2	1.3793103448275863	0.04318504789615776	1974_S_AT, 1901_S_AT	115	5	12971	45.116521739130434	1.0	0.6317574586600312	52.38638579740369
GOTERM_CC_FAT	GO:0072562~blood microparticle	5	3.4482758620689653	0.04398171552902749	31512_AT, 33516_AT, 31687_F_AT, 31525_S_AT, 32250_AT	126	154	14527	3.7433003504432074	0.9999987942475543	0.5119242041245788	45.22614010280308
GOTERM_BP_FAT	GO:0051049~regulation of transport	22	15.172413793103448	0.044374119240518525	33963_AT, 35038_AT, 1974_S_AT, 34636_AT, 1403_S_AT, 35367_AT, 1901_S_AT, 35373_AT, 37711_AT, 1910_S_AT, 1645_AT, 37172_AT, 36766_AT, 39469_S_AT, 1786_AT, 40271_AT, 37983_AT, 1391_S_AT, 37953_S_AT, 1419_G_AT, 40317_AT, 34436_AT	133	1796	16650	1.5334829278095015	1.0	0.47982939841030603	56.05638432252442
GOTERM_BP_FAT	GO:0050767~regulation of neurogenesis	11	7.586206896551724	0.044781307474710104	32073_AT, 33080_S_AT, 32680_AT, 40058_S_AT, 32717_AT, 606_AT, 39511_AT, 1355_G_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	682	16650	2.0191608052389034	1.0	0.4814663219645253	56.39435756831126
GOTERM_BP_FAT	GO:0003008~system process	24	16.551724137931036	0.045079300853331526	33963_AT, 35038_AT, 38604_AT, 38236_AT, 31621_S_AT, 38103_AT, 32418_AT, 32084_AT, 1355_G_AT, 37711_AT, 1645_AT, 1910_S_AT, 39469_S_AT, 32073_AT, 679_AT, 37983_AT, 40058_S_AT, 34249_AT, 1391_S_AT, 37953_S_AT, 39698_AT, 1419_G_AT, 40317_AT, 31687_F_AT, 37105_AT	133	2014	16650	1.4918129484585345	1.0	0.482240517526522	56.640139277779134
GOTERM_BP_FAT	GO:1902807~negative regulation of cell cycle G1/S phase transition	4	2.7586206896551726	0.045190786021080724	1974_S_AT, 822_S_AT, 38103_AT, 1910_S_AT	133	100	16650	5.007518796992481	1.0	0.4815705612552871	56.731754143131205
GOTERM_BP_FAT	GO:0014065~phosphatidylinositol 3-kinase signaling	4	2.7586206896551726	0.045190786021080724	1403_S_AT, 1355_G_AT, 35373_AT, 1901_S_AT	133	100	16650	5.007518796992481	1.0	0.4815705612552871	56.731754143131205
GOTERM_BP_FAT	GO:0098602~single organism cell adhesion	12	8.275862068965518	0.04544994595414183	37096_AT, 36703_AT, 34636_AT, 1403_S_AT, 34618_AT, 31687_F_AT, 35367_AT, 39187_AT, 35373_AT, 1901_S_AT, 1910_S_AT, 1786_AT	133	779	16650	1.9284411284951788	1.0	0.4820402735297352	56.94401708831249
GOTERM_MF_FAT	GO:0042623~ATPase activity, coupled	7	4.827586206896552	0.04579723220304345	32439_AT, 37814_G_AT, 33685_AT, 36234_AT, 1575_AT, 40294_AT, 39469_S_AT	124	326	15478	2.6802394617059173	0.9999999999977381	0.545551948319919	49.733900907995
GAD_DISEASE	Carcinoma, Squamous Cell|Head and Neck Neoplasms|Squamous cell carcinoma	3	2.0689655172413794	0.04594544447804106	1974_S_AT, 1575_AT, 1910_S_AT	115	39	12971	8.676254180602006	1.0	0.6500663505276394	54.64347509955191
KEGG_PATHWAY	hsa05222:Small cell lung cancer	4	2.7586206896551726	0.045981601532180096	1974_S_AT, 1419_G_AT, 35373_AT, 1910_S_AT	66	85	6879	4.9048128342245985	0.9997354965782227	0.7466397090354226	43.84665643906587
GOTERM_BP_FAT	GO:0050865~regulation of cell activation	9	6.206896551724138	0.04611039743751868	31512_AT, 1403_S_AT, 34618_AT, 35367_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	501	16650	2.248885687272072	1.0	0.4855615050447132	57.48051525473203
GOTERM_BP_FAT	GO:0045927~positive regulation of growth	6	4.137931034482759	0.04627816142638589	39698_AT, 606_AT, 1901_S_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	246	16650	3.0533651201173666	1.0	0.4853168319663955	57.61578392650988
GAD_DISEASE	Myocardial Infarction	10	6.896551724137931	0.04635348277886386	822_S_AT, 38236_AT, 37983_AT, 38229_AT, 1403_S_AT, 33284_AT, 1112_G_AT, 1575_AT, 32250_AT, 37172_AT	115	536	12971	2.104315379623621	1.0	0.6484608272946665	54.96844993613169
GOTERM_BP_FAT	GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent	2	1.3793103448275863	0.04664155871505408	1575_AT, 40294_AT	133	6	16650	41.72932330827067	1.0	0.48654681643270015	57.90739947295926
GOTERM_BP_FAT	GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	2	1.3793103448275863	0.04664155871505408	1575_AT, 40294_AT	133	6	16650	41.72932330827067	1.0	0.48654681643270015	57.90739947295926
GOTERM_BP_FAT	GO:0002488~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway	2	1.3793103448275863	0.04664155871505408	1575_AT, 40294_AT	133	6	16650	41.72932330827067	1.0	0.48654681643270015	57.90739947295926
GOTERM_BP_FAT	GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I	2	1.3793103448275863	0.04664155871505408	1575_AT, 40294_AT	133	6	16650	41.72932330827067	1.0	0.48654681643270015	57.90739947295926
GOTERM_BP_FAT	GO:0033087~negative regulation of immature T cell proliferation	2	1.3793103448275863	0.04664155871505408	34618_AT, 1901_S_AT	133	6	16650	41.72932330827067	1.0	0.48654681643270015	57.90739947295926
GOTERM_BP_FAT	GO:1901977~negative regulation of cell cycle checkpoint	2	1.3793103448275863	0.04664155871505408	39198_S_AT, 39094_AT	133	6	16650	41.72932330827067	1.0	0.48654681643270015	57.90739947295926
GOTERM_BP_FAT	GO:0080134~regulation of response to stress	17	11.724137931034482	0.04766532715131076	32680_AT, 37454_AT, 1403_S_AT, 32250_AT, 37968_AT, 35373_AT, 37711_AT, 37172_AT, 37096_AT, 40271_AT, 37983_AT, 39698_AT, 1419_G_AT, 40317_AT, 41280_R_AT, 1372_AT, 39094_AT	133	1285	16650	1.6561832597056845	1.0	0.49267411061886934	58.71878438532755
GOTERM_MF_FAT	GO:0004601~peroxidase activity	3	2.0689655172413794	0.04771336627250098	33284_AT, 31687_F_AT, 31525_S_AT	124	44	15478	8.510630498533724	0.9999999999992837	0.5502166565877347	51.19478563175805
GOTERM_BP_FAT	GO:0033674~positive regulation of kinase activity	9	6.206896551724138	0.047911525782326075	33963_AT, 37096_AT, 32680_AT, 32717_AT, 1403_S_AT, 1983_AT, 40186_AT, 1901_S_AT, 37711_AT	133	505	16650	2.2310727313332834	1.0	0.4929852764328395	58.911692319047006
GOTERM_BP_FAT	GO:0016477~cell migration	16	11.03448275862069	0.04805860052670906	33963_AT, 33530_AT, 37454_AT, 1403_S_AT, 35367_AT, 1355_G_AT, 35373_AT, 37711_AT, 1910_S_AT, 1786_AT, 37096_AT, 40271_AT, 36703_AT, 37983_AT, 919_AT, 1372_AT	133	1184	16650	1.6917293233082706	1.0	0.4925667114281401	59.02652543580218
GAD_DISEASE	Leukemia, Myelogenous, Chronic, BCR-ABL Positive|Neovascularization, Pathologic	3	2.0689655172413794	0.04809223086657825	38229_AT, 1575_AT, 1910_S_AT	115	40	12971	8.459347826086956	1.0	0.6574530545415624	56.32885449587726
GOTERM_BP_FAT	GO:0015711~organic anion transport	7	4.827586206896552	0.04834103544735024	35121_AT, 1391_S_AT, 31687_F_AT, 31525_S_AT, 1419_G_AT, 1355_G_AT, 34436_AT	133	331	16650	2.6474797265065986	1.0	0.4931412019236502	59.246195439407835
GOTERM_BP_FAT	GO:0007631~feeding behavior	4	2.7586206896551726	0.04859928826325227	38604_AT, 38103_AT, 1355_G_AT, 39469_S_AT	133	103	16650	4.861668734944156	1.0	0.49353495192193564	59.446082979569624
GOTERM_BP_FAT	GO:0071621~granulocyte chemotaxis	4	2.7586206896551726	0.04859928826325227	36703_AT, 37454_AT, 1403_S_AT, 35367_AT	133	103	16650	4.861668734944156	1.0	0.49353495192193564	59.446082979569624
GOTERM_BP_FAT	GO:0021953~central nervous system neuron differentiation	5	3.4482758620689653	0.04893434423714209	38604_AT, 33293_AT, 38103_AT, 34720_AT, 1355_G_AT	133	173	16650	3.6181494197922546	1.0	0.4944808637813958	59.704035894720796
GOTERM_BP_FAT	GO:0045123~cellular extravasation	3	2.0689655172413794	0.049485700178067006	33963_AT, 37096_AT, 36703_AT	133	45	16650	8.345864661654135	1.0	0.4969697559959759	60.125142415505486
GOTERM_BP_FAT	GO:0060326~cell chemotaxis	6	4.137931034482759	0.049675636516295724	33963_AT, 36703_AT, 37983_AT, 37454_AT, 1403_S_AT, 35367_AT	133	251	16650	2.9925411137405264	1.0	0.4968541597836382	60.269243806248994
GAD_DISEASE	Hepatopulmonary Syndrome|Liver Cirrhosis	4	2.7586206896551726	0.04984232994308437	37096_AT, 31621_S_AT, 36328_AT, 1419_G_AT	115	94	12971	4.799629972247919	1.0	0.6661000337424261	57.659039699038175
GOTERM_CC_FAT	GO:0005796~Golgi lumen	4	2.7586206896551726	0.049899910909462386	31793_AT, 2090_I_AT, 31506_S_AT, 34623_AT, 34546_AT	126	96	14527	4.803902116402116	0.9999998162972232	0.5395252868159383	49.59417332617792
GOTERM_BP_FAT	GO:0051094~positive regulation of developmental process	15	10.344827586206897	0.05001384368509115	33684_AT, 32717_AT, 35367_AT, 1355_G_AT, 39469_S_AT, 1910_S_AT, 37711_AT, 32073_AT, 34618_AT, 39698_AT, 1890_AT, 606_AT, 40317_AT, 2090_I_AT, 39187_AT	133	1089	16650	1.7243522028211022	1.0	0.4977929980698028	60.524618417704005
KEGG_PATHWAY	hsa05215:Prostate cancer	4	2.7586206896551726	0.05008923420376043	1974_S_AT, 35373_AT, 1901_S_AT, 1910_S_AT	66	88	6879	4.737603305785124	0.9998756941092926	0.7232610783878379	46.739895471607994
GAD_DISEASE	Malaria, Falciparum	3	2.0689655172413794	0.05027499220514985	31687_F_AT, 31525_S_AT, 1419_G_AT	115	41	12971	8.253022269353128	1.0	0.6646220884396039	57.981964481855975
GOTERM_BP_FAT	GO:2000027~regulation of organ morphogenesis	6	4.137931034482759	0.05037237579892778	33684_AT, 34720_AT, 2090_I_AT, 39187_AT, 37172_AT, 1910_S_AT	133	252	16650	2.9806659505907627	1.0	0.4988664248758643	60.7936462045212
GOTERM_BP_FAT	GO:0040017~positive regulation of locomotion	8	5.517241379310345	0.05099264300520685	33963_AT, 37096_AT, 1403_S_AT, 38482_AT, 35367_AT, 1372_AT, 35373_AT, 1910_S_AT	133	422	16650	2.373231657342408	1.0	0.5017617239923801	61.254983100585015
GOTERM_BP_FAT	GO:0009887~organ morphogenesis	14	9.655172413793103	0.05115647171769277	35038_AT, 33684_AT, 31621_S_AT, 41489_AT, 1355_G_AT, 39469_S_AT, 37172_AT, 1910_S_AT, 37711_AT, 34618_AT, 34720_AT, 39511_AT, 2090_I_AT, 39187_AT	133	992	16650	1.7667657045840406	1.0	0.5014494818938742	61.37597518040951
GOTERM_BP_FAT	GO:1901987~regulation of cell cycle phase transition	7	4.827586206896552	0.05129845522814037	1974_S_AT, 822_S_AT, 38103_AT, 39198_S_AT, 1983_AT, 39094_AT, 1910_S_AT	133	336	16650	2.6080827067669174	1.0	0.5009881921608912	61.4805451337666
GAD_DISEASE	Neoplasm Recurrence, Local|Prostatic Neoplasms	2	1.3793103448275863	0.05159758102440434	1974_S_AT, 1910_S_AT	115	6	12971	37.597101449275364	1.0	0.6697184311116602	58.95479773051603
GAD_DISEASE	alpha-Thalassemia|beta-Thalassemia	2	1.3793103448275863	0.05159758102440434	31687_F_AT, 31525_S_AT	115	6	12971	37.597101449275364	1.0	0.6697184311116602	58.95479773051603
GAD_DISEASE	anticoagulant complications	2	1.3793103448275863	0.05159758102440434	38229_AT, 1575_AT	115	6	12971	37.597101449275364	1.0	0.6697184311116602	58.95479773051603
GAD_DISEASE	pharmacogenetics of cyclosporine	2	1.3793103448275863	0.05159758102440434	38229_AT, 1575_AT	115	6	12971	37.597101449275364	1.0	0.6697184311116602	58.95479773051603
GAD_DISEASE	Nevirapine	2	1.3793103448275863	0.05159758102440434	38229_AT, 1575_AT	115	6	12971	37.597101449275364	1.0	0.6697184311116602	58.95479773051603
GAD_DISEASE	Thalassemia	2	1.3793103448275863	0.05159758102440434	31687_F_AT, 31525_S_AT	115	6	12971	37.597101449275364	1.0	0.6697184311116602	58.95479773051603
GOTERM_CC_FAT	GO:0070062~extracellular exosome	33	22.758620689655174	0.05169999069931078	33963_AT, 38646_S_AT, 33530_AT, 33284_AT, 31525_S_AT, 35915_AT, 35367_AT, 39908_AT, 679_AT, 35956_S_AT, 34012_AT, 36234_AT, 1391_S_AT, 1575_AT, 31506_S_AT, 33979_AT, 32680_AT, 31793_AT, 32084_AT, 1112_G_AT, 32250_AT, 36378_AT, 37172_AT, 36766_AT, 31512_AT, 37096_AT, 36328_AT, 32413_AT, 1890_AT, 37898_R_AT, 31687_F_AT, 38508_S_AT, 2090_I_AT, 37105_AT, 37166_AT	126	2811	14527	1.353500703020447	0.999999896589721	0.5350993250813378	50.85739147818178
GOTERM_BP_FAT	GO:0021987~cerebral cortex development	4	2.7586206896551726	0.05213043196388012	38604_AT, 38816_AT, 39511_AT, 1355_G_AT	133	106	16650	4.7240743367853595	1.0	0.5052853398792234	62.08793505035399
GOTERM_BP_FAT	GO:0046834~lipid phosphorylation	4	2.7586206896551726	0.05213043196388012	35090_G_AT, 35091_AT, 35373_AT, 1855_AT, 1901_S_AT	133	106	16650	4.7240743367853595	1.0	0.5052853398792234	62.08793505035399
GOTERM_BP_FAT	GO:0044772~mitotic cell cycle phase transition	9	6.206896551724138	0.05213118546597887	1974_S_AT, 822_S_AT, 38103_AT, 1575_AT, 38201_AT, 39198_S_AT, 1983_AT, 39094_AT, 1910_S_AT	133	514	16650	2.1920072554928174	1.0	0.5038497009103705	62.0884810250526
GOTERM_MF_FAT	GO:0001046~core promoter sequence-specific DNA binding	4	2.7586206896551726	0.05238900892461969	1974_S_AT, 39187_AT, 37711_AT, 38945_AT	124	106	15478	4.7102860620815585	0.9999999999999571	0.5747169379694101	54.59517264554714
GOTERM_MF_FAT	GO:0016684~oxidoreductase activity, acting on peroxide as acceptor	3	2.0689655172413794	0.05369685024272093	33284_AT, 31687_F_AT, 31525_S_AT	124	47	15478	7.967398764584764	0.9999999999999806	0.5739690284420343	55.506012042195984
GOTERM_BP_FAT	GO:0051270~regulation of cellular component movement	12	8.275862068965518	0.05390921769655177	35038_AT, 37096_AT, 35090_G_AT, 36703_AT, 1403_S_AT, 35091_AT, 38482_AT, 919_AT, 35367_AT, 1372_AT, 35373_AT, 1901_S_AT, 1910_S_AT	133	802	16650	1.8731367071044192	1.0	0.5144486473993928	63.35632906650969
GOTERM_BP_FAT	GO:1901214~regulation of neuron death	6	4.137931034482759	0.05394242588592965	1974_S_AT, 33293_AT, 1403_S_AT, 1355_G_AT, 37711_AT, 1910_S_AT	133	257	16650	2.92267634065709	1.0	0.5132307165707439	63.3796230119457
GOTERM_BP_FAT	GO:0010810~regulation of cell-substrate adhesion	5	3.4482758620689653	0.05419376292291184	36703_AT, 34636_AT, 35169_AT, 35373_AT, 1910_S_AT	133	179	16650	3.4968706682908386	1.0	0.5134726153454107	63.5554707403193
GOTERM_BP_FAT	GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent	2	1.3793103448275863	0.05420244037085541	1575_AT, 40294_AT	133	7	16650	35.76799140708915	1.0	0.5121032797535572	63.56152763797378
GOTERM_BP_FAT	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	2	1.3793103448275863	0.05420244037085541	1575_AT, 40294_AT	133	7	16650	35.76799140708915	1.0	0.5121032797535572	63.56152763797378
GOTERM_BP_FAT	GO:0002477~antigen processing and presentation of exogenous peptide antigen via MHC class Ib	2	1.3793103448275863	0.05420244037085541	1575_AT, 40294_AT	133	7	16650	35.76799140708915	1.0	0.5121032797535572	63.56152763797378
GOTERM_BP_FAT	GO:1903236~regulation of leukocyte tethering or rolling	2	1.3793103448275863	0.05420244037085541	37096_AT, 36703_AT	133	7	16650	35.76799140708915	1.0	0.5121032797535572	63.56152763797378
GOTERM_BP_FAT	GO:0033084~regulation of immature T cell proliferation in thymus	2	1.3793103448275863	0.05420244037085541	34618_AT, 1901_S_AT	133	7	16650	35.76799140708915	1.0	0.5121032797535572	63.56152763797378
GOTERM_CC_FAT	GO:1903561~extracellular vesicle	33	22.758620689655174	0.054778768760331845	33963_AT, 38646_S_AT, 33530_AT, 33284_AT, 31525_S_AT, 35915_AT, 35367_AT, 39908_AT, 679_AT, 35956_S_AT, 34012_AT, 36234_AT, 1391_S_AT, 1575_AT, 31506_S_AT, 33979_AT, 32680_AT, 31793_AT, 32084_AT, 1112_G_AT, 32250_AT, 36378_AT, 37172_AT, 36766_AT, 31512_AT, 37096_AT, 36328_AT, 32413_AT, 1890_AT, 37898_R_AT, 31687_F_AT, 38508_S_AT, 2090_I_AT, 37105_AT, 37166_AT	126	2825	14527	1.3467930889169828	0.9999999613952435	0.5397125560249998	52.95026810409118
GOTERM_BP_FAT	GO:0007596~blood coagulation	7	4.827586206896552	0.05499129313510335	33516_AT, 31687_F_AT, 919_AT, 35373_AT, 37172_AT, 37954_AT, 1786_AT	133	342	16650	2.5623268698060944	1.0	0.5158924165408596	64.10819475652765
GOTERM_CC_FAT	GO:0043230~extracellular organelle	33	22.758620689655174	0.05500379476174414	33963_AT, 38646_S_AT, 33530_AT, 33284_AT, 31525_S_AT, 35915_AT, 35367_AT, 39908_AT, 679_AT, 35956_S_AT, 34012_AT, 36234_AT, 1391_S_AT, 1575_AT, 31506_S_AT, 33979_AT, 32680_AT, 31793_AT, 32084_AT, 1112_G_AT, 32250_AT, 36378_AT, 37172_AT, 36766_AT, 31512_AT, 37096_AT, 36328_AT, 32413_AT, 1890_AT, 37898_R_AT, 31687_F_AT, 38508_S_AT, 2090_I_AT, 37105_AT, 37166_AT	126	2826	14527	1.3463165166986824	0.9999999640822141	0.5254108482416738	53.09995349861305
GOTERM_MF_FAT	GO:0004713~protein tyrosine kinase activity	5	3.4482758620689653	0.0554135700936249	35090_G_AT, 35091_AT, 1355_G_AT, 1855_AT, 1901_S_AT, 1786_AT	124	180	15478	3.4672939068100357	0.9999999999999931	0.5760423621769952	56.67578107672184
GOTERM_BP_FAT	GO:0003014~renal system process	4	2.7586206896551726	0.05578247002901394	37983_AT, 1391_S_AT, 31687_F_AT, 1910_S_AT	133	109	16650	4.594053942194937	1.0	0.5196413027694508	64.64868319601416
GOTERM_BP_FAT	GO:0010001~glial cell differentiation	5	3.4482758620689653	0.05601262457479598	32073_AT, 34720_AT, 39511_AT, 1355_G_AT, 1901_S_AT	133	181	16650	3.458231213392597	1.0	0.5197166824376452	64.80446241836393
GOTERM_BP_FAT	GO:0001775~cell activation	13	8.96551724137931	0.05753481713474225	33963_AT, 31512_AT, 34618_AT, 1403_S_AT, 31687_F_AT, 919_AT, 35367_AT, 39187_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	910	16650	1.7883995703544575	1.0	0.5280564291685277	65.81853846772991
GAD_DISEASE	metabolic syndrome	5	3.4482758620689653	0.057544851481941446	679_AT, 38604_AT, 31621_S_AT, 37983_AT, 37105_AT, 37172_AT	115	165	12971	3.4179183135704876	1.0	0.7059079566444624	63.07334134796692
GOTERM_BP_FAT	GO:0030258~lipid modification	6	4.137931034482759	0.057656486019148696	35090_G_AT, 37983_AT, 38229_AT, 35091_AT, 35373_AT, 1855_AT, 1901_S_AT	133	262	16650	2.8669000746140156	1.0	0.5274131476355535	65.89839073309665
GOTERM_MF_FAT	GO:0005548~phospholipid transporter activity	3	2.0689655172413794	0.057825651703647694	33685_AT, 1575_AT, 39469_S_AT	124	49	15478	7.642198815009875	0.9999999999999984	0.5825619365625887	58.27101005051871
GOTERM_MF_FAT	GO:0008009~chemokine activity	3	2.0689655172413794	0.057825651703647694	36703_AT, 37454_AT, 1403_S_AT	124	49	15478	7.642198815009875	0.9999999999999984	0.5825619365625887	58.27101005051871
GOTERM_BP_FAT	GO:0051216~cartilage development	5	3.4482758620689653	0.05786419253041083	33684_AT, 34618_AT, 34720_AT, 39187_AT, 37711_AT	133	183	16650	3.4204363367434976	1.0	0.5273171530600487	66.03430306658835
GAD_DISEASE	Tuberculosis	4	2.7586206896551726	0.05793149000347786	1403_S_AT, 32084_AT, 1575_AT, 1419_G_AT	115	100	12971	4.511652173913044	1.0	0.7039188732167699	63.32716174121433
GOTERM_BP_FAT	GO:0009991~response to extracellular stimulus	8	5.517241379310345	0.05815213691682494	32073_AT, 1974_S_AT, 38604_AT, 33684_AT, 33284_AT, 34467_G_AT, 37711_AT, 1910_S_AT	133	435	16650	2.302307492870106	1.0	0.5277262319421724	66.22187257140686
GOTERM_BP_FAT	GO:0050673~epithelial cell proliferation	7	4.827586206896552	0.05818912986286851	33080_S_AT, 1403_S_AT, 34618_AT, 34720_AT, 1901_S_AT, 37172_AT, 37711_AT	133	347	16650	2.5254057333535567	1.0	0.5265612850797297	66.24589903783584
GOTERM_BP_FAT	GO:1901701~cellular response to oxygen-containing compound	13	8.96551724137931	0.058304436249807065	32717_AT, 1403_S_AT, 33284_AT, 35169_AT, 1355_G_AT, 35373_AT, 37172_AT, 37711_AT, 33371_S_AT, 40271_AT, 37983_AT, 1419_G_AT, 2090_I_AT	133	912	16650	1.784477641472101	1.0	0.5258927093666028	66.32068556748322
GOTERM_BP_FAT	GO:0046651~lymphocyte proliferation	6	4.137931034482759	0.058416577853830746	1403_S_AT, 34618_AT, 35367_AT, 1901_S_AT, 37711_AT, 1910_S_AT	133	263	16650	2.8559993138740385	1.0	0.5252087638126657	66.39326926434808
GOTERM_MF_FAT	GO:0019903~protein phosphatase binding	4	2.7586206896551726	0.058570846948276974	1974_S_AT, 35373_AT, 1901_S_AT, 1910_S_AT	124	111	15478	4.498111014240046	0.999999999999999	0.5781449102211113	58.75266694341767
OMIM_DISEASE	611162~Malaria, resistance to	2	1.3793103448275863	0.05903619153348528	31687_F_AT, 1419_G_AT	42	7	4740	32.244897959183675	0.9955537910882087	0.9955537910882087	48.34337402338965
GAD_DISEASE	brain cancer	3	2.0689655172413794	0.05935023391015402	1974_S_AT, 1575_AT, 967_G_AT, 966_AT	115	45	12971	7.519420289855072	1.0	0.708478597752976	64.24455088764883
GAD_DISEASE	Crohn's disease ulcerative colitis	3	2.0689655172413794	0.05935023391015402	32084_AT, 1575_AT, 1419_G_AT	115	45	12971	7.519420289855072	1.0	0.708478597752976	64.24455088764883
GOTERM_BP_FAT	GO:0006796~phosphate-containing compound metabolic process	33	22.758620689655174	0.0596366145920005	33963_AT, 32148_AT, 32717_AT, 35915_AT, 40186_AT, 1355_G_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 679_AT, 35090_G_AT, 34249_AT, 35091_AT, 38948_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 1786_AT, 37096_AT, 36703_AT, 1890_AT, 1419_G_AT, 1983_AT, 37105_AT, 37166_AT	133	3083	16650	1.339994488329159	1.0	0.5313805827813995	67.17344695003122
GAD_DISEASE	clopidogrel	2	1.3793103448275863	0.05993679242113998	38229_AT, 1575_AT	115	7	12971	32.22608695652174	1.0	0.7077675886702087	64.61748844490296
GAD_DISEASE	Leukopenia|Neutropenia	2	1.3793103448275863	0.05993679242113998	38229_AT, 1575_AT	115	7	12971	32.22608695652174	1.0	0.7077675886702087	64.61748844490296
GAD_DISEASE	lung transplant complications	2	1.3793103448275863	0.05993679242113998	38229_AT, 1575_AT	115	7	12971	32.22608695652174	1.0	0.7077675886702087	64.61748844490296
GAD_DISEASE	tacrolimus	2	1.3793103448275863	0.05993679242113998	38229_AT, 1575_AT	115	7	12971	32.22608695652174	1.0	0.7077675886702087	64.61748844490296
GAD_DISEASE	lopinavir accumulation	2	1.3793103448275863	0.05993679242113998	38229_AT, 1575_AT	115	7	12971	32.22608695652174	1.0	0.7077675886702087	64.61748844490296
GAD_DISEASE	cholesterol; cholesterol, LDL	2	1.3793103448275863	0.05993679242113998	38229_AT, 1575_AT	115	7	12971	32.22608695652174	1.0	0.7077675886702087	64.61748844490296
GOTERM_BP_FAT	GO:0032943~mononuclear cell proliferation	6	4.137931034482759	0.05995403106520494	1403_S_AT, 34618_AT, 35367_AT, 1901_S_AT, 37711_AT, 1910_S_AT	133	265	16650	2.8344446020712155	1.0	0.5319461515893524	67.3736022460479
GOTERM_BP_FAT	GO:0014706~striated muscle tissue development	7	4.827586206896552	0.060160548493593265	35038_AT, 31621_S_AT, 40058_S_AT, 32717_AT, 1855_AT, 37711_AT, 1910_S_AT	133	350	16650	2.50375939849624	1.0	0.5318320665843819	67.50320748908277
GOTERM_CC_FAT	GO:0045202~synapse	12	8.275862068965518	0.060651977117070585	33293_AT, 32148_AT, 38236_AT, 40058_S_AT, 32717_AT, 37953_S_AT, 40317_AT, 41280_R_AT, 936_S_AT, 32279_AT, 1355_G_AT, 37711_AT	126	755	14527	1.8324818669189529	0.9999999941596717	0.5461264380616135	56.71580545280981
GAD_DISEASE	smoking	4	2.7586206896551726	0.060757901726402046	1974_S_AT, 38236_AT, 32418_AT, 1355_G_AT	115	102	12971	4.423188405797102	1.0	0.7085089989635833	65.13341331320018
GOTERM_MF_FAT	GO:0016887~ATPase activity	8	5.517241379310345	0.06089786421409538	34972_S_AT, 32439_AT, 37814_G_AT, 33685_AT, 36234_AT, 1575_AT, 40294_AT, 39469_S_AT	124	439	15478	2.274671173488133	0.9999999999999998	0.5837917570033633	60.22359584093269
GOTERM_BP_FAT	GO:0006793~phosphorus metabolic process	33	22.758620689655174	0.060963460837142214	33963_AT, 32148_AT, 32717_AT, 35915_AT, 40186_AT, 1355_G_AT, 35373_AT, 1855_AT, 1910_S_AT, 37711_AT, 679_AT, 35090_G_AT, 34249_AT, 35091_AT, 38948_AT, 41280_R_AT, 39094_AT, 1974_S_AT, 38236_AT, 32680_AT, 34636_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 1901_S_AT, 1645_AT, 1786_AT, 37096_AT, 36703_AT, 1890_AT, 1419_G_AT, 1983_AT, 37105_AT, 37166_AT	133	3089	16650	1.3373917149623815	1.0	0.5353278258187328	68.00248830112952
GOTERM_BP_FAT	GO:0001822~kidney development	6	4.137931034482759	0.061514495910756126	33684_AT, 40271_AT, 37983_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	267	16650	2.8132128072991467	1.0	0.5372699194575663	68.34093907854853
GOTERM_BP_FAT	GO:0032103~positive regulation of response to external stimulus	6	4.137931034482759	0.061514495910756126	33963_AT, 38604_AT, 37983_AT, 37454_AT, 1403_S_AT, 37172_AT	133	267	16650	2.8132128072991467	1.0	0.5372699194575663	68.34093907854853
GOTERM_BP_FAT	GO:0061303~cornea development in camera-type eye	2	1.3793103448275863	0.06170380898560149	33684_AT, 2090_I_AT	133	8	16650	31.296992481203006	1.0	0.5370376272850713	68.45643420070343
GOTERM_BP_FAT	GO:0002428~antigen processing and presentation of peptide antigen via MHC class Ib	2	1.3793103448275863	0.06170380898560149	1575_AT, 40294_AT	133	8	16650	31.296992481203006	1.0	0.5370376272850713	68.45643420070343
GOTERM_BP_FAT	GO:0033080~immature T cell proliferation in thymus	2	1.3793103448275863	0.06170380898560149	34618_AT, 1901_S_AT	133	8	16650	31.296992481203006	1.0	0.5370376272850713	68.45643420070343
GOTERM_BP_FAT	GO:2000109~regulation of macrophage apoptotic process	2	1.3793103448275863	0.06170380898560149	1403_S_AT, 37711_AT	133	8	16650	31.296992481203006	1.0	0.5370376272850713	68.45643420070343
GOTERM_BP_FAT	GO:0002589~regulation of antigen processing and presentation of peptide antigen via MHC class I	2	1.3793103448275863	0.06170380898560149	1575_AT, 40294_AT	133	8	16650	31.296992481203006	1.0	0.5370376272850713	68.45643420070343
GOTERM_BP_FAT	GO:0002585~positive regulation of antigen processing and presentation of peptide antigen	2	1.3793103448275863	0.06170380898560149	1575_AT, 40294_AT	133	8	16650	31.296992481203006	1.0	0.5370376272850713	68.45643420070343
KEGG_PATHWAY	hsa04066:HIF-1 signaling pathway	4	2.7586206896551726	0.06188487255118909	1419_G_AT, 35373_AT, 1901_S_AT, 1910_S_AT	66	96	6879	4.34280303030303	0.9999860419626595	0.7527689322687703	54.30447714035233
GOTERM_CC_FAT	GO:0060205~cytoplasmic membrane-bounded vesicle lumen	4	2.7586206896551726	0.06198701697041452	31793_AT, 31687_F_AT, 31525_S_AT, 31506_S_AT, 34623_AT	126	105	14527	4.392139077853363	0.9999999962043916	0.5395618971915304	57.53190328664013
GOTERM_BP_FAT	GO:0097530~granulocyte migration	4	2.7586206896551726	0.06213272747208076	36703_AT, 37454_AT, 1403_S_AT, 35367_AT	133	114	16650	4.3925603482390185	1.0	0.538230272709372	68.71663558409008
GOTERM_BP_FAT	GO:0016337~single organismal cell-cell adhesion	11	7.586206896551724	0.06255009950760136	37096_AT, 36703_AT, 34636_AT, 1403_S_AT, 34618_AT, 31687_F_AT, 35367_AT, 39187_AT, 35373_AT, 1901_S_AT, 1910_S_AT	133	725	16650	1.8994036816178377	1.0	0.5393439198664272	68.96788459453386
GOTERM_CC_FAT	GO:0031983~vesicle lumen	4	2.7586206896551726	0.06340712297296222	31793_AT, 31687_F_AT, 31525_S_AT, 31506_S_AT, 34623_AT	126	106	14527	4.350703803533992	0.9999999976016767	0.5339226593779772	58.384357586584656
GOTERM_BP_FAT	GO:0070887~cellular response to chemical stimulus	29	20.0	0.06388473879033679	33963_AT, 32717_AT, 33284_AT, 35367_AT, 1355_G_AT, 1855_AT, 35373_AT, 1910_S_AT, 37711_AT, 37983_AT, 31506_S_AT, 1974_S_AT, 33080_S_AT, 34636_AT, 38229_AT, 31793_AT, 37454_AT, 1403_S_AT, 1112_G_AT, 1331_S_AT, 35169_AT, 1901_S_AT, 37172_AT, 33371_S_AT, 40271_AT, 36703_AT, 1890_AT, 1419_G_AT, 2090_I_AT, 39187_AT	133	2648	16650	1.371016286940917	1.0	0.5457967887457068	69.75857449382026
GAD_DISEASE	graft-versus-host disease	3	2.0689655172413794	0.06408378328245634	37983_AT, 38229_AT, 1575_AT	115	47	12971	7.199444958371878	1.0	0.7239535928413451	67.15166299266188
GAD_DISEASE	Hypercholesterolemia	3	2.0689655172413794	0.06408378328245634	38604_AT, 38229_AT, 1575_AT	115	47	12971	7.199444958371878	1.0	0.7239535928413451	67.15166299266188
GOTERM_BP_FAT	GO:0016358~dendrite development	5	3.4482758620689653	0.06460056194294593	32148_AT, 32680_AT, 40058_S_AT, 32717_AT, 37711_AT	133	190	16650	3.2944202611792637	1.0	0.5485786880358828	70.17477359752783
GOTERM_BP_FAT	GO:0009628~response to abiotic stimulus	14	9.655172413793103	0.06460113736409728	1974_S_AT, 38236_AT, 33284_AT, 967_G_AT, 35373_AT, 39469_S_AT, 37172_AT, 1910_S_AT, 37096_AT, 822_S_AT, 37953_S_AT, 1419_G_AT, 40317_AT, 40790_AT, 966_AT	133	1029	16650	1.7032376860518643	1.0	0.5472352694293459	70.17510597557028
GOTERM_BP_FAT	GO:0040007~growth	13	8.96551724137931	0.06638464581165128	1974_S_AT, 38103_AT, 33284_AT, 1901_S_AT, 39469_S_AT, 1910_S_AT, 37711_AT, 679_AT, 37096_AT, 37983_AT, 40058_S_AT, 39698_AT, 606_AT, 37105_AT	133	932	16650	1.7461841298525282	1.0	0.5560246348091133	71.18866172314172
GOTERM_MF_FAT	GO:0002020~protease binding	4	2.7586206896551726	0.06642140773943024	1974_S_AT, 37096_AT, 822_S_AT, 1910_S_AT	124	117	15478	4.267438654535429	1.0	0.6078217778065802	63.521659358518015
GAD_DISEASE	Leukemia, Myeloid, Acute	3	2.0689655172413794	0.06649696569170241	1974_S_AT, 38229_AT, 1575_AT	115	48	12971	7.04945652173913	1.0	0.7333484585975203	68.54670529678776
GAD_DISEASE	liver cancer	3	2.0689655172413794	0.06649696569170241	1974_S_AT, 33284_AT, 1575_AT	115	48	12971	7.04945652173913	1.0	0.7333484585975203	68.54670529678776
GOTERM_BP_FAT	GO:0051962~positive regulation of nervous system development	8	5.517241379310345	0.06652890328336947	32073_AT, 32717_AT, 606_AT, 40317_AT, 1355_G_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	449	16650	2.2305206222683656	1.0	0.5554921308429884	71.26920359549798
GAD_DISEASE	ADHD | attention-deficit hyperactivity disorder	4	2.7586206896551726	0.06660092200650616	35648_AT, 38236_AT, 34467_G_AT, 1355_G_AT	115	106	12971	4.256275635767023	1.0	0.7298381405275687	68.60553123798692
GOTERM_MF_FAT	GO:0005126~cytokine receptor binding	6	4.137931034482759	0.06674692504404481	36703_AT, 37454_AT, 1403_S_AT, 1890_AT, 35915_AT, 35373_AT	124	273	15478	2.7433534207727757	1.0	0.6010461649265191	63.70783858137491
GOTERM_BP_FAT	GO:0048812~neuron projection morphogenesis	9	6.206896551724138	0.06733287598129406	32148_AT, 40058_S_AT, 34720_AT, 1112_G_AT, 606_AT, 1355_G_AT, 1901_S_AT, 39469_S_AT, 1910_S_AT	133	543	16650	2.0749387280355585	1.0	0.5586400627127247	71.71419556142212
GOTERM_BP_FAT	GO:0050680~negative regulation of epithelial cell proliferation	4	2.7586206896551726	0.06744471124386721	33080_S_AT, 34720_AT, 37172_AT, 37711_AT	133	118	16650	4.243659997451255	1.0	0.557926144388623	71.77557701477583
GOTERM_BP_FAT	GO:0043523~regulation of neuron apoptotic process	5	3.4482758620689653	0.06760841311116148	1974_S_AT, 33293_AT, 1355_G_AT, 37711_AT, 1910_S_AT	133	193	16650	3.243211656083213	1.0	0.5575031846728262	71.86519887515277
GOTERM_BP_FAT	GO:0030900~forebrain development	7	4.827586206896552	0.06772801348609558	38604_AT, 33684_AT, 38816_AT, 34720_AT, 39511_AT, 1355_G_AT, 37711_AT	133	361	16650	2.4274675608689313	1.0	0.5568398698029349	71.93050644258219
GOTERM_BP_FAT	GO:2000145~regulation of cell motility	11	7.586206896551724	0.06774200658994237	37096_AT, 35090_G_AT, 36703_AT, 1403_S_AT, 35091_AT, 38482_AT, 919_AT, 35367_AT, 1372_AT, 35373_AT, 1901_S_AT, 1910_S_AT	133	736	16650	1.8710158548545275	1.0	0.5555987859968663	71.9381379856632
GAD_DISEASE	diabetes, type 2; hypertension	2	1.3793103448275863	0.06820331553645459	37983_AT, 35373_AT	115	8	12971	28.19782608695652	1.0	0.734493890698734	69.49929212177311
GAD_DISEASE	vesicoureteral reflux	2	1.3793103448275863	0.06820331553645459	37983_AT, 36378_AT	115	8	12971	28.19782608695652	1.0	0.734493890698734	69.49929212177311
GAD_DISEASE	Epilepsies, Partial	2	1.3793103448275863	0.06820331553645459	1575_AT, 1355_G_AT	115	8	12971	28.19782608695652	1.0	0.734493890698734	69.49929212177311
GAD_DISEASE	Diabetes Mellitus, Type 1|Diabetic Nephropathies	2	1.3793103448275863	0.06820331553645459	1974_S_AT, 37983_AT	115	8	12971	28.19782608695652	1.0	0.734493890698734	69.49929212177311
GAD_DISEASE	cholesterol; cholesterol, HDL; triglycerides; diabetes, type 2; ulcerative colitis; cholesterol, LDL; liver disease;	2	1.3793103448275863	0.06820331553645459	38229_AT, 1575_AT	115	8	12971	28.19782608695652	1.0	0.734493890698734	69.49929212177311
GAD_DISEASE	glomerulonephritis	2	1.3793103448275863	0.06820331553645459	37983_AT, 32250_AT	115	8	12971	28.19782608695652	1.0	0.734493890698734	69.49929212177311
GOTERM_BP_FAT	GO:1901565~organonitrogen compound catabolic process	7	4.827586206896552	0.06844238581381692	38229_AT, 40735_AT, 1419_G_AT, 38201_AT, 32279_AT, 37166_AT, 37061_AT	133	362	16650	2.420761849374818	1.0	0.5581285177655428	72.31761530077063
GOTERM_BP_FAT	GO:0030595~leukocyte chemotaxis	5	3.4482758620689653	0.06862700249237319	33963_AT, 36703_AT, 37454_AT, 1403_S_AT, 35367_AT	133	194	16650	3.226494070227114	1.0	0.5578260881955031	72.41683329484347
GOTERM_BP_FAT	GO:0006811~ion transport	18	12.413793103448276	0.0689714603817708	32439_AT, 38604_AT, 38236_AT, 1403_S_AT, 32084_AT, 31525_S_AT, 35367_AT, 1355_G_AT, 37711_AT, 1910_S_AT, 35121_AT, 1391_S_AT, 37953_S_AT, 37097_AT, 1419_G_AT, 40317_AT, 31687_F_AT, 34436_AT	133	1458	16650	1.545530492898914	1.0	0.5583937080516919	72.60105667354222
GOTERM_BP_FAT	GO:2000399~negative regulation of thymocyte aggregation	2	1.3793103448275863	0.069146129451719	34618_AT, 1901_S_AT	133	9	16650	27.819548872180448	1.0	0.5580394289678474	72.69402860069685
GOTERM_BP_FAT	GO:0033085~negative regulation of T cell differentiation in thymus	2	1.3793103448275863	0.069146129451719	34618_AT, 1901_S_AT	133	9	16650	27.819548872180448	1.0	0.5580394289678474	72.69402860069685
GOTERM_BP_FAT	GO:0002484~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	2	1.3793103448275863	0.069146129451719	1575_AT, 40294_AT	133	9	16650	27.819548872180448	1.0	0.5580394289678474	72.69402860069685
GOTERM_BP_FAT	GO:0033083~regulation of immature T cell proliferation	2	1.3793103448275863	0.069146129451719	34618_AT, 1901_S_AT	133	9	16650	27.819548872180448	1.0	0.5580394289678474	72.69402860069685
GOTERM_BP_FAT	GO:0071888~macrophage apoptotic process	2	1.3793103448275863	0.069146129451719	1403_S_AT, 37711_AT	133	9	16650	27.819548872180448	1.0	0.5580394289678474	72.69402860069685
GOTERM_BP_FAT	GO:0000733~DNA strand renaturation	2	1.3793103448275863	0.069146129451719	1974_S_AT, 967_G_AT, 966_AT	133	9	16650	27.819548872180448	1.0	0.5580394289678474	72.69402860069685
GOTERM_MF_FAT	GO:0070513~death domain binding	2	1.3793103448275863	0.06930643386429386	822_S_AT, 1910_S_AT	124	9	15478	27.738351254480285	1.0	0.6069142940854253	65.14119221361541
GOTERM_MF_FAT	GO:0015280~ligand-gated sodium channel activity	2	1.3793103448275863	0.06930643386429386	37953_S_AT, 40317_AT	124	9	15478	27.738351254480285	1.0	0.6069142940854253	65.14119221361541
GOTERM_BP_FAT	GO:0044770~cell cycle phase transition	9	6.206896551724138	0.0696247266514855	1974_S_AT, 822_S_AT, 38103_AT, 1575_AT, 38201_AT, 39198_S_AT, 1983_AT, 39094_AT, 1910_S_AT	133	547	16650	2.059765501505134	1.0	0.5593249551668549	72.94724892728762
GOTERM_BP_FAT	GO:1901605~alpha-amino acid metabolic process	5	3.4482758620689653	0.06965354330146337	40735_AT, 1419_G_AT, 38201_AT, 32279_AT, 37166_AT	133	195	16650	3.209947946790052	1.0	0.5581882448991928	72.96242445493925
GOTERM_BP_FAT	GO:0006909~phagocytosis	6	4.137931034482759	0.06966102640786273	33963_AT, 31512_AT, 37096_AT, 34636_AT, 35373_AT, 1786_AT	133	277	16650	2.7116527781547735	1.0	0.556942201496262	72.96636391960834
GOTERM_BP_FAT	GO:0046649~lymphocyte activation	10	6.896551724137931	0.06992251602982089	31512_AT, 1403_S_AT, 34618_AT, 35367_AT, 39187_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	643	16650	1.9469357686595958	1.0	0.557062372176887	73.10368446681494
GOTERM_BP_FAT	GO:0050918~positive chemotaxis	3	2.0689655172413794	0.07056364231874	33963_AT, 1403_S_AT, 35367_AT	133	55	16650	6.828434723171565	1.0	0.5592017745179921	73.43758669174008
GOTERM_BP_FAT	GO:0071230~cellular response to amino acid stimulus	3	2.0689655172413794	0.07056364231874	32717_AT, 35169_AT, 1355_G_AT	133	55	16650	6.828434723171565	1.0	0.5592017745179921	73.43758669174008
GOTERM_CC_FAT	GO:0031526~brush border membrane	3	2.0689655172413794	0.07128429063474764	32084_AT, 919_AT, 34436_AT	126	51	14527	6.781979458450047	0.9999999998144393	0.5639125865582635	62.83228302856286
GOTERM_BP_FAT	GO:0060537~muscle tissue development	7	4.827586206896552	0.07208024604336517	35038_AT, 31621_S_AT, 40058_S_AT, 32717_AT, 1855_AT, 37711_AT, 1910_S_AT	133	367	16650	2.3877814427075865	1.0	0.5659087557192415	74.21192060405639
GOTERM_BP_FAT	GO:0007568~aging	6	4.137931034482759	0.0722163747543896	1974_S_AT, 33284_AT, 967_G_AT, 33922_AT, 39469_S_AT, 966_AT, 1910_S_AT	133	280	16650	2.682599355531686	1.0	0.5653452734603811	74.28037089430435
GOTERM_BP_FAT	GO:0070661~leukocyte proliferation	6	4.137931034482759	0.0722163747543896	1403_S_AT, 34618_AT, 35367_AT, 1901_S_AT, 37711_AT, 1910_S_AT	133	280	16650	2.682599355531686	1.0	0.5653452734603811	74.28037089430435
GOTERM_MF_FAT	GO:0022804~active transmembrane transporter activity	7	4.827586206896552	0.07255969686738489	32439_AT, 35121_AT, 32084_AT, 1575_AT, 37097_AT, 40294_AT, 34436_AT	124	367	15478	2.3808121648940848	1.0	0.6161440615583151	66.88695044616301
GOTERM_BP_FAT	GO:0048247~lymphocyte chemotaxis	3	2.0689655172413794	0.07280888041054036	36703_AT, 37454_AT, 1403_S_AT	133	56	16650	6.706498388829215	1.0	0.567150962420271	74.57630889251739
GOTERM_BP_FAT	GO:0051250~negative regulation of lymphocyte activation	4	2.7586206896551726	0.07295718887862057	34618_AT, 35367_AT, 1901_S_AT, 1786_AT	133	122	16650	4.104523604092197	1.0	0.5666520849317346	74.64987927893134
GOTERM_BP_FAT	GO:0045321~leukocyte activation	11	7.586206896551724	0.0732038385131043	33963_AT, 31512_AT, 1403_S_AT, 34618_AT, 35367_AT, 39187_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	747	16650	1.8434640818914756	1.0	0.5666622835147652	74.77178786269036
GAD_DISEASE	macular degeneration	6	4.137931034482759	0.07323162278016465	38604_AT, 31621_S_AT, 34720_AT, 1419_G_AT, 32250_AT, 35915_AT	115	254	12971	2.664361520027388	1.0	0.756260331420044	72.15105083043932
GOTERM_BP_FAT	GO:0072001~renal system development	6	4.137931034482759	0.07482282643801048	33684_AT, 40271_AT, 37983_AT, 2090_I_AT, 37711_AT, 1910_S_AT	133	283	16650	2.6541619065331172	1.0	0.5736565873475261	75.5583406368909
GOTERM_BP_FAT	GO:0048585~negative regulation of response to stimulus	17	11.724137931034482	0.07524692391439994	32717_AT, 34636_AT, 1403_S_AT, 41489_AT, 35367_AT, 40186_AT, 37172_AT, 1910_S_AT, 37096_AT, 33293_AT, 40271_AT, 34249_AT, 34618_AT, 41280_R_AT, 39187_AT, 1372_AT, 39094_AT	133	1369	16650	1.5545620808778702	1.0	0.5745377964091055	75.76051717243229
GOTERM_BP_FAT	GO:0050773~regulation of dendrite development	4	2.7586206896551726	0.0757869366044908	32680_AT, 40058_S_AT, 32717_AT, 37711_AT	133	124	16650	4.038321610477807	1.0	0.575991419788928	76.01566665306339
GAD_DISEASE	Atherosclerosis|Hypertension|Macular Degeneration|Prostatic Neoplasms	2	1.3793103448275863	0.07639777839365725	38229_AT, 32250_AT	115	9	12971	25.064734299516907	1.0	0.7674815448300373	73.70784497090001
GAD_DISEASE	Malaria infection	2	1.3793103448275863	0.07639777839365725	31687_F_AT, 1419_G_AT	115	9	12971	25.064734299516907	1.0	0.7674815448300373	73.70784497090001
GAD_DISEASE	bacterial infection	2	1.3793103448275863	0.07639777839365725	33284_AT, 37061_AT	115	9	12971	25.064734299516907	1.0	0.7674815448300373	73.70784497090001
GAD_DISEASE	leukemia, acute myeloid	2	1.3793103448275863	0.07639777839365725	33284_AT, 1575_AT	115	9	12971	25.064734299516907	1.0	0.7674815448300373	73.70784497090001
GAD_DISEASE	Osteosarcoma	2	1.3793103448275863	0.07639777839365725	1974_S_AT, 33284_AT	115	9	12971	25.064734299516907	1.0	0.7674815448300373	73.70784497090001
GOTERM_BP_FAT	GO:1901568~fatty acid derivative metabolic process	2	1.3793103448275863	0.07652986305729159	34636_AT, 1391_S_AT	133	10	16650	25.037593984962406	1.0	0.5784377935931736	76.36254603881491
GOTERM_BP_FAT	GO:1904994~regulation of leukocyte adhesion to vascular endothelial cell	2	1.3793103448275863	0.07652986305729159	37096_AT, 36703_AT	133	10	16650	25.037593984962406	1.0	0.5784377935931736	76.36254603881491
GOTERM_BP_FAT	GO:0033079~immature T cell proliferation	2	1.3793103448275863	0.07652986305729159	34618_AT, 1901_S_AT	133	10	16650	25.037593984962406	1.0	0.5784377935931736	76.36254603881491
GOTERM_MF_FAT	GO:0015321~sodium-dependent phosphate transmembrane transporter activity	2	1.3793103448275863	0.07670673825557499	37097_AT, 34436_AT	124	10	15478	24.96451612903226	1.0	0.6293139160524094	68.99427688170434
GOTERM_MF_FAT	GO:0005436~sodium:phosphate symporter activity	2	1.3793103448275863	0.07670673825557499	37097_AT, 34436_AT	124	10	15478	24.96451612903226	1.0	0.6293139160524094	68.99427688170434
GOTERM_BP_FAT	GO:0009636~response to toxic substance	5	3.4482758620689653	0.07706006838077581	1403_S_AT, 33284_AT, 31687_F_AT, 31525_S_AT, 1910_S_AT	133	202	16650	3.0987121268517828	1.0	0.5798104858610444	76.60719957221099
GOTERM_BP_FAT	GO:0042542~response to hydrogen peroxide	4	2.7586206896551726	0.07721988499701854	40271_AT, 31687_F_AT, 31525_S_AT, 1910_S_AT	133	125	16650	4.0060150375939845	1.0	0.579355134184526	76.68047348694422
GOTERM_BP_FAT	GO:0001658~branching involved in ureteric bud morphogenesis	3	2.0689655172413794	0.07736759815195078	33684_AT, 2090_I_AT, 1910_S_AT	133	58	16650	6.475239823697174	1.0	0.578843188774308	76.74800523308556
GOTERM_BP_FAT	GO:0070228~regulation of lymphocyte apoptotic process	3	2.0689655172413794	0.07736759815195078	1974_S_AT, 1403_S_AT, 35367_AT	133	58	16650	6.475239823697174	1.0	0.578843188774308	76.74800523308556
GOTERM_BP_FAT	GO:1901992~positive regulation of mitotic cell cycle phase transition	3	2.0689655172413794	0.07736759815195078	39198_S_AT, 1983_AT, 39094_AT	133	58	16650	6.475239823697174	1.0	0.578843188774308	76.74800523308556
GAD_DISEASE	Precursor Cell Lymphoblastic Leukemia-Lymphoma	4	2.7586206896551726	0.07741815895070481	1974_S_AT, 38229_AT, 33284_AT, 1575_AT	115	113	12971	3.9926125432858792	1.0	0.7684182245273868	74.19186653398945
GOTERM_CC_FAT	GO:0044456~synapse part	10	6.896551724137931	0.07835852797240345	33293_AT, 32148_AT, 38236_AT, 40058_S_AT, 32717_AT, 40317_AT, 936_S_AT, 32279_AT, 1355_G_AT, 37711_AT	126	607	14527	1.8994011662874923	0.9999999999817069	0.5864668680258311	66.4476561156081
GOTERM_BP_FAT	GO:0051251~positive regulation of lymphocyte activation	6	4.137931034482759	0.07837721519623597	31512_AT, 1403_S_AT, 34618_AT, 35373_AT, 37711_AT, 1910_S_AT	133	287	16650	2.617170102957743	1.0	0.5825317316389547	77.20466011890083
GOTERM_BP_FAT	GO:0002682~regulation of immune system process	17	11.724137931034482	0.07872921183063473	34636_AT, 1403_S_AT, 32250_AT, 37968_AT, 35367_AT, 1901_S_AT, 35373_AT, 1910_S_AT, 37711_AT, 1786_AT, 31512_AT, 679_AT, 37096_AT, 36703_AT, 34618_AT, 1575_AT, 40294_AT, 37105_AT	133	1378	16650	1.5444089177952136	1.0	0.5830046545622016	77.36186810275846
GOTERM_BP_FAT	GO:0002684~positive regulation of immune system process	13	8.96551724137931	0.07889181309292023	1403_S_AT, 37968_AT, 32250_AT, 35367_AT, 35373_AT, 1910_S_AT, 37711_AT, 679_AT, 37096_AT, 31512_AT, 34618_AT, 1575_AT, 40294_AT, 37105_AT	133	960	16650	1.6952537593984962	1.0	0.582562952442338	77.43414233498727
GOTERM_BP_FAT	GO:0006820~anion transport	8	5.517241379310345	0.07901212870052104	35121_AT, 1391_S_AT, 31687_F_AT, 31525_S_AT, 1419_G_AT, 37097_AT, 1355_G_AT, 34436_AT	133	468	16650	2.1399652978600345	1.0	0.5819205426881574	77.48748072590897
GOTERM_BP_FAT	GO:0051402~neuron apoptotic process	5	3.4482758620689653	0.0792464440604071	1974_S_AT, 33293_AT, 1355_G_AT, 37711_AT, 1910_S_AT	133	204	16650	3.068332596196373	1.0	0.5818285734392852	77.59101586311262
GOTERM_BP_FAT	GO:0060998~regulation of dendritic spine development	3	2.0689655172413794	0.07968008834632553	40058_S_AT, 32717_AT, 37711_AT	133	59	16650	6.3654899961768825	1.0	0.5826897441014587	77.78144131830867
GOTERM_BP_FAT	GO:0033993~response to lipid	12	8.275862068965518	0.07977211300685613	32439_AT, 31793_AT, 1403_S_AT, 33284_AT, 1331_S_AT, 1910_S_AT, 37711_AT, 679_AT, 37096_AT, 34618_AT, 1419_G_AT, 31506_S_AT, 2090_I_AT, 37105_AT	133	860	16650	1.7468088826717958	1.0	0.581919172516423	77.82165481478124
GAD_DISEASE	Glomerulonephritis, IGA	4	2.7586206896551726	0.08064267706986045	37983_AT, 1403_S_AT, 33284_AT, 32250_AT	115	115	12971	3.9231758034026463	1.0	0.7790440240629626	75.66692523290828
KEGG_PATHWAY	hsa05014:Amyotrophic lateral sclerosis (ALS)	3	2.0689655172413794	0.0806458912573526	1974_S_AT, 38236_AT, 1910_S_AT	66	50	6879	6.253636363636364	0.9999995930943358	0.8050407935890806	64.32885852482286
GOTERM_BP_FAT	GO:0048666~neuron development	13	8.96551724137931	0.08127421279798419	38604_AT, 32148_AT, 32680_AT, 40058_S_AT, 32717_AT, 34720_AT, 1112_G_AT, 606_AT, 1355_G_AT, 1901_S_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	965	16650	1.6864700611632708	1.0	0.5878149362482263	78.46840821757534
GAD_DISEASE	Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes	5	3.4482758620689653	0.08140647519665743	38604_AT, 31621_S_AT, 37983_AT, 1419_G_AT, 34623_AT	115	186	12971	3.0320243104254323	1.0	0.7787188922810495	76.00451661431364
GAD_DISEASE	gastric cancer	3	2.0689655172413794	0.08158149244548671	1974_S_AT, 1575_AT, 1901_S_AT	115	54	12971	6.266183574879227	1.0	0.7758913207813718	76.08124973892293
GOTERM_BP_FAT	GO:0009411~response to UV	4	2.7586206896551726	0.08158997358026468	1974_S_AT, 37096_AT, 35373_AT, 1910_S_AT	133	128	16650	3.9121240601503757	1.0	0.5880897174565936	78.60207812307114
GOTERM_BP_FAT	GO:0003300~cardiac muscle hypertrophy	3	2.0689655172413794	0.08201401697306712	32073_AT, 40058_S_AT, 37711_AT	133	60	16650	6.259398496240601	1.0	0.5888670211104791	78.78035386138498
GAD_DISEASE	Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes|Obstetric Labor, Premature|Pre-Eclampsia|Premature Birth	5	3.4482758620689653	0.08264895582879947	38604_AT, 31621_S_AT, 37983_AT, 1419_G_AT, 34623_AT	115	187	12971	3.015810276679842	1.0	0.7768930495279207	76.54428621898525
GOTERM_BP_FAT	GO:0002521~leukocyte differentiation	8	5.517241379310345	0.08322113852018116	34618_AT, 35367_AT, 39187_AT, 35373_AT, 1901_S_AT, 37711_AT, 1910_S_AT, 1786_AT	133	474	16650	2.1128771295326922	1.0	0.5932500288362826	79.28019839134039
GOTERM_CC_FAT	GO:0044433~cytoplasmic vesicle part	10	6.896551724137931	0.0834251085046267	33371_S_AT, 33963_AT, 33685_AT, 31793_AT, 606_AT, 31687_F_AT, 31525_S_AT, 2090_I_AT, 32279_AT, 31506_S_AT, 34623_AT	126	615	14527	1.8746935088398504	0.9999999999965574	0.5975421816032567	68.83389381870218
GOTERM_BP_FAT	GO:0034374~low-density lipoprotein particle remodeling	2	1.3793103448275863	0.08385546751041244	37983_AT, 33284_AT	133	11	16650	22.76144907723855	1.0	0.5949597764761617	79.53838162535737
GOTERM_BP_FAT	GO:0044341~sodium-dependent phosphate transport	2	1.3793103448275863	0.08385546751041244	37097_AT, 34436_AT	133	11	16650	22.76144907723855	1.0	0.5949597764761617	79.53838162535737
GOTERM_BP_FAT	GO:0032429~regulation of phospholipase A2 activity	2	1.3793103448275863	0.08385546751041244	37983_AT, 37954_AT	133	11	16650	22.76144907723855	1.0	0.5949597764761617	79.53838162535737
GAD_DISEASE	chronic obstructive pulmonary disease/COPD	3	2.0689655172413794	0.08419015370494569	1974_S_AT, 37983_AT, 1403_S_AT	115	55	12971	6.152252964426878	1.0	0.7798427370123409	77.19796347275121
GAD_DISEASE	Cardiomyopathies	2	1.3793103448275863	0.08452080364308377	35038_AT, 32084_AT	115	10	12971	22.558260869565217	1.0	0.777751916079696	77.33595347325446
GAD_DISEASE	Hypertrophy, Left Ventricular|Left Ventricular Hypertrophy	2	1.3793103448275863	0.08452080364308377	35038_AT, 37983_AT	115	10	12971	22.558260869565217	1.0	0.777751916079696	77.33595347325446
GOTERM_BP_FAT	GO:0000302~response to reactive oxygen species	5	3.4482758620689653	0.0859896697561521	40271_AT, 33284_AT, 31687_F_AT, 31525_S_AT, 1910_S_AT	133	210	16650	2.9806659505907627	1.0	0.6033986257976144	80.38490236278135
KEGG_PATHWAY	hsa05213:Endometrial cancer	3	2.0689655172413794	0.0862675093552666	1974_S_AT, 35373_AT, 1901_S_AT	66	52	6879	6.013111888111888	0.9999998608968764	0.7937786202552233	66.91274985333938
GAD_DISEASE	rheumatoid arthritis	5	3.4482758620689653	0.08643259561230622	1403_S_AT, 32084_AT, 1575_AT, 31525_S_AT, 1419_G_AT	115	190	12971	2.9681922196796338	1.0	0.7821294074836356	78.11852711777092
GOTERM_BP_FAT	GO:0010517~regulation of phospholipase activity	3	2.0689655172413794	0.08674427938018654	37983_AT, 1403_S_AT, 37954_AT	133	62	16650	6.057482415716711	1.0	0.605564074532906	80.67621418952392
GOTERM_BP_FAT	GO:0014897~striated muscle hypertrophy	3	2.0689655172413794	0.08674427938018654	32073_AT, 40058_S_AT, 37711_AT	133	62	16650	6.057482415716711	1.0	0.605564074532906	80.67621418952392
GOTERM_BP_FAT	GO:0060395~SMAD protein signal transduction	3	2.0689655172413794	0.08674427938018654	40271_AT, 1890_AT, 35915_AT	133	62	16650	6.057482415716711	1.0	0.605564074532906	80.67621418952392
GOTERM_BP_FAT	GO:0050853~B cell receptor signaling pathway	3	2.0689655172413794	0.08674427938018654	31512_AT, 37711_AT, 1910_S_AT	133	62	16650	6.057482415716711	1.0	0.605564074532906	80.67621418952392
GOTERM_BP_FAT	GO:0015914~phospholipid transport	3	2.0689655172413794	0.08674427938018654	33685_AT, 1575_AT, 39469_S_AT	133	62	16650	6.057482415716711	1.0	0.605564074532906	80.67621418952392
GOTERM_BP_FAT	GO:0050769~positive regulation of neurogenesis	7	4.827586206896552	0.08772638206963312	32073_AT, 32717_AT, 606_AT, 1355_G_AT, 39469_S_AT, 37711_AT, 1910_S_AT	133	387	16650	2.2643818849449207	1.0	0.6087049014414236	81.04922952374916
GOTERM_BP_FAT	GO:0002683~negative regulation of immune system process	7	4.827586206896552	0.08855432705937442	36703_AT, 34636_AT, 34618_AT, 35367_AT, 35373_AT, 1901_S_AT, 1786_AT	133	388	16650	2.25854584915898	1.0	0.6111358910372231	81.3583982851884
GOTERM_BP_FAT	GO:0031347~regulation of defense response	10	6.896551724137931	0.0888965025485656	37096_AT, 37983_AT, 37454_AT, 1403_S_AT, 1419_G_AT, 37968_AT, 32250_AT, 1372_AT, 39094_AT, 37711_AT	133	676	16650	1.85189304622503	1.0	0.6114411671487981	81.48477548569537
GOTERM_BP_FAT	GO:0035725~sodium ion transmembrane transport	4	2.7586206896551726	0.08910732704937487	37953_S_AT, 40317_AT, 37097_AT, 34436_AT	133	133	16650	3.7650517270620156	1.0	0.6111776926754281	81.5622367695279
GOTERM_BP_FAT	GO:0022408~negative regulation of cell-cell adhesion	4	2.7586206896551726	0.08910732704937487	36703_AT, 34618_AT, 35367_AT, 1901_S_AT	133	133	16650	3.7650517270620156	1.0	0.6111776926754281	81.5622367695279
GOTERM_BP_FAT	GO:0032835~glomerulus development	3	2.0689655172413794	0.08913967340991208	40271_AT, 37711_AT, 1910_S_AT	133	63	16650	5.961331901181525	1.0	0.6101459058790156	81.57409436464317
GOTERM_MF_FAT	GO:0042379~chemokine receptor binding	3	2.0689655172413794	0.0894768874164624	36703_AT, 37454_AT, 1403_S_AT	124	63	15478	5.943932411674346	1.0	0.6804325801806914	74.724970582419
GOTERM_CC_FAT	GO:0005768~endosome	12	8.275862068965518	0.08996616377394409	33371_S_AT, 33080_S_AT, 32680_AT, 38691_S_AT, 606_AT, 34467_G_AT, 936_S_AT, 40294_AT, 1355_G_AT, 1901_S_AT, 39469_S_AT, 37954_AT	126	811	14527	1.7059479772180142	0.999999999999607	0.6140943327375432	71.68249869369092
GOTERM_BP_FAT	GO:0051098~regulation of binding	6	4.137931034482759	0.09054623408971509	33080_S_AT, 36479_AT, 34720_AT, 39698_AT, 37711_AT, 1910_S_AT	133	300	16650	2.5037593984962405	1.0	0.615008745981874	82.08280172791626
GOTERM_BP_FAT	GO:0002583~regulation of antigen processing and presentation of peptide antigen	2	1.3793103448275863	0.09112339696726192	1575_AT, 40294_AT	133	12	16650	20.864661654135336	1.0	0.6162938782176581	82.28767860199777
GOTERM_BP_FAT	GO:0033077~T cell differentiation in thymus	3	2.0689655172413794	0.09155462620818589	34618_AT, 1901_S_AT, 1910_S_AT	133	64	16650	5.868186090225564	1.0	0.616953696773276	82.43930624615297
GOTERM_BP_FAT	GO:0060675~ureteric bud morphogenesis	3	2.0689655172413794	0.09155462620818589	33684_AT, 2090_I_AT, 1910_S_AT	133	64	16650	5.868186090225564	1.0	0.616953696773276	82.43930624615297
GAD_DISEASE	diabetes, type 2	8	5.517241379310345	0.09194215944999584	38646_S_AT, 38604_AT, 37983_AT, 36328_AT, 1403_S_AT, 1419_G_AT, 1983_AT, 35373_AT	115	439	12971	2.0554224026938694	1.0	0.7999927742560929	80.23407694537025
KEGG_PATHWAY	hsa05217:Basal cell carcinoma	3	2.0689655172413794	0.0920044111051648	1974_S_AT, 33684_AT, 2090_I_AT	66	54	6879	5.790404040404041	0.999999953798692	0.7846472666888846	69.37142029289653
GOTERM_BP_FAT	GO:0007612~learning	4	2.7586206896551726	0.09200851584278459	38236_AT, 34249_AT, 37953_S_AT, 1355_G_AT	133	135	16650	3.7092731829573933	1.0	0.6177041586750184	82.5975764983524
GOTERM_BP_FAT	GO:0050880~regulation of blood vessel size	4	2.7586206896551726	0.09200851584278459	37983_AT, 40317_AT, 31687_F_AT, 1419_G_AT	133	135	16650	3.7092731829573933	1.0	0.6177041586750184	82.5975764983524
GAD_DISEASE	irinotecan pharmacokinetics	2	1.3793103448275863	0.09257300859371811	38229_AT, 1575_AT	115	11	12971	20.507509881422926	1.0	0.7990679700598502	80.46363664248513
GAD_DISEASE	paediatric renal allograft	2	1.3793103448275863	0.09257300859371811	38229_AT, 1575_AT	115	11	12971	20.507509881422926	1.0	0.7990679700598502	80.46363664248513
GAD_DISEASE	Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1|Diabetic Nephropathies|Diabetic Nephropathy	2	1.3793103448275863	0.09257300859371811	38604_AT, 35367_AT	115	11	12971	20.507509881422926	1.0	0.7990679700598502	80.46363664248513
GAD_DISEASE	cerebral infarct	2	1.3793103448275863	0.09257300859371811	37983_AT, 33284_AT	115	11	12971	20.507509881422926	1.0	0.7990679700598502	80.46363664248513
GAD_DISEASE	Essential Hypertension	2	1.3793103448275863	0.09257300859371811	37983_AT, 1419_G_AT	115	11	12971	20.507509881422926	1.0	0.7990679700598502	80.46363664248513
GAD_DISEASE	Eye Diseases|Hypersensitivity|Respiratory Tract Diseases	2	1.3793103448275863	0.09257300859371811	1403_S_AT, 33284_AT	115	11	12971	20.507509881422926	1.0	0.7990679700598502	80.46363664248513
GAD_DISEASE	Carcinoma, Renal Cell|Gilbert Disease|Hyperbilirubinemia|Kidney Neoplasms|Renal Cell Carcinoma	2	1.3793103448275863	0.09257300859371811	38229_AT, 1575_AT	115	11	12971	20.507509881422926	1.0	0.7990679700598502	80.46363664248513
GOTERM_BP_FAT	GO:0035150~regulation of tube size	4	2.7586206896551726	0.09334490392332769	37983_AT, 40317_AT, 31687_F_AT, 1419_G_AT	133	136	16650	3.6819991154356475	1.0	0.6221180945250859	83.05578301490021
GOTERM_BP_FAT	GO:0006979~response to oxidative stress	7	4.827586206896552	0.09361228749303971	1974_S_AT, 40271_AT, 33284_AT, 31687_F_AT, 31525_S_AT, 1910_S_AT, 38945_AT	133	394	16650	2.2241517499332084	1.0	0.6220723276730306	83.14608151087775
GOTERM_BP_FAT	GO:0007420~brain development	10	6.896551724137931	0.09391894878333021	38604_AT, 33684_AT, 33293_AT, 32717_AT, 38816_AT, 34720_AT, 39511_AT, 1355_G_AT, 37711_AT, 1910_S_AT	133	684	16650	1.8302334784329244	1.0	0.6221888307182066	83.24908477057707
GOTERM_BP_FAT	GO:0050778~positive regulation of immune response	10	6.896551724137931	0.09391894878333021	31512_AT, 37096_AT, 679_AT, 1403_S_AT, 37968_AT, 32250_AT, 35367_AT, 35373_AT, 37105_AT, 37711_AT, 1910_S_AT	133	684	16650	1.8302334784329244	1.0	0.6221888307182066	83.24908477057707
GOTERM_BP_FAT	GO:0072171~mesonephric tubule morphogenesis	3	2.0689655172413794	0.09398868289867088	33684_AT, 2090_I_AT, 1910_S_AT	133	65	16650	5.7779063042220935	1.0	0.6213318778425685	83.27242434394937
GOTERM_BP_FAT	GO:1901989~positive regulation of cell cycle phase transition	3	2.0689655172413794	0.09398868289867088	39198_S_AT, 1983_AT, 39094_AT	133	65	16650	5.7779063042220935	1.0	0.6213318778425685	83.27242434394937
GOTERM_MF_FAT	GO:0004714~transmembrane receptor protein tyrosine kinase activity	3	2.0689655172413794	0.0943429142483672	1355_G_AT, 1901_S_AT, 1786_AT	124	65	15478	5.761042183622828	1.0	0.6929904939390596	76.63607769640892
GAD_DISEASE	Esophageal Neoplasms|Head and Neck Neoplasms|Laryngeal Neoplasms|Mouth Neoplasms|Pharyngeal Neoplasms	3	2.0689655172413794	0.09487117055555566	1974_S_AT, 33284_AT, 1901_S_AT	115	59	12971	5.73515106853353	1.0	0.8041442124473495	81.27888497866967
GAD_DISEASE	Endometrial Neoplasms	3	2.0689655172413794	0.09487117055555566	1974_S_AT, 36328_AT, 1901_S_AT	115	59	12971	5.73515106853353	1.0	0.8041442124473495	81.27888497866967
GAD_DISEASE	drug-related genes 	5	3.4482758620689653	0.09558363658291351	38229_AT, 32084_AT, 1575_AT, 1391_S_AT, 40294_AT	115	197	12971	2.862723460604723	1.0	0.8035104907125649	81.52505502248634
GOTERM_BP_FAT	GO:0043549~regulation of kinase activity	11	7.586206896551724	0.09596846354222109	33963_AT, 37096_AT, 32680_AT, 32717_AT, 1403_S_AT, 41280_R_AT, 1983_AT, 40186_AT, 35373_AT, 1901_S_AT, 37711_AT	133	788	16650	1.7475478035189496	1.0	0.6282539267529557	83.92236915120938
GOTERM_BP_FAT	GO:0014896~muscle hypertrophy	3	2.0689655172413794	0.09644139448227268	32073_AT, 40058_S_AT, 37711_AT	133	66	16650	5.690362269309637	1.0	0.6290197855737898	84.07405851334651
GOTERM_BP_FAT	GO:0031589~cell-substrate adhesion	6	4.137931034482759	0.09647597105973477	36703_AT, 34636_AT, 35169_AT, 35373_AT, 1910_S_AT, 1786_AT	133	306	16650	2.4546660769570985	1.0	0.6280249416020112	84.08509550507061
GOTERM_BP_FAT	GO:0061061~muscle structure development	9	6.206896551724138	0.09657420181049478	35038_AT, 31621_S_AT, 40058_S_AT, 32717_AT, 39698_AT, 1890_AT, 1855_AT, 37711_AT, 1910_S_AT	133	589	16650	1.9128891839105402	1.0	0.6272888376404537	84.11641176650889
GOTERM_BP_FAT	GO:0045930~negative regulation of mitotic cell cycle	5	3.4482758620689653	0.09661099982074656	1974_S_AT, 822_S_AT, 38103_AT, 39198_S_AT, 1910_S_AT	133	219	16650	2.858172829333608	1.0	0.6263097157761074	84.12812808674886
GOTERM_BP_FAT	GO:0043524~negative regulation of neuron apoptotic process	4	2.7586206896551726	0.09689951482286602	33293_AT, 1355_G_AT, 37711_AT, 1910_S_AT	133	138	16650	3.628636809414841	1.0	0.6263411552655365	84.21970738569425
GOTERM_BP_FAT	GO:0007611~learning or memory	5	3.4482758620689653	0.09782782114195533	38236_AT, 34249_AT, 37953_S_AT, 1355_G_AT, 37711_AT	133	220	16650	2.845181134654819	1.0	0.6289145677350592	84.5109911656869
KEGG_PATHWAY	hsa05223:Non-small cell lung cancer	3	2.0689655172413794	0.09785043160060382	1974_S_AT, 35373_AT, 1901_S_AT	66	56	6879	5.583603896103896	0.9999999850808015	0.7772528661364732	71.70325080842895
GOTERM_BP_FAT	GO:0046415~urate metabolic process	2	1.3793103448275863	0.09833410208031886	37097_AT, 34436_AT	133	13	16650	19.259687680740313	1.0	0.6297984892552602	84.66770360383335
GOTERM_MF_FAT	GO:0046914~transition metal ion binding	17	11.724137931034482	0.0985166011097546	1974_S_AT, 38236_AT, 32717_AT, 34636_AT, 38229_AT, 33516_AT, 31525_S_AT, 35439_AT, 37172_AT, 36713_AT, 32073_AT, 40058_S_AT, 1391_S_AT, 31687_F_AT, 33922_AT, 37166_AT, 35213_AT	124	1423	15478	1.4912044068641896	1.0	0.7020108301164129	78.16708898970363
GOTERM_BP_FAT	GO:0050764~regulation of phagocytosis	3	2.0689655172413794	0.09891231778478048	33963_AT, 34636_AT, 1786_AT	133	67	16650	5.605431489170687	1.0	0.6309581654069893	84.84484980445308
